var title_f32_61_33744="Ileocolonic intussusception";
var content_f32_61_33744=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71734&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71734&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ileocolonic intussusception",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Surgical view of an ileocolonic intussusception, the most common form of intussusception in infants and young children. The terminal ileum (intussusceptum) is seen extending in to the cecum (intussuscipiens).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David Wesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33744=[""].join("\n");
var outline_f32_61_33744=null;
var title_f32_61_33745="Hypothermia tutorial";
var content_f32_61_33745=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypothermia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 325px; height: 132px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    J waves or Osborne waves are characteristic of hypothermia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33745=[""].join("\n");
var outline_f32_61_33745=null;
var title_f32_61_33746="Patient information: Tdap vaccine (The Basics)";
var content_f32_61_33746=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86733\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/38/14956\">",
"         Recommended vaccine schedule for children age 7 to 18 years (United States, 2013)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?30/34/31266\">",
"         Patient information: Tetanus (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/52/8003\">",
"         Patient information: Vaccines and pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?23/4/23619\">",
"         Patient information: Vaccines for adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/22/28003\">",
"         Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?18/7/18547\">",
"         Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/38/36450\">",
"         Patient information: Whooping cough (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?38/25/39318\">",
"         Patient information: Adult vaccines (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/18/37156\">",
"         Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?41/36/42566\">",
"         Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/42/18084\">",
"         Patient information: Why does my child need vaccines? (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Tdap vaccine (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H81091501\">",
"      <span class=\"h1\">",
"       What is the Tdap vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The Tdap vaccine is a treatment to prevent 3 different diseases: tetanus, diphtheria, and pertussis. All the vaccines are given together in 1 shot.",
"     </p>",
"     <p>",
"      All 3 of these diseases can be serious and even deadly. Diphtheria can cause a thick covering in the back of the throat that can lead to breathing problems. Tetanus is a serious infection that causes muscle stiffness and spasms. Pertussis can cause a severe cough. Another name for pertussis is &ldquo;whooping cough.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81091516\">",
"      <span class=\"h1\">",
"       Why should I get the Tdap vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The Tdap vaccine can help keep you from getting diphtheria, tetanus, or whooping cough. If you do get sick, being vaccinated can keep you from getting severely ill. Being vaccinated also helps keep people around you from getting sick.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81091533\">",
"      <span class=\"h1\">",
"       Who should get the Tdap vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The following people should get a Tdap vaccine:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Children age 7 to 18",
"        </strong>",
"        &ndash; Doctors recommend a Tdap vaccine as a &ldquo;booster.&rdquo; This is given to children who got diphtheria, tetanus, and whooping cough vaccines usually given before age 7 (",
"        <a class=\"graphic graphic_table graphicRef73404 \" href=\"mobipreview.htm?14/38/14956\">",
"         table 1",
"        </a>",
"        ). A booster is a vaccine dose given a number of years after the first dose. It reminds the body how to prevent infection. Boosters are important because some vaccines, including shots given to young children for diphtheria, tetanus, and whooping cough, stop working well over time. If your child missed the earlier vaccine, he or she can get a Tdap vaccine whenever your doctor recommends it.",
"       </li>",
"       <li>",
"        <strong>",
"         Adults age 19 and older",
"        </strong>",
"        who have never had a Tdap vaccine &ndash; This vaccine is especially important for adults age 65 and older who spend time with children younger than 1. These adults include grandparents, childcare workers, doctors, nurses, and other health care workers.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you don&rsquo;t know if you have had a Tdap vaccine, your doctor will probably give you 1. This vaccine is important to protect you and other people, especially babies. Whooping cough can be very serious for babies and even cause death.",
"     </p>",
"     <p>",
"      After getting the Tdap vaccine, adults should get vaccines against diphtheria and tetanus every 10 years. These are also given together in 1 shot.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81091573\">",
"      <span class=\"h1\">",
"       What side effects can the Tdap vaccine cause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The Tdap vaccine might not cause any side effects. If it does, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Redness, swelling, or soreness where the shot was given",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Tiredness",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Like all vaccines, the Tdap vaccine sometimes causes more serious side effects, such as severe allergic reactions. But serious side effects are rare. If you ever had a severe allergic reaction to latex, tell your doctor or nurse. Some Tdap vaccines contain latex, but others do not.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81091590\">",
"      <span class=\"h1\">",
"       Should pregnant women get the Tdap vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The Tdap vaccine is safe to use in pregnancy and",
"      <strong>",
"       all",
"      </strong>",
"      pregnant women should get it after 20 weeks of pregnancy, even if they have had the Tdap vaccine or the pertussis vaccine before.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H81091607\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/34/31266?source=see_link\">",
"       Patient information: Tetanus (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23619?source=see_link\">",
"       Patient information: Vaccines for adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/22/28003?source=see_link\">",
"       Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/7/18547?source=see_link\">",
"       Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/52/8003?source=see_link\">",
"       Patient information: Vaccines and pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/38/36450?source=see_link\">",
"       Patient information: Whooping cough (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/25/39318?source=see_link\">",
"       Patient information: Adult vaccines (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/18/37156?source=see_link\">",
"       Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/36/42566?source=see_link\">",
"       Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/42/18084?source=see_link\">",
"       Patient information: Why does my child need vaccines? (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/61/33746?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86733 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33746=[""].join("\n");
var outline_f32_61_33746=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81091501\">",
"      What is the Tdap vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81091516\">",
"      Why should I get the Tdap vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81091533\">",
"      Who should get the Tdap vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81091573\">",
"      What side effects can the Tdap vaccine cause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81091590\">",
"      Should pregnant women get the Tdap vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81091607\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86733\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/38/14956\">",
"      Recommended vaccine schedule for children age 7 to 18 years (United States, 2013)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/25/39318?source=related_link\">",
"      Patient information: Adult vaccines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/34/31266?source=related_link\">",
"      Patient information: Tetanus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/52/8003?source=related_link\">",
"      Patient information: Vaccines and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23619?source=related_link\">",
"      Patient information: Vaccines for adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/22/28003?source=related_link\">",
"      Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/18/37156?source=related_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/7/18547?source=related_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/36/42566?source=related_link\">",
"      Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/38/36450?source=related_link\">",
"      Patient information: Whooping cough (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/42/18084?source=related_link\">",
"      Patient information: Why does my child need vaccines? (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_61_33747="Stress fractures of the metatarsal shaft";
var content_f32_61_33747=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stress fractures of the metatarsal shaft",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     James R Clugston, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     Robert L Hatch, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33747/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/61/33747/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metatarsal stress fractures were first described by Briethaupt in 1855 and termed \"march fractures\" since they commonly occur in military recruits. This topic will discuss stress fractures of the metatarsal shaft. An overview of stress fractures in general is found elsewhere, as is a discussion of traumatic, non-stress fractures of the metatarsal shaft. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=see_link\">",
"     \"Overview of stress fractures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/20/12614?source=see_link\">",
"     \"Metatarsal shaft fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A range of factors that increase weight-bearing loads on particular metatarsals or decrease the ability to handle loads predispose individuals to metatarsal stress fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. These factors include anatomic abnormalities, such as dorsal or plantar-flexed metatarsals; a long second metatarsal, or excessively tight gastrocnemius muscles; physiologic abnormalities such as obesity or osteopenia associated with amenorrhea; and external factors such as poorly fitting shoes, increases in training volume or intensity, and changes in training surfaces. Such causative factors must be effectively addressed or injury will recur. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of stress fractures\", section on 'Epidemiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/3/36919?source=see_link&amp;anchor=H7#H7\">",
"     \"Amenorrhea and infertility associated with exercise\", section on 'Consequences of exercise-induced amenorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In athletes, the incidence of metatarsal stress fractures is second only to the incidence of tibial stress fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. For reference purposes, the metatarsals are numbered from first (largest) to fifth (smallest). Stress fractures of the second, third, and fourth metatarsals account for 90 percent of all metatarsal stress fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. They are seen more often in the pes planus (flat) foot, compared with tibial stress fractures that occur more frequently in a pes cavus (high arched) foot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. They may occur several weeks after an abrupt increase in activity or with chronic overload.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metatarsal stress fractures result from repetitive stress to the forefoot, usually from running, jumping, dancing, and other repetitive weight-bearing activities.",
"   </p>",
"   <p>",
"    A disproportionate number of stress fractures occur in the second metatarsal shaft, especially in the neck. Several mechanisms are proposed to explain this phenomenon. The base of the second metatarsal is recessed and more firmly fixed at the tarsal-metatarsal joint, via ligamentous attachment to the first and second cuneiforms, than the other metatarsals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The resulting increased rigidity probably allows less motion in the sagittal plane at the metatarsal base and increases bending forces in the second metatarsal diaphysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. Another proposed mechanism states that if the second metatarsal is longer than the first (ie, Morton's foot), the second metatarsal is subjected to greater amounts of stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/1,2,6\">",
"     1,2,6",
"    </a>",
"    ]. It is debated whether this increased stress is due to the increased length of the second metatarsal or to the decreased mobility of the first metatarsal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. As the forefoot pronates during normal gate, the first metatarsal dorsiflexes and transfers load to the lesser metatarsals. The second metatarsal receives a greater share of this load than the other metatarsals.",
"   </p>",
"   <p>",
"    First metatarsal stress fractures are rare and usually occur around the metaphyseal-diaphyseal junction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. Proximal metatarsal stress fractures, particularly of the fifth metatarsal, have a worse prognosis and generally require more aggressive treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/1,2,7\">",
"     1,2,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION AND EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with stress fractures of the metatarsal shaft describe a history of gradually worsening pain in the forefoot. Initially the pain is intermittent and occurs only with use. The patient may present with poorly defined forefoot pain or point tenderness over a metatarsal shaft (",
"    <a class=\"graphic graphic_figure graphicRef78924 graphicRef61079 graphicRef71857 \" href=\"mobipreview.htm?30/38/31338\">",
"     figure 1A-C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Gentle axial loading of the metatarsal head may produce pain at the fracture site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. This is done by holding the toe in line with its corresponding metatarsal, ie without angulation, and pushing the toe in toward the metatarsal. This maneuver should produce pain if the metatarsal is fractured, but it should not produce pain in patients with soft tissue injury alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Weight-bearing is possible but usually produces pain. If the causative activity continues, the injury can progress, with swelling, severe pain even with normal activities, and frank fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early stress fractures are often not seen on radiographs. The first radiographic evidence of a stress fracture usually occurs no earlier than two to six weeks after the onset of symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4,8\">",
"     4,8",
"    </a>",
"    ]. Narrowing of the medullary canal, cortical hypertrophy, faint lucency, and periosteal thickening develop first, followed by callus formation, sometimes as early as four to five weeks after symptom onset. Distinct, well-organized callus is usually seen after several months. (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54301 \" href=\"mobipreview.htm?12/36/12866\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    MRI and technetium bone scanning beyond 48 to 72 hours after symptom onset are useful in early diagnosis but often not necessary, since a presumptive clinical diagnosis may be made in patients with an appropriate history and examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=see_link&amp;anchor=H23#H23\">",
"     \"Overview of stress fractures\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most metatarsal shaft stress fractures do not require casting or immobilization - fractures of the fifth metatarsal being a notable exception (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Fifth metatarsal stress fractures'",
"    </a>",
"    below). They usually respond well to cessation of the causative activity for four to eight weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/6\">",
"     6",
"    </a>",
"    ]. Crutches and partial weight-bearing for several weeks may be helpful in patients who have pain with walking. A short-leg cast and non-weight-bearing can be used for short periods of time in patients with severe pain.",
"   </p>",
"   <p>",
"    Higher impact activities can be resumed gradually after four to eight weeks if there is no pain with normal activities. Recurrence is possible if predisposing factors are not corrected, resumption of normal activities occurs prematurely, or the intensity of activity is increased too rapidly.",
"   </p>",
"   <p>",
"    The use of a custom orthotic may benefit certain foot structures such as a rigid or long second metatarsal, but evidence for injury prevention measures is lacking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33747/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    may be used for pain. The effect of nonsteroidal antiinflammatory drugs (NSAIDs) on fracture healing is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/48/13066?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview of selective COX-2 inhibitors\", section on 'Possible effect on fracture healing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fifth metatarsal stress fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress fractures of the proximal diaphysis of the fifth metatarsal, although relatively uncommon, have high rates of nonunion. They generally occur as a result of repetitive stress. Referral to an orthopedist should be strongly considered with such injuries, as many will be treated with internal fixation either initially or following nonunion. These fractures are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/873?source=see_link&amp;anchor=H29#H29\">",
"     \"Proximal fifth metatarsal fractures\", section on 'Stress fractures of the proximal diaphysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stress fractures of the metatarsal shaft are common. Most can generally be managed with activity reduction alone, if recognized early. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Numerous potential predisposing factors exist. These must be corrected, or injury will likely recur. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stress fractures generally present with a gradual progression of symptoms. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical presentation and examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early radiographs of metatarsal stress fractures are often unremarkable, and diagnosis may be made on clinical grounds. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Radiographic findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MRI and Technetium bone scan obtained beyond 48 to 72 hours after symptom onset are useful in early diagnosis, but often not necessary.",
"     </li>",
"     <li>",
"      Stress fractures of the proximal shaft of the fifth metatarsal have higher rates of delayed healing and nonunion, require more prolonged immobilization, and must be closely followed. These fractures are generally referred to an orthopedist because management often involves surgical fixation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Fifth metatarsal stress fractures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     DiGiovanni CW, Benirschke SK, Hansen ST. Metatarsal fractures. In: Skeletal Trauma: Fractures, Dislocations, Ligamentous Injuries, Browner BD, Jupiter JB, Levine AM, Trafton PG (Eds), WB Saunders, Philadelphia 2002. p.2458.",
"    </li>",
"    <li>",
"     Early JS. Metatarsal fractures. In: Rockwood and Green's Fractures in Adults, Bucholz RW, Heckman JD, Rockwood CA, Green DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2001. p.2215.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33747/abstract/3\">",
"      Sanderlin BW, Raspa RF. Common stress fractures. Am Fam Physician 2003; 68:1527.",
"     </a>",
"    </li>",
"    <li>",
"     Simons SM. Foot injuries in the runner. In: Textbook of Running Medicine, O'Connor FG, Wilder RP (Eds), McGraw-Hill, New York 2001. p.213.",
"    </li>",
"    <li>",
"     Simons SM, Sloan BK. Foot injuries. In: Pediatric Sports Medicine for Primary Care, Birrer RB, Griesemer BA, Cataletto MD (Eds), Lippincott Williams &amp; Wilkins, Baltimore 2002. p.431.",
"    </li>",
"    <li>",
"     Clinical Sports Medicine, 2nd, Brukner P, Khan K (Eds), McGraw-Hill, New York 2001. p.596.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33747/abstract/7\">",
"      Nielsen, Lindblad, Faun. Long-term results after fracture of the fifth metatarsal. J Foot Ankle Surg 1998; 4:227.",
"     </a>",
"    </li>",
"    <li>",
"     Eiff MP, Hatch RL, Calmbach W. Fracture Management for Primary Care, 2nd, WB Saunders, Philadelphia 2002.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 223 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-422ACB6E1F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33747=[""].join("\n");
var outline_f32_61_33747=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL PRESENTATION AND EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fifth metatarsal stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/223\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/223|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?12/36/12866\" title=\"picture 1\">",
"      Metatarsal stress fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/223|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/7/30835\" title=\"figure 1A\">",
"      Foot anatomy lateral view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/40/38530\" title=\"figure 1B\">",
"      Foot anatomy medial view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/20/2375\" title=\"figure 1C\">",
"      Foot anatomy superior view",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/3/36919?source=related_link\">",
"      Amenorrhea and infertility associated with exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/20/12614?source=related_link\">",
"      Metatarsal shaft fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/48/13066?source=related_link\">",
"      Overview of selective COX-2 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=related_link\">",
"      Overview of stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/873?source=related_link\">",
"      Proximal fifth metatarsal fractures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_61_33748="Hepatic iron concentration and hepatic iron index in the diagnosis of iron overload and hereditary hemochromatosis";
var content_f32_61_33748=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hepatic iron concentration and hepatic iron index in the diagnosis of iron overload and hereditary hemochromatosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33748/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33748/contributors\">",
"     Bruce R Bacon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33748/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33748/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33748/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33748/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/61/33748/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of iron overload is suggested by a variety of laboratory tests, including elevations in the concentrations of plasma iron and ferritin and by an increase in transferrin saturation. Optimal strategies for confirming the diagnosis in patients suspected of having iron overload continue to evolve.",
"   </p>",
"   <p>",
"    The availability of genetic testing for hereditary causes of iron overload has permitted a means to establish a diagnosis, in some cases obviating the need for further confirmation by liver biopsy before initiating specific treatment. On the other hand, the relationship between genetic predisposition to iron overload and its phenotypic expression is incompletely understood. As a result, genetic testing does not always provide a definitive appraisal of whether total body iron stores are increased. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/13/2266?source=see_link\">",
"     \"Genetics of hereditary hemochromatosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, there continues to be a need for tests to confirm the presence and degree of iron overload. As a general rule, there have been three such approaches",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Imaging tests",
"     </li>",
"     <li>",
"      Quantitative phlebotomy",
"     </li>",
"     <li>",
"      Direct measurement of hepatic iron concentration (HIC) by percutaneous liver biopsy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While imaging studies, such as CT scan, magnetic resonance imaging, and magnetic susceptibility measurements can support the presence of iron overload (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69367 \" href=\"mobipreview.htm?35/31/36337\">",
"     image 1",
"    </a>",
"    ), they are not accurate enough at lower levels of iron overload to confidently establish a diagnosis. Thus, their role in diagnosis is limited. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=see_link&amp;anchor=H5#H5\">",
"     \"Pathophysiology and diagnosis of iron overload syndromes\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One can clinically confirm the presence of iron overload in most patients by determining the number of weekly 500 mL phlebotomies, each of which removes 200 to 250 mg of elemental iron, which are required to produce iron-limited erythropoiesis. This procedure is called quantitative phlebotomy. Normal iron stores are approximately 750 mg in women and approximately 1000 mg in men. Usually patients with normal iron stores will achieve iron-limited erythropoiesis after six or fewer therapeutic phlebotomies. Thus, patients with significant degrees of iron overload due to hemochromatosis will require many more than six therapeutic phlebotomies. However, in most patients it is desirable to secure a clear diagnosis before proceeding with phlebotomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=see_link&amp;anchor=H14#H14\">",
"     \"Pathophysiology and diagnosis of iron overload syndromes\", section on 'Response to phlebotomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A traditional means of confirming the presence of iron overload has been a liver biopsy with quantitative determination of iron concentration by histochemical analysis (ie, Perls' Prussian Blue staining) and biochemical determination of iron concentration (with calculation of the hepatic iron index) (",
"    <a class=\"graphic graphic_picture graphicRef70985 graphicRef50096 \" href=\"mobipreview.htm?30/58/31658\">",
"     picture 1A-B",
"    </a>",
"    ). An additional benefit of a liver biopsy is that it permits determination of the degree of histologic injury, particularly whether advanced fibrosis or cirrhosis has developed.",
"   </p>",
"   <p>",
"    The availability of genetic testing for hereditary hemochromatosis (eg, HFE gene mutation analysis) has diminished the need for quantitative hepatic iron determination as a tool for the definitive diagnosis of hereditary hemochromatosis. Both the hepatic iron concentration and hepatic iron index can provide complementary information when genetic testing is positive. In the absence of a positive genetic test, HIC and HII assume increased importance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HEPATIC IRON CONCENTRATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hepatic iron concentration (HIC) is usually reported as micrograms of iron per gram dry weight of liver. This is then typically converted to micromoles of iron per gram by dividing by 56, the molecular weight of iron. Normal values for HIC are &lt;25",
"    <span class=\"nowrap\">",
"     micromoles/g",
"    </span>",
"    (&lt;1400",
"    <span class=\"nowrap\">",
"     microg/g),",
"    </span>",
"    while values &gt;71",
"    <span class=\"nowrap\">",
"     micromoles/g",
"    </span>",
"    are consistent with an increase in liver iron, such as is seen in patients with HH or transfusional iron overload. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathophysiology and diagnosis of iron overload syndromes\", section on 'Liver biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The degree of total body iron overload can be roughly estimated from the hepatic iron concentration (",
"    <a class=\"graphic graphic_figure graphicRef55632 \" href=\"mobipreview.htm?41/44/42701\">",
"     figure 1",
"    </a>",
"    ). As a result, the hepatic iron concentration (HIC) can be used to estimate the number of phlebotomy sessions that will be required in patients in whom phlebotomy is needed:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Phlebotomy units = ([HIC -1400] X",
"    <span class=\"nowrap\">",
"     3)/1000",
"    </span>",
"   </p>",
"   <p>",
"    where HIC, hepatic iron concentration, is measured in",
"    <span class=\"nowrap\">",
"     microg/g",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HEPATIC IRON INDEX",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hepatic iron index (HII) was developed in 1986 with the hope that it could help distinguish patients with hereditary hemochromatosis from other causes of iron overload. The availability of genetic testing has demonstrated that the HII is not as accurate as originally believed.",
"   </p>",
"   <p>",
"    The HII is calculated by taking the hepatic iron concentration (HIC, in micromoles per gram dry weight) and dividing by the patient's age in years. The rationale is based upon the concept that, in individuals with hereditary hemochromatosis, there is a progressive increase in iron concentration with age. In contrast, progressive iron deposition does not occur in other types of liver disease with mild iron overload, such as porphyria cutanea tarda, alcoholic liver disease, or chronic viral hepatitis (including hepatitis C virus infection, which is also responsible for many cases of acquired porphyria cutanea tarda). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/45/30421?source=see_link\">",
"     \"Porphyria cutanea tarda and hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to the availability of genetic testing, several studies showed that the majority of patients with typical phenotypic homozygous HH generally had an HII &ge;1.9, while normal individuals, or those with one of the causes of mild iron overload, and most heterozygotes for HH generally had an HII below 1.5 (",
"    <a class=\"graphic graphic_figure graphicRef80174 \" href=\"mobipreview.htm?21/45/22238\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33748/abstract/1-6\">",
"     1-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the larger studies, for example, focused on 509 patients undergoing liver biopsy; there was a clinical suspicion of iron overload in one-third of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33748/abstract/6\">",
"     6",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      55 patients met clinical and histologic criteria consistent with homozygous HH.",
"     </li>",
"     <li>",
"      The HII was &ge;1.9 in 93 percent of these 55 patients, but in none of the 454 patients with other liver diseases.",
"     </li>",
"     <li>",
"      The hepatic iron concentration was equally useful; a value above 71",
"      <span class=\"nowrap\">",
"       micromoles/g",
"      </span>",
"      dry weight was present in 54 of the 55 patients with homozygous HH and in only one of the 454 other patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It should be recognized that, with the advent of genetic testing, we now know that from 30 to 50 percent of patients who are C282Y homozygotes have no phenotypic expression (eg, elevated transferrin saturation or elevated ferritin levels) and thus would not have an elevated HII. For these reasons, HII has lessened in importance in the diagnosis of hemochromatosis, which now requires genetic testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33748/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Examples",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential utility of the HIC and HII can be illustrated from the following two case histories of patients with suspected HH who underwent liver biopsy. Both were referred by primary care clinicians because of abnormal iron studies. The serum ferritin concentration was above 500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (normal range 24 to 218",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    in both patients and HFE gene mutation analysis was negative in both.",
"   </p>",
"   <p>",
"    The first patient was a 41 year-old man who had a hepatic iron concentration (HIC) of 9240 microg per gram dry weight. His HIC and HII can be calculated as follows. The iron concentration should be divided by 56 (the molecular weight of iron) to convert from units of",
"    <span class=\"nowrap\">",
"     microg/g",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     micromoles/g.",
"    </span>",
"    This value should then be divided by the patient's age to calculate the HII:",
"   </p>",
"   <p>",
"    &nbsp; HIC = 9240 &divide; 56 = 165",
"    <span class=\"nowrap\">",
"     micromoles/g",
"    </span>",
"    (normal: &lt;25)",
"    <br/>",
"    &nbsp; HII = 9240 &divide; 56 &divide; 41 = 4.0 (normal: &lt; 1.5)",
"   </p>",
"   <p>",
"    The value for HIC is markedly increased, consistent with a marked degree of hepatic iron overload. The value for HII is also elevated. Both the HIC and HII are consistent with values seen in patients with HH. From the formula noted above, approximately 24 units of blood would need to be removed to deplete this patient's iron stores. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Hepatic iron concentration'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The second patient was a 61 year-old woman who had a hepatic iron concentration of 3447 microg per gram dry weight. Thus:",
"   </p>",
"   <p>",
"    &nbsp; HIC = 3447 &divide; 56 = 62",
"    <span class=\"nowrap\">",
"     micromoles/g",
"    </span>",
"    (normal: &lt;25)",
"    <br/>",
"    &nbsp; HII = 3447 &divide; 56 &divide; 61 = 1.0 (normal: &lt;1.5)",
"   </p>",
"   <p>",
"    There was no previous history of excessive blood loss or donation. The HIC is increased, but not to the degree usually seen in severe forms of iron overload. From the formula noted above, approximately six units of blood would need to be removed to deplete this patient's iron stores. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Hepatic iron concentration'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Test limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The availability of genetic testing for hereditary hemochromatosis permits a more detailed understanding of the test characteristics of the HII. As a result, it has become increasingly apparent that the HII is not as accurate as was previously believed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some patients with iron overload",
"      <strong>",
"       not",
"      </strong>",
"      due to genetic HH may have a HII &gt;1.9 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33748/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 66 patients with symptomatic HH who were C282Y homozygotes and had an elevated hepatic iron concentration, only 85 percent had a HII &gt;1.9 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33748/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prospective population studies have shown that 30 to 50 percent of patients who are asymptomatic C282Y homozygotes may not have phenotypic expression of HH [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33748/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It is not possible to differentiate between patients with homozygous and heterozygous HH when values for HII are in the range of 1.5 to 1.9.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of the hepatic iron index has greatly diminished with the availability of genetic testing for hereditary hemochromatosis. Thus, its role is generally limited to settings in which genetic testing is unavailable or when serum iron studies are abnormal and genetic testing is negative.",
"   </p>",
"   <p>",
"    Quantitative iron determination in liver biopsy specimens remains a useful tool for establishing the presence of iron overload in some settings. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with suspected iron overload in whom results of genetic testing remain equivocal.",
"     </li>",
"     <li>",
"      In patients diagnosed with hereditary hemochromatosis in whom it is unclear whether iron overload is present (eg, patients with mildly elevated iron saturation).",
"     </li>",
"     <li>",
"      In patients with hemochromatosis who are already undergoing a liver biopsy to determine the degree of histologic injury. The degree of iron overload may help provide some insight into potential injury to other organs and may help to predict the amount of phlebotomy that will be required, as noted above. A liver biopsy is, however, not necessary in all patients diagnosed with hereditary hemochromatosis by genetic testing. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=see_link&amp;anchor=H12#H12\">",
"       \"Pathophysiology and diagnosis of iron overload syndromes\", section on 'Patients who may not need a liver biopsy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114314225\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/1\">",
"      Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/2\">",
"      Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990; 12:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/3\">",
"      Olynyk J, Hall P, Sallie R, et al. Computerized measurement of iron in liver biopsies: a comparison with biochemical iron measurement. Hepatology 1990; 12:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/4\">",
"      Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990; 99:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/5\">",
"      Deugnier YM, Turlin B, Powell LW, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993; 17:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/6\">",
"      Kowdley KV, Trainer TD, Saltzman JR, et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology 1997; 113:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/7\">",
"      Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G--&gt; A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/8\">",
"      Cotler SJ, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998; 29:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33748/abstract/9\">",
"      Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130:953.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3614 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-3399DFF423-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33748=[""].join("\n");
var outline_f32_61_33748=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HEPATIC IRON CONCENTRATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HEPATIC IRON INDEX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Examples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Test limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H114314225\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/3614\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3614|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?35/31/36337\" title=\"diagnostic image 1\">",
"      Hemochromatosis of liver CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3614|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/44/42701\" title=\"figure 1\">",
"      Iron stores thalassemia major",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/45/22238\" title=\"figure 2\">",
"      Hepatic iron index",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3614|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/40/18056\" title=\"picture 1A\">",
"      Iron overload liver Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/53/3927\" title=\"picture 1B\">",
"      Iron overload liver Perls",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/13/2266?source=related_link\">",
"      Genetics of hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/19/35129?source=related_link\">",
"      Pathophysiology and diagnosis of iron overload syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/45/30421?source=related_link\">",
"      Porphyria cutanea tarda and hepatitis C virus infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_61_33749="Endosc acute lye ingestion";
var content_f32_61_33749=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopy in acute lye ingestion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 228px; height: 665px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Esophagus reveals progressive circumferential mucosal ulceration and exudates (Grade 2B). B) Stomach at the level of the incisura reveals diffuse deep ulceration with hemorrhage and exudates (Grade 2B). C) Duodenum only reveals erythema and edema (Grade 1). In this patient, endoscopy was performed eight hours after ingestion in order to stage the disease. A nasogastric tube was left in place during and after the procedure (A).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Maximilian Lee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33749=[""].join("\n");
var outline_f32_61_33749=null;
var title_f32_61_33750="Gonorrhea penis edema and discharge";
var content_f32_61_33750=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gonorrhea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 436px; height: 382px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 23-year-old man complained of profuse and purulent penile discharge with dysuria five days after unprotected sexual contact. Gram stain of the urethral discharge showed polymorphonuclear cells with intracellular Gram negative diplococci.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; SV Rakhesh, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33750=[""].join("\n");
var outline_f32_61_33750=null;
var title_f32_61_33751="Microbiology, epidemiology, and pathogenesis of Brucella";
var content_f32_61_33751=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microbiology, epidemiology, and pathogenesis of Brucella",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Mile Bosilkovski, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33751/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/61/33751/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellosis is a zoonotic infection transmitted to humans by contact with fluids from infected animals (sheep, cattle, goats, pigs, or other animals) or derived food products such as unpasteurized milk and cheese. It is one of the most widespread zoonoses worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/1\">",
"     1",
"    </a>",
"    ]. Brucellosis has high morbidity both for humans and animals; it is an important cause of economic loss and public health problems in many developing countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/2\">",
"     2",
"    </a>",
"    ]. The prevalence of brucellosis has been increasing due to growing international tourism and migration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The microbiology, epidemiology, and pathogenesis of Brucella spp will be reviewed here. The clinical manifestations, diagnosis, and treatment of brucellosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16058?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of brucellosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2037820\">",
"    <span class=\"h1\">",
"     TAXONOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Six species are recognized within the genus Brucella based on phenotypic characteristics, antigenic variation, and prevalence of infection in different animal hosts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. B. melitensis (small ruminants), B. abortus (cattle), B. suis (swine), and B. canis (dogs) are known to cause human disease. B. neotomae (desert wood rats) and B. ovis (sheep) are not pathogenic to humans. The majority of human cases worldwide are attributed to B. melitensis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7\">",
"     7",
"    </a>",
"    ]. In general, B. melitensis and B. suis are more virulent for humans than B. abortus or B. canis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/8\">",
"     8",
"    </a>",
"    ]. B. melitensis, B. abortus, and B. suis have 3, 7, and 5 biotypes respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/5,9\">",
"     5,9",
"    </a>",
"    ]. Two additional Brucella species, B. pinipedialis and B. ceti, have been isolated from marine mammals and detected as sporadic human pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. B. pinipedialis and B. ceti differ phenotypically from the other species by their pattern of metabolic activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The genome of most Brucella species consists of two circular chromosomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/9\">",
"     9",
"    </a>",
"    ]. Natural plasmids have not been detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/14\">",
"     14",
"    </a>",
"    ]. Sequencing and annotation of the genomes of B. suis, B. melitensis, and B. abortus has been completed; the majority of the open reading frames share greater than 99 percent sequence identity between species [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The taxonomy of the genus Brucella is confounded by a dichotomy between the traditional (phenotypically and host preference based) and molecular species definitions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/9,18\">",
"     9,18",
"    </a>",
"    ]. DNA relatedness indicates that the six classical species together with the marine mammal-derived strains represent a single genomic species [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. However, some argue that the concept of genomic species is not scientifically valid in all bacterial groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/22\">",
"     22",
"    </a>",
"    ] and differences at the genetic level support the validity of the classical species [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The International Committee on Systematic Bacteriology subcommittee on the taxonomy of Brucella retains the traditional taxonomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellae are small, nonmotile, facultative intracellular aerobic rods, 0.5 to 0.7 micron in diameter and 0.6 to 1.5 micron in length [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/18,25\">",
"     18,25",
"    </a>",
"    ]. Gram staining demonstrates single, tiny, gram-negative coccobacilli. With the exception of F. tularensis, Brucella is the smallest gram-negative organism likely to be seen in the clinical laboratory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/9\">",
"     9",
"    </a>",
"    ]. Brucella lacks capsules, spores, and flagella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most strains require complex media for growth, which may be improved by adding serum or blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/9\">",
"     9",
"    </a>",
"    ]. The optimum growth temperature is 35 to 37&deg;C. Some biovars of B. abortus and B. suis require supplementary carbon dioxide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26\">",
"     26",
"    </a>",
"    ]. Bacterial growth is slow. The classic biphasic (solid and liquid) blood culture technique of Ruiz-Castaneda is still used in developing settings, but automated blood culture systems are more effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7\">",
"     7",
"    </a>",
"    ]. Colonies are usually 0.5 to 1.0 mm in diameter, raised and convex, with an entire edge and a smooth, shiny surface [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Brucella organisms can survive up to two days in milk at 8&deg;C, up to three weeks in frozen meat and up to three months in goat cheese. Brucellae shed in animal excretions may remain viable for &gt;40 days if the soil is damp. The organisms are sensitive to heat, ionizing radiation, most commonly-used disinfectants, and to pasteurization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human brucellosis due to B. melitensis infection is the most common zoonosis worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/4\">",
"     4",
"    </a>",
"    ]. This infection appears to be re-emerging; it is estimated that the number of Brucella infected individuals may be up to 26 times higher than the 500,000 cases reported annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Major endemic areas include countries of the Mediterranean basin, Persian Gulf, the Indian subcontinent, and parts of Mexico and Central and South America [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/29\">",
"     29",
"    </a>",
"    ]. New foci that have emerged include the Balkan Peninsula and many of the former Soviet Union Asian Republics, such as Kazakhstan, Kyrgyzstan, and Tajikistan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Animal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellosis is almost invariably transmitted to humans from infected domestic animals and their contaminated products [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/30\">",
"     30",
"    </a>",
"    ]. Abortion or premature births are characteristic (but not specific) signs of brucellosis in animal hosts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/8\">",
"     8",
"    </a>",
"    ]. Infected animals excrete Brucellae in urine, milk, placenta, and the products of miscarriages. In this way the bacteria are disseminated and infect other animals and humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bovine B. melitensis infection is emerging as an increasingly serious public health problem in some countries. A related problem has been observed in some South American countries, where B. suis biovar 1 has become established in cattle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/14,18,30\">",
"     14,18,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Brucellosis vaccines for animal use (B. abortus B19 and RB51 for cattle; B. melitensis Rev 1 for small ruminants) are live attenuated vaccines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/6,8,18,31\">",
"     6,8,18,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16058?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical manifestations, diagnosis, and treatment of brucellosis\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Human infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of Brucella infection in humans depends upon several factors, including geography, husbandry practices, slaughtering, food preparation techniques, and trade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/32\">",
"     32",
"    </a>",
"    ]. All age groups and both sexes are affected. Humans acquire the infection through the consumption of products from infected animals, such as unpasteurized milk, cheese, and insufficiently cooked or raw meat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Infection may also result from the entry of the bacteria from infected animals or their secretions through skin lesions, conjunctiva, or from inhalation of contaminated dust or aerosols [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7,26\">",
"     7,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Family history of brucellosis in endemic regions varies from 9 to 51 percent; screening household members of an index case detects additional unrecognized cases, allowing early diagnosis and prevention of complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/30,34\">",
"     30,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, 100 to 200 cases of human brucellosis are reported annually, most of them due to B. melitensis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/29\">",
"     29",
"    </a>",
"    ]. Imported unpasteurized dairy products, such as fresh goat or sheep cheese from neighboring countries (particularly Mexico), are an important source of infection in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/4,18,29,31\">",
"     4,18,29,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human-to-human transmission is unusual. Rare cases due to blood transfusion, tissue transplantation, breast-feeding, sexual contact, congenital, laboratory, and nosocomial infection have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Brucellosis vaccines for animal use are live attenuated vaccines and are known to cause disease in humans during the process of preparation or by accidental inoculation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/6,8,18,31\">",
"     6,8,18,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2042154\">",
"    <span class=\"h3\">",
"     Occupational exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory workers handling Brucella cultures are at a high risk of acquiring brucellosis through accidents, aerosolization,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inadequate laboratory precautions (",
"    <a class=\"graphic graphic_table graphicRef78971 \" href=\"mobipreview.htm?16/20/16715\">",
"     table 1",
"    </a>",
"    ). Laboratory-associated infections represent 2 percent of reported cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/38\">",
"     38",
"    </a>",
"    ]. In one review of laboratory-associated infections, Brucella spp accounted for approximately 8 percent of all laboratory infections, 16 percent of bacterial infections, and 4 percent of deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/39\">",
"     39",
"    </a>",
"    ]. Biosafety level 3 (BSL-3) practices, containment equipment, and facilities are recommended for all manipulations of Brucella cultures, and laboratory workers should be informed in advance about the diagnostic possibility of brucellosis in order to implement appropriate diagnostic precautions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/4,40\">",
"     4,40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16058?source=see_link&amp;anchor=H22057110#H22057110\">",
"     \"Clinical manifestations, diagnosis, and treatment of brucellosis\", section on 'Post exposure prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellae are readily ingested by polymorphonuclear cells and macrophages, which then pass to local lymph nodes (",
"    <a class=\"graphic graphic_figure graphicRef77627 \" href=\"mobipreview.htm?32/6/32871\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/6,41\">",
"     6,41",
"    </a>",
"    ]. Organisms replicate intracellularly, and bacteria from lysed cells can infect other cells or disseminate systemically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/6\">",
"     6",
"    </a>",
"    ]. Some Brucellae are destroyed within the lysosomes of phagocytic cells, while others are capable of preventing phagosome-lysosome fusion and avoiding intracellular killing in lysosomes to reach an endoplasmic reticulum-derived vacuole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the intracellular stage, Brucellae display a range of survival strategies to suppress host immune response and avoid immediate destruction; they circumvent strong activation of the innate immune system, withstand the direct action of complement and other bactericidal substances, and evade the action of polymorphonuclear cells and macrophages. Brucella establish long-lasting infection within host cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/41,42,44\">",
"     41,42,44",
"    </a>",
"    ]. All these activities may promote the chronicity of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No classical virulence factors, such as toxins, cytolysins, capsules, fimbria, flagella, plasmids, lysogenic phages, resistant forms, antigenic variation, endotoxic lipopolysaccharide (LPS), or apoptotic inducers, have been described in Brucellae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/42,48\">",
"     42,48",
"    </a>",
"    ]. The smooth LPS and proteins involved in signaling, gene regulation, and transmembrane transportation are suspected to be involved in virulence. The LPS does not trigger a strong innate immune response, and thus, the synthesis of inflammatory cytokines is low during the early stages of infection, which prevents a timely triggering of Th1 responses. Moreover, LPS has a role in cell entry and immune evasion of the infected cell and is essential for intracellular survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. In addition, the LPS in Brucella may be involved in the inhibition of apoptosis of infected cells, thus preventing host cell elimination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/45,52\">",
"     45,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A regulatory two-component system (Brucella virulence-related regulator or sensor",
"    <span class=\"nowrap\">",
"     proteins-BvrR/BvrS)",
"    </span>",
"    controls the outer membrane composition and is involved in aspects of the pathogen metabolism after ingestion by phagocytic cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. Brucella possesses a type IV secretion system VirB and periplasmic cyclic beta-1,2-glucans, which enable the pathogen to reach its replicating niche in the endoplasmic reticulum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/41,42,51,56\">",
"     41,42,51,56",
"    </a>",
"    ]. Once inside the endoplasmic reticulum, Brucella replicates extensively without restricting basic cellular functions or generating obvious cell damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Brucella does not infect cells by intracellular spreading from cell to cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     The host response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibody response in brucellosis plays a limited part in the overall host response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7\">",
"     7",
"    </a>",
"    ]. Cell-mediated immunity appears to be the principal mechanism of recovery as well as the mechanism for partial resistance to subsequent reinfection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26,57,58\">",
"     26,57,58",
"    </a>",
"    ]. The serum antibody response to Brucella infection in humans is characterized by an initial rise in antibody titers of the IgM class, followed in several weeks by a predominance of IgG antibodies. The IgG titers of agglutinins decline after successful treatment, although they may persist at high levels for months in cured patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/59-61\">",
"     59-61",
"    </a>",
"    ]. IgG and IgA titers may be increased in the setting of relapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Control of brucellosis depends on activated macrophages and hence requires development of a Th1 type cell-mediated immune response involving IL-2, IL-12, interferon-gamma (IFN-gamma), and TNF-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/14,42\">",
"     14,42",
"    </a>",
"    ]. During infection, smooth LPS does not activate the complement pathway. In addition, impaired activity of natural killer cells and impaired macrophage generation of reactive oxygen intermediates and interferon regulatory factors have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7\">",
"     7",
"    </a>",
"    ]. Brucella LPS is a poor inducer of IFN-gamma and TNF-alpha, both of which are essential for the elimination of the organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. IFN-gamma has a central role in the pathogenesis of brucellosis by activating macrophages, by inducing apoptosis, converting IgG to IgG2a, and increasing the expression of antigen-presenting molecules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7\">",
"     7",
"    </a>",
"    ]. In a study of patients with a polymorphism in the IFN-gamma gene, a significant increase in the IFN-gamma",
"    <span class=\"nowrap\">",
"     +874A/A",
"    </span>",
"    genotype was evident in the Brucella-infected group compared with controls, suggesting that those homozygous for the +874 allele may be relatively more susceptible to infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/64\">",
"     64",
"    </a>",
"    ]. TNF-alpha and IL-12 are essential to develop the Th1 type macrophage response leading to clearing of the organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. &gamma;&delta; T cells, and predominantly the fraction of V&gamma;9V&delta;2 T cells, apparently continue to function and aid survival of the host [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/45,67\">",
"     45,67",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"   </p>",
"   <p>",
"    In summary, the immune response in brucellosis can be classified into three mechanisms. First, IFN-gamma activates the bactericidal function in macrophages to hamper the intracellular survival of Brucella. Then, cytotoxicity of CD8+ and &gamma;&delta; T cells destroys the infected macrophages. Finally, Th1-type antibodies opsonize the pathogen to facilitate phagocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H266929977\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;In humans, Brucella spp infection results in the formation of noncaseating sarcoidosis-like granulomas, consisting of epithelioid cells, polymorphonuclear leukocytes, lymphocytes, and some giant cells. The granulomatous response is characteristic of B. abortus infection. In B. melitensis infection, the granulomata are very small. B. suis infection is often accompanied by chronic abscess formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26,58\">",
"     26,58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Brucellosis is a zoonotic infection transmitted to humans by contact with fluids from infected animals (sheep, cattle, goats, pigs, or other animals) or derived food products such as unpasteurized milk and cheese. B. melitensis is the species that causes most of the infections in humans. B. abortus, B. suis, and B. canis also have potential to cause human infections. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2037820\">",
"       'Taxonomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Brucella spp are small gram-negative aerobic coccobacilli lacking a capsule. The organisms require complex media and conditions for growth. Brucella organisms can survive for weeks in the environment. They are sensitive to heat, most commonly used disinfectants, and to pasteurization. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Brucellosis occurs worldwide; major endemic areas include countries of the Mediterranean basin, Persian Gulf, the Indian subcontinent, and parts of Mexico and Central and South America. Domestic animal hosts can harbor a variety of different Brucella species: B. abortus in cattle, B. melitensis in sheep, goats, and camels, and B. suis in swine. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2037820\">",
"       'Taxonomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Humans can acquire brucellosis via direct inoculation through cuts and skin abrasions, direct conjunctival inoculation, inhalation of infectious aerosols, or ingestion of contaminated food. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Human infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Brucellosis is among the most commonly reported laboratory-acquired bacterial infections. Laboratory workers handling Brucella cultures are at high risk of acquiring brucellosis through accidents, aerosolization,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      inadequate laboratory precautions. Biosafety level 3 practices are recommended for all manipulations of Brucella cultures, and laboratory workers should be informed in advance about the diagnostic possibility of brucellosis in order to implement appropriate diagnostic precautions (",
"      <a class=\"graphic graphic_table graphicRef78971 \" href=\"mobipreview.htm?16/20/16715\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2042154\">",
"       'Occupational exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lipopolysaccharide (LPS) has a role in cell entry and immune evasion of the infected cell and is essential for intracellular survival. Brucella spp invade and persist in the host via inhibition of programmed cell death. Replication of the bacterium takes place in the endoplasmic reticulum. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The human host response is both humoral and T cell mediated. Cell-mediated immunity appears to be the principal mechanism of recovery. Antibodies are important for diagnostic purposes, but appear to play a minor role in the immune response to infection. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/1\">",
"      Bosilkovski M, Dimzova M, Grozdanovski K. Natural history of brucellosis in an endemic region in different time periods. Acta Clin Croat 2009; 48:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/2\">",
"      Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/3\">",
"      Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/4\">",
"      Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006; 63:2229.",
"     </a>",
"    </li>",
"    <li>",
"     Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory. Institut National de la recherche Agronomique, Paris, France 1988.",
"    </li>",
"    <li>",
"     Wright SG. Brucellosis. In: Hunter&rsquo;s Tropical Medicine and Emerging Infectious Diseases, 8th ed, Strickland GT (Ed), W.B. Saunders Company, Philadelphia 2000. p.416.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/7\">",
"      Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352:2325.",
"     </a>",
"    </li>",
"    <li>",
"     WHO/CDS/EPR/2006.7. Brucellosis in humans and animals Geneva: World Health Organization, 2006.",
"    </li>",
"    <li>",
"     Lindquist D, Chu MC, Probert WWS. Francisella and Brucella. In: Manual of Clinical Microbiology, 9th ed, Murray PR, Baron EJO, Jorgensen JH, et al (Eds), ASM Press, Washington, DC 2007. p.824.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/10\">",
"      Sohn AH, Probert WS, Glaser CA, et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003; 9:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/11\">",
"      McDonald WL, Jamaludin R, Mackereth G, et al. Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol 2006; 44:4363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/12\">",
"      Centers for Disease Control and Prevention (CDC). Human exposures to marine Brucella isolated from a harbor porpoise - Maine, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/13\">",
"      Jahans KL, Foster G, Broughton ES. The characterisation of Brucella strains isolated from marine mammals. Vet Microbiol 1997; 57:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/14\">",
"      Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/15\">",
"      Halling SM, Peterson-Burch BD, Bricker BJ, et al. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J Bacteriol 2005; 187:2715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/16\">",
"      DelVecchio VG, Kapatral V, Redkar RJ, et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci U S A 2002; 99:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/17\">",
"      Paulsen IT, Seshadri R, Nelson KE, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci U S A 2002; 99:13148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/18\">",
"      Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 2005; 36:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/19\">",
"      Bricker BJ, Ewalt DR, MacMillan AP, et al. Molecular characterization of Brucella strains isolated from marine mammals. J Clin Microbiol 2000; 38:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/20\">",
"      G&aacute;ndara B, Merino AL, Rogel MA, Mart&iacute;nez-Romero E. Limited genetic diversity of Brucella spp. J Clin Microbiol 2001; 39:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/21\">",
"      Verger JM, Grimont F, Grimont PAD, Grayon M. Brucella: A monospecific genus shown by deoxyribonucleic acid hybridization. Int J Syst Bacteriol 1985; 35:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/22\">",
"      Moreno E, Cloeckaert A, Moriy&oacute;n I. Brucella evolution and taxonomy. Vet Microbiol 2002; 90:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/23\">",
"      Chain PS, Comerci DJ, Tolmasky ME, et al. Whole-genome analyses of speciation events in pathogenic Brucellae. Infect Immun 2005; 73:8353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/24\">",
"      Scholz HC, Hubalek Z, Sedl&aacute;cek I, et al. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol 2008; 58:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/25\">",
"      Al Dahouk S, N&ouml;ckler K, Tomaso H, et al. Seroprevalence of brucellosis, tularemia, and yersiniosis in wild boars (Sus scrofa) from north-eastern Germany. J Vet Med B Infect Dis Vet Public Health 2005; 52:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/26\">",
"      Doganay M, Aygen B. Human brucellosis: an overview. Int J Infect Dis 2003; 7:173.",
"     </a>",
"    </li>",
"    <li>",
"     Corbel MJ. Overview. In: Brucellosis, Madkuor MM (Ed), Butterworths, University Press, Cambridge (UK) 1989. p.71.",
"    </li>",
"    <li>",
"     Corbel MJ. Microbiology of the genus Brucella. In: Brucellosis: Clinical and Laboratory Aspects, Young EJ, Corbel MJ (Eds), CRC Press, Boca Raton 1989. p.53.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/29\">",
"      Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis 2006; 6:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/30\">",
"      Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 2007; 25:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/31\">",
"      Young EJ. Brucellosis: current epidemiology, diagnosis, and management. Curr Clin Top Infect Dis 1995; 15:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/32\">",
"      Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J 2004; 45:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/33\">",
"      Bosilkovski M, Krteva L, Dimzova M, Kondova I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis 2007; 11:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/34\">",
"      Bosilkovski M, Krteva L, Dimzova M, et al. Human brucellosis in Macedonia - 10 years of clinical experience in endemic region. Croat Med J 2010; 51:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/35\">",
"      Poulou A, Markou F, Xipolitos I, Skandalakis PN. A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant. J Infect 2006; 53:e39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/36\">",
"      Mesner O, Riesenberg K, Biliar N, et al. The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case. Clin Infect Dis 2007; 45:e135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/37\">",
"      Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis--a sexually transmissible agent? Lancet 1996; 347:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/38\">",
"      Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 2000; 38:2005.",
"     </a>",
"    </li>",
"    <li>",
"     Harding AL, Byers KB. Epidemiology of laboratory-associated infections. In: Biological safety: principles and practices (Third edition), Fleming DO, Hunt DL (Eds), ASM Press, Washington, DC 2000. p.35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/40\">",
"      Gruner E, Bernasconi E, Galeazzi RL, et al. Brucellosis: an occupational hazard for medical laboratory personnel. Report of five cases. Infection 1994; 22:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/41\">",
"      Barquero-Calvo E, Chaves-Olarte E, Weiss DS, et al. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2007; 2:e631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/42\">",
"      Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 2002; 90:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/43\">",
"      Pizarro-Cerd&aacute; J, Moreno E, Gorvel JP. Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. Microbes Infect 2000; 2:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/44\">",
"      Delrue RM, Lestrate P, Tibor A, et al. Brucella pathogenesis, genes identified from random large-scale screens. FEMS Microbiol Lett 2004; 231:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/45\">",
"      Dornand J, Gross A, Lafont V, et al. The innate immune response against Brucella in humans. Vet Microbiol 2002; 90:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/46\">",
"      Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 2003; 16:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/47\">",
"      Skendros P, Sarantopoulos A, Tselios K, Boura P. Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs. Clin Dev Immunol 2008; 2008:327346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/48\">",
"      Moreno E, Moriyon I. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci U S A 2002; 99:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/49\">",
"      DelVecchio VG, Kapatral V, Elzer P, et al. The genome of Brucella melitensis. Vet Microbiol 2002; 90:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/50\">",
"      Lapaque N, Moriyon I, Moreno E, Gorvel JP. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol 2005; 8:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/51\">",
"      Boschiroli ML, Ouahrani-Bettache S, Foulongne V, et al. Type IV secretion and Brucella virulence. Vet Microbiol 2002; 90:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/52\">",
"      Gross A, Terraza A, Ouahrani-Bettache S, et al. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 2000; 68:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/53\">",
"      Guzman-Verri C, Manterola L, Sola-Landa A, et al. The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A 2002; 99:12375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/54\">",
"      L&oacute;pez-Go&ntilde;i I, Guzm&aacute;n-Verri C, Manterola L, et al. Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol 2002; 90:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/55\">",
"      Manterola L, Moriy&oacute;n I, Moreno E, et al. The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides. J Bacteriol 2005; 187:5631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/56\">",
"      Arenas GN, Staskevich AS, Aballay A, Mayorga LS. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect Immun 2000; 68:4255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/57\">",
"      Skendros P, Pappas G, Boura P. Cell-mediated immunity in human brucellosis. Microbes Infect 2011; 13:134.",
"     </a>",
"    </li>",
"    <li>",
"     Gotuzzo E. Brucellosis. In: Tropical Infectious Diseases. Principles, Pathogens, and Practice, Guerrant RL, Walker DH, Weller PF (Eds), Churchill Livingstone, Philadelphia 1999. p.498.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/59\">",
"      Gazapo E, Gonzalez Lahoz J, Subiza JL, et al. Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis 1989; 159:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/60\">",
"      Ariza J, Pellicer T, Pallar&eacute;s R, et al. Specific antibody profile in human brucellosis. Clin Infect Dis 1992; 14:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/61\">",
"      Al Dahouk S, Tomaso H, N&ouml;ckler K, et al. Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab 2003; 49:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/62\">",
"      Zhan Y, Cheers C. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun 1995; 63:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/63\">",
"      Caron E, Liautard JP, K&ouml;hler S. Differentiated U937 cells exhibit increased bactericidal activity upon LPS activation and discriminate between virulent and avirulent Listeria and Brucella species. J Leukoc Biol 1994; 56:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/64\">",
"      Bravo MJ, de Dios Colmenero J, Alonso A, Caballero A. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. Eur J Immunogenet 2003; 30:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/65\">",
"      Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 1996; 64:2782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/66\">",
"      Zhan Y, Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J Immunol 1998; 161:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33751/abstract/67\">",
"      Oliaro J, Dudal S, Liautard J, et al. Vgamma9Vdelta2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella. J Leukoc Biol 2005; 77:652.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3147 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-210.101.131.232-947418B5B9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33751=[""].join("\n");
var outline_f32_61_33751=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2037820\">",
"      TAXONOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Animal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Human infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2042154\">",
"      - Occupational exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      The host response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H266929977\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3147\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3147|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/6/32871\" title=\"figure 1\">",
"      Pathogenesis of Brucella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3147|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/20/16715\" title=\"table 1\">",
"      Lab practices to avoid Brucella exposure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16058?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of brucellosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_61_33752="Microcystic adnexal carcinoma";
var content_f32_61_33752=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microcystic adnexal carcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33752/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33752/contributors\">",
"     Mary E Maloney, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33752/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33752/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33752/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33752/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/61/33752/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H14228933\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microcystic adnexal carcinoma (MAC) is an infiltrative cutaneous tumor that most often presents as a scar-like papule or plaque on sun-exposed skin. Historical terms that have been used to refer to this tumor include sclerosing sweat duct carcinoma, malignant syringoma, and syringoid carcinoma. Tissue invasion by MAC frequently extends far beyond the clinical margins of the tumor. In addition, perineural involvement is common.",
"   </p>",
"   <p>",
"    Although metastasis and death from MAC are rare events, significant morbidity can occur as a result of deep local tissue invasion, and treatment of MAC is recommended. Surgery that results in complete removal of the tumor is the treatment of choice for MAC.",
"   </p>",
"   <p>",
"    The epidemiology, diagnosis, and management of MAC will be discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14228940\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAC is a rare tumor that was first described in 1982 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/1\">",
"     1",
"    </a>",
"    ]. In retrospect, earlier reports documented this tumor prior to its recognition as a distinct entity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vast majority of reported cases of MAC have been in white individuals; however, MAC can also occur in other populations. An analysis of data from the Surveillance, Epidemiology, and End Results (SEER) database collected between 1973 and 2004 found an incidence rate of 6.5 per 10 million white individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. The incidence rates for black subjects and",
"    <span class=\"nowrap\">",
"     Asian/Pacific",
"    </span>",
"    Islanders were significantly lower at 1.9 and 1.6 per 10 million individuals, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sex distribution in studies of patients with MAC has varied from fairly equivalent proportions to a slight female predominance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/6,8-10\">",
"     6,8-10",
"    </a>",
"    ]. In the SEER database analysis, which represents the largest reported series of patients with MAC (n = 223), 57 percent of patients were female and 43 percent were male [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MAC most commonly affects middle-aged and older adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/6,8\">",
"     6,8",
"    </a>",
"    ]. The median age for the development of MAC in the SEER database analysis was 68 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"     8",
"    </a>",
"    ]. Rarely, the tumor occurs in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Congenital MAC has been described in a few neonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1692579\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rarity of MAC makes it difficult to draw definitive conclusions on risk factors for the disease. Ultraviolet radiation, ionizing radiation, and immunosuppression have been proposed as potential contributory factors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Ultraviolet radiation &ndash;",
"      </strong>",
"      The common localization of tumors to the head and neck and the elevated frequency in white individuals suggests that exposure to ultraviolet radiation may contribute to the development of MAC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"       8",
"      </a>",
"      ]. Also in support of a role for ultraviolet radiation, a series of 48 patients with MAC in the United States (where drivers sit in the left side of the vehicle) found a predominance of left-sided lesions (52 percent on left, 25 percent on right, and 23 percent in midline or unspecified) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9\">",
"       9",
"      </a>",
"      ], whereas a series of 14 patients in Australia (where drivers sit in the right side of the vehicle) found that more lesions occurred on the right side (56 versus 38 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/15\">",
"       15",
"      </a>",
"      ]. However, ultraviolet light-induced p53 mutations, which have been associated with the development of other cutaneous carcinomas, lack a strong association with MAC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Ionizing radiation &ndash;",
"      </strong>",
"      The development of tumors in sites of previous radiation therapy has been reported in multiple patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/6,17-22\">",
"       6,17-22",
"      </a>",
"      ]. These case reports raise the question of whether ionizing radiation increases risk for MAC.",
"     </li>",
"     <li>",
"      <strong>",
"       Immunosuppression &ndash;",
"      </strong>",
"      Although immunosuppression increases risk for cutaneous squamous cell carcinoma and basal cell carcinoma, the effect of immunosuppression on the risk for development of MAC is unclear (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37832?source=see_link\">",
"       \"Epidemiology and risk factors for skin cancer in solid organ transplant recipients\"",
"      </a>",
"      ). Aggressive tumor behavior has been reported in a few immunosuppressed patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Other &ndash;",
"      </strong>",
"      MAC has arisen within a nevus sebaceous in at least one patient [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/25\">",
"       25",
"      </a>",
"      ] and in an association with multiple benign syringomas in at least two patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3514792\">",
"    <span class=\"h1\">",
"     HISTOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histologic studies strongly suggest that MAC derives from pluripotent cells that exhibit differentiation towards both eccrine structures and hair follicles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/1,27-31\">",
"     1,27-31",
"    </a>",
"    ]. Immunohistochemical stains that demonstrate hard keratins in the superficial cystic component of MAC support the presence of follicular differentiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/27,28,32\">",
"     27,28,32",
"    </a>",
"    ], and the often positive stains for carcinoembryonic antigen in MAC tumors indicate the presence of eccrine differentiation (",
"    <a class=\"graphic graphic_table graphicRef85945 \" href=\"mobipreview.htm?25/41/26269\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/28,30,33,34\">",
"     28,30,33,34",
"    </a>",
"    ]. Of note, sebaceous differentiation has also been detected in at least two cases of MAC, a finding that lends additional support to the status of pluripotent cells as the cells of tumor origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Little data are available on the cytogenetic analysis of MAC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. One study found a clonal chromosome 6q deletion similar to that seen in salivary tumors, suggesting a histogenetic relationship between these tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3514918\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAC most frequently manifests as a fairly unremarkable white or yellowish papule or plaque with or without overlying telangiectasias (",
"    <a class=\"graphic graphic_picture graphicRef86192 graphicRef86193 graphicRef86194 graphicRef86195 \" href=\"mobipreview.htm?36/52/37706\">",
"     picture 1A-D",
"    </a>",
"    ). Individuals with dark skin may present with only an ill-defined papule or nodule that lacks surface or pigmentary changes. The tumor margins are often indistinct, a feature consistent with the common discrepancy between the clinical size of the tumor and the more extensive tumor invasion regularly detected on histological examination. MAC usually presents as a solitary tumor. However, multiple primary tumors have occurred in at least one patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tumor development is usually characterized by slow, gradual growth; periods of stability and more rapid growth may be observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"     38",
"    </a>",
"    ]. Early tumors are often only slightly elevated; a more nodular quality tends to develop over time. Tumors that seem fixed to underlying tissues may have invaded underlying structures such as muscle, cartilage, and bone. Ulceration and necrosis are rare findings.",
"   </p>",
"   <p>",
"    The vast majority of tumors occur on the head and neck, many of which can be found on the central face [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"     38",
"    </a>",
"    ]. In an analysis of SEER data on 223 patients with MAC, tumors were located on the head and neck in 74 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"     8",
"    </a>",
"    ]. However, tumors may develop in any cutaneous site. Examples of additional reported sites of MAC include the trunk and extremities, breast, vulva, auditory canal, axilla, perineum, hands, feet, and scalp [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/3,4,6,32,39-41\">",
"     3,4,6,32,39-41",
"    </a>",
"    ]. Rarely, MAC develops in extracutaneous locations. MAC involving the tongue, oral cavity, or maxillary sinus has been documented in a few patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8,42\">",
"     8,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with MAC do not experience associated symptoms. Occasionally, symptoms related to perineural invasion, such as burning, pain, hyperesthesia, or paraesthesias are present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/43\">",
"     43",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3515538\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The assessment of skin biopsy findings is usually sufficient for the diagnosis of MAC. Despite the relative ease of skin biopsy procedures, the undramatic clinical appearance and insidious growth of MAC can lead to a delay in biopsy and diagnosis for several years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/17,33,43\">",
"     17,33,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1692653\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superficial shave biopsies are not recommended for the diagnosis of MAC, since the recognition of the architecture of this deeply infiltrative tumor and the detection of perineural invasion are useful for diagnosis. The depth of the biopsy should extend into the deep dermis and subcutis. Thus, punch biopsies, incisional or excisional biopsies, or deep (saucerization) shave biopsies are preferred. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40264?source=see_link&amp;anchor=H5#H5\">",
"     \"Skin biopsy techniques\", section on 'Biopsy techniques'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of fine needle aspiration for the diagnosis of MAC has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/44\">",
"     44",
"    </a>",
"    ]. However, in such cases, a subsequent larger tissue specimen is necessary to confirm the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14228954\">",
"    <span class=\"h3\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathology findings of MAC consist of a deeply infiltrative tumor composed of small nests and cords of bland-appearing cells. The common histologic features of MAC are listed below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small, keratin-filled cysts in the upper dermis (",
"      <a class=\"graphic graphic_picture graphicRef85586 \" href=\"mobipreview.htm?33/10/33961\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Nests and cords of epithelial cells within a hyalinized stroma that seem to form ductal structures; these structures decrease in size at greater depths (",
"      <a class=\"graphic graphic_picture graphicRef85587 graphicRef85588 \" href=\"mobipreview.htm?41/19/42298\">",
"       picture 3A-B",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Little, if any, cytologic atypia and few mitoses",
"     </li>",
"     <li>",
"      Perineural invasion (",
"      <a class=\"graphic graphic_picture graphicRef85585 \" href=\"mobipreview.htm?5/40/5768\">",
"       picture 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Deep infiltration within the dermis (infiltration into the subcutaneous tissue, muscle, or deeper structures may also be present) (",
"      <a class=\"graphic graphic_picture graphicRef85589 \" href=\"mobipreview.htm?8/57/9110\">",
"       picture 5",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When MAC encounters bone or cartilage, the tumor may grow laterally along the periosteal or perichondrial plane or may directly invade these structures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/43\">",
"     43",
"    </a>",
"    ]. Although not typically seen, amyloid deposition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/31\">",
"     31",
"    </a>",
"    ] and an inflammatory infiltrate with eosinophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/27,46\">",
"     27,46",
"    </a>",
"    ] have been detected in specimens of MAC. Findings of necrosis and ulceration are uncommon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H857060\">",
"    <span class=\"h3\">",
"     Histological differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other cutaneous tumors share pathological features with MAC. Careful assessment of the histological features is essential for obtaining the correct diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9,27,47\">",
"     9,27,47",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef85946 \" href=\"mobipreview.htm?1/4/1099\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The histological differential diagnosis for MAC primarily consists of benign or malignant cutaneous tumors. The recognition of ductal features in MAC distinguishes it from desmoplastic trichoepithelioma and trichoadenoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/48\">",
"     48",
"    </a>",
"    ], which are adnexal tumors of follicular origin. The asymmetrical architecture, single-cell strands, and the perineural and deep invasion of MAC differentiate MAC from syringoma, a benign eccrine tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/48\">",
"     48",
"    </a>",
"    ]. Other disorders to consider in the histological differential diagnosis include morpheaform basal cell carcinoma, desmoplastic squamous cell carcinoma, and metastatic breast carcinoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14228968\">",
"    <span class=\"h2\">",
"     Immunohistochemistry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tests beyond routine hematoxylin and eosin staining of pathology specimens are not typically needed for the diagnosis of MAC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"     38",
"    </a>",
"    ]. However, immunohistochemical studies are occasionally utilized to support the diagnosis and rule out other disorders when the diagnosis is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/16,28,49-54\">",
"     16,28,49-54",
"    </a>",
"    ]. In particular, the carcinoembryonic antigen stain, which is positive in half of specimens from MAC, is useful for distinguishing MAC from basal cell carcinoma and squamous cell carcinoma (",
"    <a class=\"graphic graphic_picture graphicRef85590 \" href=\"mobipreview.htm?8/63/9207\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"     38",
"    </a>",
"    ]. The immunohistochemical characteristics of MAC and several disorders that may be mistaken for MAC are provided in a table (",
"    <a class=\"graphic graphic_table graphicRef85945 \" href=\"mobipreview.htm?25/41/26269\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3515548\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indurated papules, plaques, or nodules of MAC may clinically resemble scars, morpheaform basal cell carcinoma (",
"    <a class=\"graphic graphic_picture graphicRef56527 \" href=\"mobipreview.htm?0/33/533\">",
"     picture 7",
"    </a>",
"    ), squamous cell carcinoma, syringomas (",
"    <a class=\"graphic graphic_picture graphicRef85851 \" href=\"mobipreview.htm?29/21/30037\">",
"     picture 8",
"    </a>",
"    ), and cysts (",
"    <a class=\"graphic graphic_table graphicRef85947 \" href=\"mobipreview.htm?0/30/491\">",
"     table 3",
"    </a>",
"    ). Histopathological examination distinguishes MAC from these disorders. (See",
"    <a class=\"local\" href=\"#H14228954\">",
"     'Pathology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H857060\">",
"     'Histological differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14228982\">",
"    <span class=\"h1\">",
"     EVALUATION AND STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients diagnosed with MAC should receive a full skin examination that includes careful inspection of the tumor site to assess the clinical extent of the tumor. While nodal spread is rare, palpation of the regional lymph nodes should also be performed to assess for enlarged lymph nodes that may indicate regional metastasis. If enlarged lymph nodes are detected, lymph node biopsy via fine needle aspiration or surgical removal of the enlarged lymph node is indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiologic studies are not necessary in most patients diagnosed with MAC. However, if the physical examination suggests that the tumor may be fixed to underlying structures or there is a large tumor (eg, &ge;2 cm) in the periorbital area, a CT or MRI is useful for evaluating for invasion of bone, other deep structures, or the orbit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/45,56-59\">",
"     45,56-59",
"    </a>",
"    ]. Radiologic imaging of other body sites is not indicated in the absence of signs or symptoms suggestive of distant disease.",
"   </p>",
"   <p>",
"    The staging of MAC correlates with the staging system for cutaneous squamous cell carcinoma outlined by the American Joint Committee on Cancer Staging (",
"    <a class=\"graphic graphic_table graphicRef78140 \" href=\"mobipreview.htm?5/0/5134\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14228989\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is the primary treatment modality utilized for the management of MAC. Radiation therapy has been employed in select cases; however, the indications for radiation therapy remain uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1197621\">",
"    <span class=\"h2\">",
"     Local disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1693603\">",
"    <span class=\"h3\">",
"     Approach to treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery that results in complete removal of the tumor is the treatment of choice for locally invasive MAC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"     8",
"    </a>",
"    ]. The surgical techniques most commonly utilized for MAC include Mohs surgery and conventional surgical excision with postoperative margin assessment. No high-quality trials have evaluated Mohs surgery or conventional surgical excision for the treatment of MAC, and the relative efficacy of these procedures for improving patient outcomes remains uncertain.",
"   </p>",
"   <p>",
"    We prefer Mohs surgery, a procedure that involves histological assessment of the complete tissue margin, for the treatment of MAC. This is because the infiltrative quality and often extensive subclinical extension of this tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] can make complete removal by other surgical procedures challenging. In one retrospective study that included 26 patients with MAC who were treated with Mohs surgery, defect sizes were an average of six times larger than the clinical size of the tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=see_link\">",
"     \"Mohs surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When Mohs surgery is not an option (eg, tumor size or patient comorbidities prohibit treatment in an outpatient setting or the procedure is unavailable), conventional surgical excision with postoperative pathological margin assessment can be utilized for treatment. Intraoperative frozen sections are useful for guiding the extent of excision in these cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1196579\">",
"    <span class=\"h3\">",
"     Mohs surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mohs surgery is an outpatient procedure that allows for intraoperative assessment of 100 percent of the excised tumor margin. This enables the surgeon to confirm complete removal of the tumor on the day of surgery prior to wound closure and allows for the sparing of the maximum amount of healthy tissue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=see_link&amp;anchor=H9314583#H9314583\">",
"     \"Mohs surgery\", section on 'Surgical technique'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=see_link&amp;anchor=H9483394#H9483394\">",
"     \"Mohs surgery\", section on 'Advantages'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparison to conventional surgical excision, Mohs surgery may reduce the need for subsequent surgical procedures. A retrospective study of 48 patients with MAC found that 7 of 23 patients (30 percent) treated with conventional surgical excision did not achieve clear margins after the procedure and had to return for additional surgery. In contrast, clear margins were achieved within a single treatment session in all 22 patients who were treated with Mohs surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MAC has recurred after Mohs surgery, a finding that reflects the difficulty in achieving complete removal of the tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/48\">",
"     48",
"    </a>",
"    ]. A prospective study found that MAC recurred in 1 of 20 patients who were followed for at least five years after Mohs surgery for primary or recurrent tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/47\">",
"     47",
"    </a>",
"    ]. Retrospective studies with more than 10 patients have found recurrence rates after Mohs surgery between 0 and 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9,10,23,47,61\">",
"     9,10,23,47,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disadvantages of Mohs surgery include its status as a potentially lengthy procedure and as a specialized surgical technique that is not available in all clinical settings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=see_link&amp;anchor=H9483386#H9483386\">",
"     \"Mohs surgery\", section on 'Advantages and disadvantages'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several authors have suggested alterations to the standard Mohs surgery procedure in attempts to improve surgical outcomes. One example is the use of a toluidine blue stain, which may facilitate the identification of isolated tumor nests and perineural invasion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/62\">",
"     62",
"    </a>",
"    ]. In addition, because the histological detection of small islands or strands of tumor cells may be easier in permanent sections than in the frozen sections typically utilized in Mohs surgery, techniques utilizing permanent sections have been proposed as methods that may reduce the risk for treatment failure. These include the obtainment of an additional layer of tissue for permanent sections after apparent tumor clearance via Mohs surgery and the performance of a staged Mohs surgery-like procedure utilizing permanent rather than frozen sections (&ldquo;slow Mohs&rdquo;) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/43,63,64\">",
"     43,63,64",
"    </a>",
"    ]. The effects of these procedures on patient outcomes have not been evaluated in formal studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1196586\">",
"    <span class=\"h3\">",
"     Conventional surgical excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conventional surgical excision has been successfully used for the treatment of MAC. Conventional surgical excision is more widely available than Mohs surgery.",
"   </p>",
"   <p>",
"    A major challenge with conventional surgical excision is the often extensive subclinical extension of MAC, a feature that makes it difficult to identify the surgical margin that is likely to result in complete removal of the tumor. Surgical margins are determined on an individual basis, with reported margins ranging from a few millimeters to 5 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"     38",
"    </a>",
"    ]. Reexcision is performed if postoperative histologic examination reveals that a tumor is not completely removed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the impact of the addition of intraoperative frozen sections to traditional surgical excision in MAC has not been specifically studied, our experience suggests that this intervention may help surgeons to more closely approximate the amount of tissue removal necessary for tumor removal during surgery. Frozen sections may be particularly useful in sites on the head and neck where tissue sparing is a significant concern. We suggest the use of intraoperative frozen sections to guide the extent of excision when feasible.",
"   </p>",
"   <p>",
"    Another challenge of conventional surgical excision is the fact that less than 1 percent of the tissue margin is typically evaluated during histological examination of the excised tissue. Due to the infiltrative and often asymmetric architecture of MAC, this could lead to a failure to detect residual tumor. Data are limited on the frequency with which tumor recurrence develops following conventional surgical excision. The likelihood of recurrence was high in a retrospective study in which 15 patients were followed for 3 to 25 years; tumors recurred in seven patients (47 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14229010\">",
"    <span class=\"h3\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role radiation therapy should play in the treatment of MAC is uncertain. Case reports suggest that radiation therapy alone is capable of achieving clinical clearance of tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]; however, tumors may recur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/66,68\">",
"     66,68",
"    </a>",
"    ] or fail to respond to therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/42\">",
"     42",
"    </a>",
"    ]. Of note, the recurrence of MAC in a histologically more aggressive form after radiation therapy has been reported in one patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/69\">",
"     69",
"    </a>",
"    ]. This finding has not been documented elsewhere.",
"   </p>",
"   <p>",
"    The use of radiation therapy as an adjuvant to surgical intervention was evaluated in a retrospective study of 14 patients with MAC (11 of whom had positive surgical margins) who were followed for a median of five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/15\">",
"     15",
"    </a>",
"    ]. In the study, 13 of 14 patients achieved local control, prompting the authors to suggest that conventional surgical excision plus radiation therapy could yield success rates similar to those observed with Mohs surgery.",
"   </p>",
"   <p>",
"    Currently, data are insufficient to support a routine recommendation for the use of radiation therapy in patients with MAC. Complete surgical excision remains our treatment of choice for MAC; we reserve radiation therapy for the infrequent cases in which complete surgical removal is not possible and for adjuvant treatment following the complete excision of recurrent tumors in critical locations, such as the periorbital area. Additional studies are necessary to determine the efficacy, safety, indications, and optimal treatment regimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1197613\">",
"    <span class=\"h2\">",
"     Metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Locoregional or distant metastasis of MAC is a rare event, and standards for the approach to such patients are lacking. Data on the management of metastatic disease are limited to case reports. A patient with a 4 cm tumor in the axilla for whom excision of the tumor and axillary lymph nodes revealed two positive lymph nodes exhibited no signs of tumor recurrence for 31 months after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/41\">",
"     41",
"    </a>",
"    ]. A separate patient with MAC on the scalp and biopsy-confirmed cervical lymph node involvement who was treated with a modified radical neck dissection and radiation therapy had no signs of recurrence at one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other case reports document failures to respond to treatments directed at metastatic disease. An immunocompromised patient with intransit metastases failed to achieve a lasting response with radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/24\">",
"     24",
"    </a>",
"    ]. In addition, a single course of cisplatinum and 5-fluororuracil resulted in no improvement or minimal improvement in two patients with MAC and distant metastases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/56,68\">",
"     56,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14229024\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAC is primarily a locally aggressive tumor. Metastasis to the lymph nodes or other sites is uncommon. As of 2011, fewer than 10 cases of regional lymph node or distant metastasis had been reported in the literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/66\">",
"     66",
"    </a>",
"    ]. The rarity of metastasis is supported by SEER data; among 223 patients with MAC, regional lymph node involvement was present in three patients (1 percent) and distant metastases occurred in one patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"     8",
"    </a>",
"    ]. Deep local invasion occurred more frequently; extension into the subcutaneous tissue was noted in 7 percent of patients, and invasion of the underlying soft tissue, muscle, or bone, was documented in 9 percent of patients.",
"   </p>",
"   <p>",
"    Tumor recurrence resulting from incomplete removal of the tumor is the major prognostic concern in MAC (",
"    <a class=\"graphic graphic_picture graphicRef86196 \" href=\"mobipreview.htm?21/29/21969\">",
"     picture 9",
"    </a>",
"    ). The time course to tumor recurrence varies widely. Most cases recur within two to three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"     38",
"    </a>",
"    ]. However, recurrence up to 29 years after has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/6\">",
"     6",
"    </a>",
"    ]. Risk factors for tumor recurrence have not been definitively established. Some authors propose that tumors that demonstrate perineural invasion may be more likely to recur after Mohs surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/64\">",
"     64",
"    </a>",
"    ]. This may be due to tumor &ldquo;skip&rdquo; areas along involved nerves that lead to failures to detect residual perineural tumor.",
"   </p>",
"   <p>",
"    There are multiple reports of MAC extending into the orbit, leading to tumor invasion into the brain through the optic nerve or the nerves superior to the orbit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/45,58,64,68,70\">",
"     45,58,64,68,70",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"    This suggests that this location is associated with increased risk for morbidity and that treatment should be followed with close long-term monitoring.",
"   </p>",
"   <p>",
"    A few cases of death related to local tumor extension into vital areas (eg, intracranial invasion) have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/57,64,71\">",
"     57,64,71",
"    </a>",
"    ]. Only one death directly attributable to metastatic MAC has been documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33752/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14229031\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines for the follow-up of patients with MAC have not been established. The potential for delayed recurrence after years indicates that long-term follow-up is necessary. We typically follow patients every 6 to 12 months and perform a full skin examination and lymph node palpation at each visit. Patients with histories of tumors that invade into deep, vital, or conduit structures (such as the orbit) likely need to be followed more closely. The optimal frequency of follow-up of these patients depends on the individual clinical scenario.",
"   </p>",
"   <p>",
"    We usually perform radiologic imaging only if signs or symptoms suggestive of extracutaneous involvement are present. Occasionally radiologic studies (CT or MRI) are used to follow patients with deeply invasive tumors in which physical examination is not adequate for assessing signs of tumor recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14229038\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Microcystic adnexal carcinoma is a rare, infiltrative cutaneous tumor that is often found on the head and neck. White middle-aged and elderly adults are most commonly affected. (See",
"      <a class=\"local\" href=\"#H14228940\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk factors for MAC are poorly defined. Exposure to ultraviolet radiation may play a role in the development of some tumors. (See",
"      <a class=\"local\" href=\"#H1692579\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MAC most commonly presents as a non-ulcerated white or yellow papule, plaque, or nodule on the skin. The head and neck are frequent sites for involvement. Tumors usually grow slowly over the course of years. (See",
"      <a class=\"local\" href=\"#H3514918\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of MAC is based upon the detection of consistent pathological findings. Characteristic features include small keratin-filled cysts, nest and cords of cells that resemble ductal structures, and an infiltrative growth pattern. Perineural invasion is common. Immunohistochemical studies are occasionally used to distinguish MAC from other disorders (",
"      <a class=\"graphic graphic_table graphicRef85945 \" href=\"mobipreview.htm?25/41/26269\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3515538\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of the patient with MAC should include a complete skin examination with careful attention to the tumor site and lymph node palpation. Most patients do not require radiologic studies. (See",
"      <a class=\"local\" href=\"#H14228982\">",
"       'Evaluation and staging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with MAC, we suggest treatment with Mohs surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If Mohs surgery cannot be performed, patients may be treated with conventional surgical excision with pathological margin assessment. Intraoperative frozen sections are useful for guiding the extent of conventional surgical excision.",
"     </li>",
"     <li>",
"      Data are limited on the efficacy of radiation therapy for the treatment of MAC. We typically reserve radiation therapy for tumors for which complete excision is not possible and for use as an adjuvant to complete excision of recurrent tumors in critical locations (eg, periorbital area). The optimal treatment regimen for radiation therapy has not been determined. Further study is necessary prior to a recommendation for the routine use of this modality. (See",
"      <a class=\"local\" href=\"#H14229010\">",
"       'Radiation therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recurrence of MAC may occur after many years. Patients should be routinely followed for signs of disease recurrence. (See",
"      <a class=\"local\" href=\"#H14229024\">",
"       'Prognosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14229031\">",
"       'Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/1\">",
"      Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer 1982; 50:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/2\">",
"      Stern JB, Stout DA. Trichofolliculoma showing perineural invasion. Trichofolliculocarcinoma? Arch Dermatol 1979; 115:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/3\">",
"      Page RN, Hanggi MC, King R, Googe PB. Multiple microcystic adnexal carcinomas. Cutis 2007; 79:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/4\">",
"      Buhl A, Landow S, Lee YC, et al. Microcystic adnexal carcinoma of the vulva. Gynecol Oncol 2001; 82:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/5\">",
"      Nadiminti H, Nadiminti U, Washington C. Microcystic adnexal carcinoma in African-Americans. Dermatol Surg 2007; 33:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/6\">",
"      Ohtsuka H, Nagamatsu S. Microcystic adnexal carcinoma: review of 51 Japanese patients. Dermatology 2002; 204:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/7\">",
"      Sabhikhi AK, Rao CR, Kumar RV, Hazarika D. Microcystic adnexal carcinoma. Int J Dermatol 1997; 36:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/8\">",
"      Yu JB, Blitzblau RC, Patel SC, et al. Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol 2010; 33:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/9\">",
"      Chiller K, Passaro D, Scheuller M, et al. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000; 136:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/10\">",
"      Thomas CJ, Wood GC, Marks VJ. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience. Dermatol Surg 2007; 33:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/11\">",
"      McAlvany JP, Stonecipher MR, Leshin B, et al. Sclerosing sweat duct carcinoma in an 11-year-old boy. J Dermatol Surg Oncol 1994; 20:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/12\">",
"      Nelson PS, Bourgeois KM, Nicotri T Jr, et al. Sclerosing sweat duct carcinoma in a 6-year-old African American child. Pediatr Dermatol 2008; 25:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/13\">",
"      Smart DR, Taintor AR, Kelly ME, et al. Microcystic adnexal carcinoma: the first reported congenital case. Pediatr Dermatol 2011; 28:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/14\">",
"      Fu T, Clark FL, Lorenz HP, Bruckner AL. Congenital microcystic adnexal carcinoma. Arch Dermatol 2011; 147:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/15\">",
"      Baxi S, Deb S, Weedon D, et al. Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy. J Med Imaging Radiat Oncol 2010; 54:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/16\">",
"      Smith KJ, Williams J, Corbett D, Skelton H. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol 2001; 25:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/17\">",
"      Borenstein A, Seidman DS, Trau H, Tsur H. Microcystic adnexal carcinoma following radiotherapy in childhood. Am J Med Sci 1991; 301:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/18\">",
"      Beer KT, B&uuml;hler SS, Mullis P, et al. A microcystic adnexal carcinoma in the auditory canal 15 years after radiotherapy of a 12-year-old boy with nasopharynx carcinoma. Strahlenther Onkol 2005; 181:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/19\">",
"      Antley CA, Carney M, Smoller BR. Microcystic adnexal carcinoma arising in the setting of previous radiation therapy. J Cutan Pathol 1999; 26:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/20\">",
"      Abbate M, Zeitouni NC, Seyler M, et al. Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg 2003; 29:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/21\">",
"      Lober CW, Larbig GG. Microcystic adnexal carcinoma (sclerosing sweat duct carcinoma). South Med J 1994; 87:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/22\">",
"      Schwarze HP, Loche F, Lamant L, et al. Microcystic adnexal carcinoma induced by multiple radiation therapy. Int J Dermatol 2000; 39:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/23\">",
"      Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg 2001; 27:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/24\">",
"      Carroll P, Goldstein GD, Brown CW Jr. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg 2000; 26:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/25\">",
"      Lountzis N, Junkins-Hopkins J, Uberti-Benz M, Elenitsas R. Microcystic adnexal carcinoma arising within a nevus sebaceus. Cutis 2007; 80:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/26\">",
"      Liang CA, Busam KJ, Nehal KS. Microcystic adnexal carcinoma associated with multiple benign syringomatous proliferations: a report of two cases. Dermatol Surg 2011; 37:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/27\">",
"      LeBoit PE, Sexton M. Microcystic adnexal carcinoma of the skin. A reappraisal of the differentiation and differential diagnosis of an underrecognized neoplasm. J Am Acad Dermatol 1993; 29:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/28\">",
"      Wick MR, Cooper PH, Swanson PE, et al. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors. Arch Dermatol 1990; 126:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/29\">",
"      Kazakov DV, Kacerovska D, Michal M. Microcystic adnexal carcinoma with multiple areas of follicular differentiation toward germinative cells and specific follicular stroma (trichoblastomatous areas). Am J Dermatopathol 2011; 33:e47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/30\">",
"      Nickoloff BJ, Fleischmann HE, Carmel J, et al. Microcystic adnexal carcinoma. Immunohistologic observations suggesting dual (pilar and eccrine) differentiation. Arch Dermatol 1986; 122:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/31\">",
"      Kato H, Mizuno N, Nakagawa K, et al. Microcystic adnexal carcinoma: a light microscopic, immunohistochemical and ultrastructural study. J Cutan Pathol 1990; 17:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/32\">",
"      Callahan EF, Vidimos AT, Bergfeld WF. Microcystic adnexal carcinoma (MAC) of the scalp with extensive pilar differentiation. Dermatol Surg 2002; 28:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/33\">",
"      Ongenae KC, Verhaegh ME, Vermeulen AH, Naeyaert JM. Microcystic adnexal carcinoma: an uncommon tumor with debatable origin. Dermatol Surg 2001; 27:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/34\">",
"      Requena L, Marquina A, Alegre V, et al. Sclerosing-sweat-duct (microcystic adnexal) carcinoma--a tumor from a single eccrine origin. Clin Exp Dermatol 1990; 15:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/35\">",
"      Pujol RM, LeBoit PE, Su WP. Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol 1997; 19:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/36\">",
"      Wohlfahrt C, Ternesten A, Sahlin P, et al. Cytogenetic and fluorescence in situ hybridization analyses of a microcystic adnexal carcinoma with del(6)(q23q25). Cancer Genet Cytogenet 1997; 98:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/37\">",
"      Vogelbruch M, B&ouml;cking A, R&uuml;tten A, et al. DNA image cytometry in malignant and benign sweat gland tumours. Br J Dermatol 2000; 142:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/38\">",
"      Wetter R, Goldstein GD. Microcystic adnexal carcinoma: a diagnostic and therapeutic challenge. Dermatol Ther 2008; 21:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/39\">",
"      Yavuzer R, Boyaci M, Sari A, Ataolu O. Microcystic adnexal carcinoma of the breast: a very rare breast skin tumor. Dermatol Surg 2002; 28:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/40\">",
"      Chi J, Jung YG, Rho YS, Lim HJ. Microcystic adnexal carcinoma of external auditory canal: report of a case. Otolaryngol Head Neck Surg 2002; 127:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/41\">",
"      Ban M, Sugie S, Kamiya H, Kitajima Y. Microcystic adnexal carcinoma with lymph node metastasis. Dermatology 2003; 207:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/42\">",
"      Schipper JH, Holecek BU, Sievers KW. A tumour derived from Ebner's glands: microcystic adnexal carcinoma of the tongue. J Laryngol Otol 1995; 109:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/43\">",
"      Sebastien TS, Nelson BR, Lowe L, et al. Microcystic adnexal carcinoma. J Am Acad Dermatol 1993; 29:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/44\">",
"      Sirikanjanapong S, Seymour AW, Amin B. Cytologic features of microcystic adnexal carcinoma. Cytojournal 2011; 8:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/45\">",
"      Cooper PH, Mills SE. Microcystic adnexal carcinoma. J Am Acad Dermatol 1984; 10:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/46\">",
"      McCalmont TH, Ye J. Eosinophils as a clue to the diagnosis of microcystic adnexal carcinoma. J Cutan Pathol 2011; 38:849, 850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/47\">",
"      Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol 2005; 52:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/48\">",
"      Diamantis SA, Marks VJ. Mohs micrographic surgery in the treatment of microcystic adnexal carcinoma. Dermatol Clin 2011; 29:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/49\">",
"      Krahl D, Sellheyer K. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. J Cutan Pathol 2007; 34:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/50\">",
"      Hoang MP, Dresser KA, Kapur P, et al. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol 2008; 21:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/51\">",
"      Abesamis-Cubillan E, El-Shabrawi-Caelen L, LeBoit PE. Merked cells and sclerosing epithelial neoplasms. Am J Dermatopathol 2000; 22:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/52\">",
"      Vidal CI, Goldberg M, Burstein DE, et al. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors. Am J Dermatopathol 2010; 32:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/53\">",
"      Plaza JA, Ortega PF, Stockman DL, Suster S. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol 2010; 37:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/54\">",
"      Rollins-Raval M, Chivukula M, Tseng GC, et al. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature. Arch Pathol Lab Med 2011; 135:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/55\">",
"      Rotter N, Wagner H, Fuchshuber S, Issing WJ. Cervical metastases of microcystic adnexal carcinoma in an otherwise healthy woman. Eur Arch Otorhinolaryngol 2003; 260:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/56\">",
"      Gabillot-Carr&eacute; M, Weill F, Mamelle G, et al. Microcystic adnexal carcinoma: report of seven cases including one with lung metastasis. Dermatology 2006; 212:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/57\">",
"      Gomez-Maestra MJ, Espa&ntilde;a-Gregori E, Avi&ntilde;&oacute;-Martinez JA, et al. Brainstem and cavernous sinus metastases arising from a microcystic adnexal carcinoma of the eyebrow by perineural spreading. Can J Ophthalmol 2009; 44:e17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/58\">",
"      Birkby CS, Argenyi ZB, Whitaker DC. Microcystic adnexal carcinoma with mandibular invasion and bone marrow replacement. J Dermatol Surg Oncol 1989; 15:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/59\">",
"      Nagatsuka H, Rivera RS, Gunduz M, et al. Microcystic adnexal carcinoma with mandibular bone marrow involvement: a case report with immunohistochemistry. Am J Dermatopathol 2006; 28:518.",
"     </a>",
"    </li>",
"    <li>",
"     Edge SF, Byrd DR, Compton CC, et al. AJCC cancer staging manual, 7th ed, Springer, New York 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/61\">",
"      Friedman PM, Friedman RH, Jiang SB, et al. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol 1999; 41:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/62\">",
"      Wang SQ, Goldberg LH, Nemeth A. The merits of adding toluidine blue-stained slides in Mohs surgery in the treatment of a microcystic adnexal carcinoma. J Am Acad Dermatol 2007; 56:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/63\">",
"      Khachemoune A, Olbricht SM, Johnson DS. Microcystic adnexal carcinoma: report of four cases treated with Mohs' micrographic surgical technique. Int J Dermatol 2005; 44:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/64\">",
"      Palamaras I, McKenna JD, Robson A, Barlow RJ. Microcystic adnexal carcinoma: a case series treated with mohs micrographic surgery and identification of patients in whom paraffin sections may be preferable. Dermatol Surg 2010; 36:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/65\">",
"      Cooper PH, Mills SE, Leonard DD, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol 1985; 9:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/66\">",
"      Pugh TJ, Lee NY, Pacheco T, Raben D. Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literature. Head Neck 2012; 34:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/67\">",
"      Gulmen S, Pullon PA. Sweat gland carcinoma of the lips. Oral Surg Oral Med Oral Pathol 1976; 41:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/68\">",
"      Bier-Laning CM, Hom DB, Gapany M, et al. Microcystic adnexal carcinoma: management options based on long-term follow-up. Laryngoscope 1995; 105:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/69\">",
"      Stein JM, Ormsby A, Esclamado R, Bailin P. The effect of radiation therapy on microcystic adnexal carcinoma: a case report. Head Neck 2003; 25:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/70\">",
"      Ohta M, Hiramoto M, Ohtsuka H. Metastatic microcystic adnexal carcinoma: an autopsy case. Dermatol Surg 2004; 30:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33752/abstract/71\">",
"      Yugueros P, Kane WJ, Goellner JR. Sweat gland carcinoma: a clinicopathologic analysis of an expanded series in a single institution. Plast Reconstr Surg 1998; 102:705.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13719 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-64F316EBC0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33752=[""].join("\n");
var outline_f32_61_33752=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14229038\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14228933\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14228940\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1692579\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3514792\">",
"      HISTOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3514918\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3515538\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1692653\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14228954\">",
"      - Pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H857060\">",
"      - Histological differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14228968\">",
"      Immunohistochemistry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3515548\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14228982\">",
"      EVALUATION AND STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14228989\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1197621\">",
"      Local disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1693603\">",
"      - Approach to treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1196579\">",
"      - Mohs surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1196586\">",
"      - Conventional surgical excision",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14229010\">",
"      - Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1197613\">",
"      Metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14229024\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14229031\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14229038\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13719\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13719|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/63/20466\" title=\"picture 1A\">",
"      Periorbital microcystic adnexal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/39/23155\" title=\"picture 1B\">",
"      Periorbital microcystic adnexal carcinoma outlined",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/18/292\" title=\"picture 1C\">",
"      Microcystic adnexal carcinoma on cheek",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/54/25444\" title=\"picture 1D\">",
"      Microcystic adnexal carcinoma on cheek outlined",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/10/33961\" title=\"picture 2\">",
"      Microcystic adnexal carcinoma keratin cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/2/18474\" title=\"picture 3A\">",
"      Microcystic adnexal carcinoma tumor cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/58/36776\" title=\"picture 3B\">",
"      Microcystic adnexal carcinoma light microscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/40/5768\" title=\"picture 4\">",
"      Microcystic adnexal carcinoma perineural invasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?8/57/9110\" title=\"picture 5\">",
"      Microcystic adnexal carcinoma invading bone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?8/63/9207\" title=\"picture 6\">",
"      Microcystic adnexal carcinoma CEA stain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/33/533\" title=\"picture 7\">",
"      Infiltrative basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/21/30037\" title=\"picture 8\">",
"      Periocular syringomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/29/21969\" title=\"picture 9\">",
"      Recurrent microcystic adnexal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13719|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/41/26269\" title=\"table 1\">",
"      Immunohistochemical staining of cutaneous tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/4/1099\" title=\"table 2\">",
"      Histologic differential of microcystic adnexal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/30/491\" title=\"table 3\">",
"      Clinical differential of microcystic adnexal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/0/5134\" title=\"table 4\">",
"      TNM stage cutaneous SCC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37832?source=related_link\">",
"      Epidemiology and risk factors for skin cancer in solid organ transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/63/17400?source=related_link\">",
"      Mohs surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40264?source=related_link\">",
"      Skin biopsy techniques",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_61_33753="Inhalant abuse in children and adolescents";
var content_f32_61_33753=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Inhalant abuse in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     Erin E Endom, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     Holly Perry, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/61/33753/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/61/33753/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalants are substances with significant acute and chronic toxicity that are abused for their intoxicating properties. They have a wide variety of chemical structures with the majority being hydrocarbons (aliphatic, aromatic, or halogenated), nitrites, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1\">",
"     1",
"    </a>",
"    ]. Inhalants are similar in that they are all volatile substances, highly lipid soluble, and readily absorbed across the pulmonary bed.",
"   </p>",
"   <p>",
"    Inhalant abuse is a common problem in adolescents due to several factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inhalants are readily accessible: An average home has between 30 and 50 products with abuse potential.",
"     </li>",
"     <li>",
"      They are inexpensive and legal to buy and possess.",
"     </li>",
"     <li>",
"      The perceived risk of use is low [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of these factors, inhalants are frequently the first drugs of abuse used by children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. In addition to being a common practice, inhalant abuse is a serious problem as it is associated with permanent brain injury, cardiac dysfunction, liver toxicity, acute renal failure, and death.",
"   </p>",
"   <p>",
"    The epidemiology, clinical manifestations, toxic effects, and management of inhalant use will be reviewed here. Substances that are snorted (eg, cocaine) or smoked (eg, tobacco, marijuana, cocaine, and opiates) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=see_link\">",
"     \"Cocaine: Acute intoxication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=see_link\">",
"     \"Cannabis use disorders: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/3/1079?source=see_link\">",
"     \"Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/28/4554?source=see_link\">",
"     \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/21/22874?source=see_link\">",
"     \"Opioid intoxication in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, inhalant abuse is common with approximately 11 percent of high school students reporting having used inhalants in their lifetime [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/4\">",
"     4",
"    </a>",
"    ]. An estimated 800,000 US children experiment with inhalants annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/5\">",
"     5",
"    </a>",
"    ]. Unlike nearly all other classes of drugs, their use is most common among younger adolescents with use peaking between seventh and ninth grade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of inhalant abuse in children 12 to 18 years old has fluctuated over the past 25 years based on surveys of adolescents. Incidence of use tripled between 1983 and 1993 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/6\">",
"     6",
"    </a>",
"    ], peaking in 1995, and then showed a steady decline until 2002. Since that time, incidence has gradually increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/2\">",
"     2",
"    </a>",
"    ]. Unlike other drugs of abuse, male and female adolescents report a similar rate of inhalant abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/5\">",
"     5",
"    </a>",
"    ]. In the past, Native American children were at higher risk for inhalant abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. However, rates of abuse have fallen steadily in this group since 1985 and are now at levels comparable to the general population. Education on prevention and treatment is thought to be responsible for this trend [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/9\">",
"     9",
"    </a>",
"    ]. A slightly higher incidence of inhalant abuse in rural communities continues to be noted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to national survey data, exposures in 12 to 17 year old patients reported to US regional poison control centers declined from 73 cases per million in 1993 to 33 cases per million in 2003, and the peak age of exposure was 14 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/11\">",
"     11",
"    </a>",
"    ]. Among all patients, there were 167 deaths out of 35,453 exposures between 1993 and 2008. Butane, propane, and air fresheners were associated with the highest fatality rate. Males comprised 73 percent of all cases reported to poison centers suggesting that boys may have riskier inhalant abuse behaviors.",
"   </p>",
"   <p>",
"    Numerous studies have demonstrated significant mental health and behavioral co-morbidities among patients who are inhalant abusers. They are more likely to have an episode of major depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/5,12,13\">",
"     5,12,13",
"    </a>",
"    ], suicidality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/14\">",
"     14",
"    </a>",
"    ], conduct disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/12\">",
"     12",
"    </a>",
"    ], and are at an increased risk for future drug abuse problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Volatile hydrocarbons and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    have a similar mechanism of action. Like ethanol and other inhalational anesthetic agents, they are highly lipid soluble. They are rapidly absorbed across the pulmonary bed into the bloodstream and are distributed throughout the body [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/16\">",
"     16",
"    </a>",
"    ]. Neurons, which have a high lipid content, are particularly susceptible to the solvent properties of these compounds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These inhalants act as central nervous system (CNS) depressants. CNS depression is thought to be mediated by alteration of neuronal membrane function at glutamate or gamma amino butyric acid receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These inhalants produce an effect within seconds that typically lasts 15 to 45 minutes. There have been rare cases of prolonged symptoms when large quantities have been inhaled [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/22\">",
"     22",
"    </a>",
"    ]. Initial euphoria is followed by lethargy. Judgment and coordination are impaired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/23\">",
"     23",
"    </a>",
"    ]. Intoxication is maintained through repeated use. Symptoms of tolerance to the effects of inhalants and physiologic withdrawal have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nitrites produce their pleasurable effects by intense vasodilation which produces a sensation of heat and warmth. Absorption is rapid across the pulmonary bed leading to onset of hypotension and reflex tachycardia within seconds of inhalation. Effects are brief, lasting less than five minutes. Nitrites are also used to enhance sexual pleasure by prolonging penile erection and promoting anal sphincter relaxation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TECHNIQUES (SNIFFING, HUFFING, OR BAGGING)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, the most frequently used inhalants include glue, shoe polish, or toluene (30 percent); gasoline or lighter fluid (25 percent);",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    or \"whippets\" (25 percent); and spray paints (23 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/5\">",
"     5",
"    </a>",
"    ]. Each of these substances may contain more than one toxic compound (",
"    <a class=\"graphic graphic_table graphicRef75970 \" href=\"mobipreview.htm?28/60/29644\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inhalants may be sniffed directly from a container or sprayed directly on to a heated surface to enhance vaporization (\"sniffing\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/24\">",
"     24",
"    </a>",
"    ]. Volatile liquid substances also may be inhaled from a saturated cloth that is held under the nose or near the mouth (\"huffing\"), or from a bag that is placed over the mouth, nose, or head (\"bagging\"). The risk of asphyxia is increased with bagging because the partial pressure of hydrocarbon displaces oxygen in the alveoli. The possibility of a suicide attempt should be considered in an individual who \"bags\" inhalants, particularly when the bag is placed over the head [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25\">",
"     25",
"    </a>",
"    ]. The concentration of the inhaled substance increases from sniffing, to huffing, to bagging.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"     Nitrous oxide",
"    </a>",
"    is abused most commonly as \"whippets\". These are small, cylindrical metal bulbs with a pierceable end that contains compressed nitrous oxide, which are meant for use as a propellant for whipped cream makers. When misused, the end is pierced with a \"cracker\" and the escaping gas is captured in a balloon and then inhaled. Nitrous oxide can also be sniffed from whipped cream canisters.",
"   </p>",
"   <p>",
"    The desired effects of inhalant abuse include euphoria, lightheadedness, and a general state of intoxication similar to that produced by alcohol or marijuana. The effects usually last for only 15 to 30 minutes, but can be sustained by continuous or repeated use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RECOGNITION OF INHALANT ABUSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalant abuse frequently goes undetected. Clues to inhalant abuse include chemical odors on the breath, skin, or clothes, and empty solvent containers or bags, rags, or gauze in the child's possession or trash [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25\">",
"     25",
"    </a>",
"    ]. \"Glue-sniffer's rash\" is an eczematoid dermatitis with erythema, inflammatory changes, and pruritus that occurs in the perioral area and extends to the midface. It is caused by the drying effects of hydrocarbons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/27\">",
"     27",
"    </a>",
"    ]. Symptoms and signs of inhalant use are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef62589 \" href=\"mobipreview.htm?35/58/36780\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TOXICITY AND CLINICAL FINDINGS BY AGENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the vast majority of children who abuse volatile inhalant substances do not seek or require medical attention, inhalant abuse is potentially life-threatening. Death may result from asphyxia, suffocation, choking on vomitus, careless or dangerous behavior in potentially dangerous settings, and sudden sniffing death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/28,29\">",
"     28,29",
"    </a>",
"    ] seen with hydrocarbon abuse, especially halogenated hydrocarbons. Diagnosis of inhalant abuse is primarily based on history or circumstance (eg, patient found unresponsive with toxic inhalant or inhalant apparatus nearby). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Techniques (sniffing, huffing, or bagging)'",
"    </a>",
"    above.) In addition, specific findings are associated with certain agents (",
"    <a class=\"graphic graphic_table graphicRef68976 \" href=\"mobipreview.htm?18/48/19212\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hydrocarbons",
"    </span>",
"    &nbsp;&mdash;&nbsp;Household products abused as inhalants typically contain a mixture of hydrocarbons. They are categorized by structure: aliphatic, aromatic, and halogenated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27736?source=see_link\">",
"     \"Hydrocarbon poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aliphatic compounds are straight-chain compounds and include butane, propane, kerosene, and mineral seal oil. Gasoline is a mixture of aliphatic hydrocarbons that also may contain other substances such as xylene, toluene, benzene, naphthalene, or lead [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/16,30\">",
"     16,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aromatic hydrocarbons are cyclic compounds containing a benzene ring and are used as industrial solvents; benzene, toluene, and xylene are encountered most commonly. Toluene is found in a large number of household products including glues, adhesives, acrylic paints, paint thinners, and automotive products [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Halogenated hydrocarbons include fluorinated hydrocarbons (freons) and chlorinated hydrocarbons (carbon tetrachloride, trichloroethylene, trichloroethane). They are used as solvents, degreasers, and spot removers, and in the dry cleaning industry. Freons are widely used as refrigerants and in fire extinguishers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/31-33\">",
"     31-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most important toxicities are cardiac and neurological, although hydrocarbons are toxic to essentially all body systems. Certain agents are more closely associated with a particular toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     CNS effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute CNS effects include slurred speech, ataxia, disorientation, headache, hallucinations, agitation, violent behavior, and seizures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/6,28,34-36\">",
"     6,28,34-36",
"    </a>",
"    ]. Generalized CNS depression may involve the respiratory centers of the brain, rarely causing respiratory arrest and death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/37\">",
"     37",
"    </a>",
"    ]. Toluene intoxication can cause temporary or progressive cerebellar dysfunction and cranial neuropathies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1,6\">",
"     1,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long-term CNS effects are equally worrisome and include neurocognitive impairment, cerebellar dysfunction, and peripheral neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25,38\">",
"     25,38",
"    </a>",
"    ]. The neurologic findings may be related to loss of brain mass or abnormal perfusion. Computed tomography (CT) and magnetic resonance imaging (MRI) of inhalant users demonstrates loss of brain mass and degeneration of white matter (also called \"toxic leukoencephalopathy\"), respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. Single photon emission computed tomography (SPECT) in long-term inhalant users demonstrates abnormal perfusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abuse of gasoline can lead to persistent peripheral neuropathy and myopathy with myoglobinuria and creatine kinase elevation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. In addition, Parkinsonism can be caused by octane-enhancing additives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/48\">",
"     48",
"    </a>",
"    ], and lead poisoning may occur if lead-containing gasoline is inhaled. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=see_link\">",
"     \"Childhood lead poisoning: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Cardiovascular effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arrhythmias, myocarditis, or myocardial infarction may rarely occur with acute or chronic use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/7,49\">",
"     7,49",
"    </a>",
"    ]. Chronic heavy use of toluene has been reported to result in a statistically significant increase in QT dispersal, a marker for sudden death in a variety of clinical conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    \"Sudden sniffing death\" where a patient has cardiovascular collapse associated with inhalation of volatile compound has been reported with all classes of hydrocarbon, but is most commonly seen in children who abuse halogenated hydrocarbons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/29,51\">",
"     29,51",
"    </a>",
"    ]. Although a rare event, it is unpredictable and can occur in first time users. Commonly, it follows exertion or masturbation, both of which lead to increased catecholamine release [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/29,52\">",
"     29,52",
"    </a>",
"    ]. It is thought to be due to sensitization of the myocardium to catecholamines that is possibly accentuated by hypoxia associated with inhalant abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1,27,29,37\">",
"     1,27,29,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other effects",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Pulmonary effects",
"      </strong>",
"      &ndash; Hypoxia may result from displacement of oxygen in the alveoli, particularly with butane, isobutane, propane, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"       nitrous oxide",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/34\">",
"       34",
"      </a>",
"      ], or suffocation when the patient huffs using a plastic bag. Pneumonitis with surfactant dysfunction, bronchospasm, or noncardiogenic or hemorrhagic pulmonary edema may occur [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/27,31,49,53\">",
"       27,31,49,53",
"      </a>",
"      ]. Exposure to fluorocarbon may cause a reactive airway syndrome similar to asthma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/54\">",
"       54",
"      </a>",
"      ]. Pneumothorax may occur if gas is inhaled directly from a pressurized tank [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/53/40793?source=see_link\">",
"       \"Spontaneous pneumothorax in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Gastrointestinal effects",
"      </strong>",
"      &ndash; The gastrointestinal effects of inhalant use include nausea, vomiting, and abdominal cramps [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/34,49\">",
"       34,49",
"      </a>",
"      ]. Anorexia and loss of weight may occur with chronic abuse [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25\">",
"       25",
"      </a>",
"      ]. Chlorinated solvents such as trichloroethylene and 1,1,1-trichloroethane are hepatotoxic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Renal effects",
"      </strong>",
"      &ndash; Volatile substance use may cause metabolic acidosis, urinary calculi, and glomerulonephritis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/14,21,34,56\">",
"       14,21,34,56",
"      </a>",
"      ]. Toluene, in particular, causes metabolic acidosis with profound potassium and phosphate wasting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/57,58\">",
"       57,58",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21526?source=see_link&amp;anchor=H8#H8\">",
"       \"The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis\", section on 'Toluene inhalation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/17/5402?source=see_link&amp;anchor=H9060678#H9060678\">",
"       \"Causes of hypokalemia\", section on 'Nonreabsorbable anions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Hematologic effects",
"      </strong>",
"      &ndash; Inhalant abuse, particularly chronic abuse of benzene, may cause aplastic anemia and malignancy (eg, leukemia, lymphoma, multiple myeloma) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25,55,59-61\">",
"       25,55,59-61",
"      </a>",
"      ]. Inhalation of methylene chloride (dichloromethane), which is metabolized to carbon monoxide, can result in a clinically important carboxyhemoglobin level [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Dermatologic effects",
"      </strong>",
"      &ndash; \"Glue-sniffer's rash\" is an eczematoid dermatitis with erythema, inflammatory changes, and pruritus that occurs in the perioral area and extends to the midface. It is caused by the drying effects of hydrocarbons [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/27\">",
"       27",
"      </a>",
"      ]. Burns may occur when a flammable inhalant ignites.",
"     </li>",
"     <li>",
"      <strong>",
"       Musculoskeletal effects",
"      </strong>",
"      &ndash; Heavy toluene abuse is associated with generalized muscular weakness (often to the point of quadriparesis) and is typically accompanied by metabolic acidosis, profound hypokalemia, hypophosphatemia, rhabdomyolysis, and elevated creatine kinase. These metabolic abnormalities are caused primarily by the conversion of toluene to hippuric acid, with the subsequent rapid excretion of hippurate in the urine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/63\">",
"       63",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21526?source=see_link&amp;anchor=H8#H8\">",
"       \"The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis\", section on 'Toluene inhalation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Pregnancy and postnatal effects",
"      </strong>",
"      &ndash; Inhalant use during pregnancy may increase the risk of spontaneous abortion, premature delivery, or fetal malformation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/64-66\">",
"       64-66",
"      </a>",
"      ]. Toluene, in particular, is associated with oral clefts, micrognathia, microcephaly, growth deficiency, and developmental delay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/67\">",
"       67",
"      </a>",
"      ]. Infants born to mothers who used inhalants during pregnancy may have symptoms of withdrawal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Miscellaneous",
"      </strong>",
"      &ndash; Trauma can result from falls, drowning, or motor vehicle accidents during the period of intoxication [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/69,70\">",
"       69,70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Nitrous oxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"     Nitrous oxide",
"    </a>",
"    (NO) is used as a propellant in canisters of whipped cream, as a power booster in automobiles and motorcycles, and as a",
"    <span class=\"nowrap\">",
"     sedative/amnestic",
"    </span>",
"    agent for painful medical and dental procedures. It usually is inhaled from a balloon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/23\">",
"     23",
"    </a>",
"    ]. Neurologic, hematologic, and reproductive toxicity may result from exposure to NO.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Neurologic effects",
"      </strong>",
"      &ndash; Neurologic toxicity is well documented in patients who abuse NO. Abuse is associated with a myriad of neurological findings including polyneuropathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/26,71-73\">",
"       26,71-73",
"      </a>",
"      ], ataxia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/72,74,75\">",
"       72,74,75",
"      </a>",
"      ], and psychosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/74,76\">",
"       74,76",
"      </a>",
"      ]. Neurotoxicity is potentially reversible with B12 supplementation and abstinence from NO.",
"      <br/>",
"      <br/>",
"      The neurotoxicity of NO is due to its effects on vitamin B12. Vitamin B12 is a coenzyme of methionine synthase.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"       Nitrous oxide",
"      </a>",
"      converts vitamin B12 from the active monovalent form to the inactive bivalent form, thereby causing an irreversible inhibition of methionine synthase. Methionine synthase is a ubiquitous cytosolic enzyme that plays a crucial role in the generation of methyl groups for the synthesis of DNA, RNA, and myelin, among other products. The clinical effects are similar to the subacute combined degeneration syndrome associated with pernicious anemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/77\">",
"       77",
"      </a>",
"      ]. Nitrous oxide is known to precipitate vitamin B12 deficiency when used on a chronic basis or acutely in patients with marginal stores of vitamin B12 such as the elderly or malnourished [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Hematologic effects",
"      </strong>",
"      &ndash; NO has the potential for causing megaloblastic anemia on the basis of its interaction with B12. This has not been reported in patients who abuse NO, although it has been noted when NO was used as an anesthetic agent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/78,79\">",
"       78,79",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Reproductive effects",
"      </strong>",
"      &ndash; Given NO effects on Vitamin B12 and methionine synthase, it is plausible to assume that NO may have reproductive health risks. Animal studies have demonstrated fetotoxicity with prolonged exposure to NO. Human studies are difficult to interpret given the number of confounding variables [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/21\">",
"       21",
"      </a>",
"      ]. However, a study of occupationally exposed healthcare workers has demonstrated a dose-dependent correlation between NO exposure and DNA damage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Pulmonary effects",
"      </strong>",
"      &ndash; Pneumothorax may occur if gas is inhaled directly from a pressurized tank [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25,81\">",
"       25,81",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/53/40793?source=see_link\">",
"       \"Spontaneous pneumothorax in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Nitrites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alkyl nitrites (amyl, butyl, and isobutyl nitrites) have been used and abused for nearly 150 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/82\">",
"     82",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/25/405?source=see_link\">",
"     Amyl nitrite",
"    </a>",
"    is available by prescription for treatment of angina pectoris and as part of the \"cyanide kit\" for treatment of cyanide toxicity. It is available in a glass ampule encased in a woven absorbent covering. The ampule is broken or \"popped\" and the covering held close to the nose and inhaled. Butyl and isobutyl nitrites (also known as \"Rush\" and \"Climax\") are used as room deodorizers, particularly for locker rooms. They also are sold as \"liquid incense.\" They were banned by the Anti-Drug Abuse Act of 1988, but are still available illegally, as are isopropyl and cyclohexyl nitrites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/82\">",
"     82",
"    </a>",
"    ]. They are typically sniffed directly from the container.",
"   </p>",
"   <p>",
"    Inhalation of nitrate causes smooth muscle relaxation resulting in peripheral vasodilatation, flushing, and hypotension with reflex tachycardia. Dilation of cerebral blood vessels causes an increase in intracranial pressure (the \"rush\" reportedly experienced by users), headache, nausea, and syncope. Skin irritation, tracheobronchitis, and allergic reactions with wheezing and pruritus may occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/83,84\">",
"     83,84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inhalation of nitrite may cause acute acquired methemoglobinemia, although this toxicity is much more common after oral ingestions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/82,85\">",
"     82,85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/46/43753?source=see_link&amp;anchor=H8#H8\">",
"     \"Extrinsic nonautoimmune hemolytic anemia due to drugs and toxins\", section on 'Nitrites'",
"    </a>",
"    .) Patients with acute acquired methemoglobinemia are symptomatic because the acute impairment of oxygen delivery to tissues does not allow sufficient time for compensatory mechanisms. Early symptoms include headache, fatigue, dyspnea, and lethargy. At higher methemoglobin levels (eg, greater than 70 percent), respiratory depression, altered consciousness, shock, seizures, and death may occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/16,82,86,87\">",
"     16,82,86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, nitrite vapors are highly flammable, and serious burn injuries can occur if the substance comes into contact with a candle, cigarette, or other open flame.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with inhalant intoxication should have the following performed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pulse oximetry",
"     </li>",
"     <li>",
"      Electrocardiogram and continuous cardiac monitoring for arrhythmias",
"     </li>",
"     <li>",
"      Urine screen for drugs of abuse",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, the following may be performed, especially in adolescents suspected of chronic abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete blood count to evaluate for bone marrow suppression (benzene abuse)",
"     </li>",
"     <li>",
"      Serum electrolytes to identify hypokalemia and metabolic acidosis (toluene abuse)",
"     </li>",
"     <li>",
"      Liver enzymes (AST [aspartate aminotransferase] and ALT [alanine aminotransferase]), blood urea nitrogen, and serum creatinine to detect liver or renal impairment (halogenated hydrocarbons)",
"     </li>",
"     <li>",
"      Urine rapid dipstick and microscopic urinalysis to assess for renal tubular acidosis (chronic toluene use) or findings consistent with interstitial nephritis (halogenated hydrocarbons). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/32/10759?source=see_link\">",
"       \"Overview of renal tubular acidosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Methemoglobin levels should be obtained if nitrite abuse is suspected or if clinical features of methemoglobinemia are evident (eg, chocolate brown venous blood or cyanosis that does not resolve with supplemental oxygen). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A venous blood lead level is appropriate in patients in whom volatile abuse using leaded gasoline is suspected.",
"   </p>",
"   <p>",
"    A chest radiograph should be obtained in patients with hypoxemia, rales, or respiratory distress. Abnormalities on chest radiograph may develop as late as 24 hours after exposure in symptomatic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/27\">",
"     27",
"    </a>",
"    ]. They include increased bronchovascular markings, bibasilar and perihilar infiltrates, and pneumatoceles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although exposure to some hydrocarbons may be confirmed by detection of urinary metabolites (eg, trichloroethanol after chlorinated hydrocarbon exposure, hippuric acid after toluene exposure) or directly measured in the blood (eg, toluene), these laboratory studies are not rapidly available and do not change management priorities. Thus, the diagnosis of hydrocarbon exposure is based on clinical features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many other toxins may cause altered mental status or cardiac arrhythmias in overdose. Often, characteristic clinical findings can help differentiate these from inhalant abuse (",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"mobipreview.htm?43/6/44140\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When hydrocarbons are inhaled, the characteristic sweet solvent odor of halogenated hydrocarbons or the \"glue\" odor of toluene may be detectable on the breath.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of acute inhalant intoxication is supportive. Maintenance of cardiorespiratory function and removal of the child from the source of the toxin (eg, bottle, rag or bag, or contaminated clothing) are of primary importance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplemental 100 percent oxygen by a nonrebreather face mask is administered to treat hypoxia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Airway and breathing",
"      </strong>",
"      &ndash; Respiratory depression often responds transiently to tactile stimulation of the patient. However, clinicians should proceed with endotracheal intubation and mechanical ventilation if there is any doubt about the patient's ability to breathe adequately on their own or if pulmonary aspiration poses a significant risk.",
"     </li>",
"     <li>",
"      <strong>",
"       Circulation",
"      </strong>",
"      &ndash; Children with ventricular arrhythmias should receive countershock treatment according to standard protocols (",
"      <a class=\"graphic graphic_algorithm graphicRef67438 \" href=\"mobipreview.htm?11/37/11860\">",
"       algorithm 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_algorithm graphicRef80003 \" href=\"mobipreview.htm?41/30/42470\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/49/21272?source=see_link\">",
"       \"Defibrillation and cardioversion in children (including automated external defibrillation)\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Children who have inhaled halogenated hydrocarbons may develop ventricular arrhythmias in response to parenterally administered epinephrine or other catecholamines (eg, norepinephrine) because these treatments can precipitate or worsen arrhythmias in the irritable myocardium [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/49,61\">",
"       49,61",
"      </a>",
"      ]. In contrast,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/41/9882?source=see_link\">",
"       amiodarone",
"      </a>",
"      has been successfully used to treat butane-induced ventricular fibrillation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/88\">",
"       88",
"      </a>",
"      ]. We suggest that these patients receive intravenous amiodarone (5 mg per kilogram) or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/57/37776?source=see_link\">",
"       lidocaine",
"      </a>",
"      (1 mg per kilogram) instead of catecholamines.",
"      <br/>",
"      <br/>",
"      For patients who persist with ventricular arrhythmias despite the use of Pediatric Advanced Life Support protocols, the clinician may attempt administration of",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/62/36840?source=see_link\">",
"       propranolol",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/48/5895?source=see_link\">",
"       esmolol",
"      </a>",
"      , which have reversed arrhythmias in patients poisoned with trichloroethylene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/89,90\">",
"       89,90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Antidotes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific antidotes may be necessary to treat methemoglobinemia caused by nitrite exposure or lead toxicity due to inhalation of leaded gasoline:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with methemoglobinemia who are symptomatic should be treated with high-dose oxygen and intravenous",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/61/20438?source=see_link\">",
"       methylene blue",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=see_link&amp;anchor=H24#H24\">",
"       \"Clinical features, diagnosis, and treatment of methemoglobinemia\", section on 'Acquired methemoglobinemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lead toxicity may require chelation therapy, depending on the results of lead levels obtained from whole blood. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/5/21594?source=see_link\">",
"       \"Childhood lead poisoning: Management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Psychiatric care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acutely, patients with findings of inhalation abuse should undergo screening for depression and suicidality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term management includes referral for addiction treatment and a formal period of detoxification if indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25\">",
"     25",
"    </a>",
"    ]. Chronic complications of abuse may resolve if the patient remains drug-free. Polydrug use and coexisting psychopathology are common occurrences, complicating the treatment of these children. Residential treatment may improve outcome. Systematic data comparing different approaches to treatment are lacking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with significant toxicity marked by central nervous system findings (eg, coma, seizures) or cardiac arrhythmias warrant hospital admission to a unit with pediatric critical care capability.",
"   </p>",
"   <p>",
"    Children who receive treatment for methemoglobinemia or lead toxicity may also require admission depending on the degree of toxicity.",
"   </p>",
"   <p>",
"    Children who express suicidal thoughts need urgent psychiatric evaluation for possible admission to a mental health facility.",
"   </p>",
"   <p>",
"    Patients who are asymptomatic in the emergency department or have mild symptoms (eg, lethargy) that quickly resolve may be discharged home as long as appropriate mental health and primary care follow-up are assured.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Pediatrics encourages pediatricians to increase their awareness of the clinical features and complications of inhalant abuse and to promote education about the health hazards of inhalants to children, adolescents, parents, teachers, and vendors of volatile substances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/61/33753/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Massachusetts Department of Public Health has developed a suggested action plan for prevention of inhalant abuse (",
"    <a class=\"external\" href=\"file://www.mass.gov/eohhs/gov/departments/dph/programs/substance-abuse/prevention/inhalant-abuse/prevention/suggested-action-plan.html\">",
"     file://www.mass.gov/eohhs/gov/departments/dph/programs/substance-abuse/prevention/inhalant-abuse/prevention/suggested-action-plan.html",
"    </a>",
"    ). Their suggestions include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Review purchases of school supplies and substitute water-based products for solvent-based products whenever possible. Explain that the school is looking for ways to reduce indoor air pollution. Describing solvent-based products as inhalants or drugs may arouse the curiosity of students.",
"     </li>",
"     <li>",
"      Closely monitor the use of solvent-based products and gases; in schools, such products should be checked out and in.",
"     </li>",
"     <li>",
"      Provide information to school faculty, staff, and nurses.",
"     </li>",
"     <li>",
"      Educate parents about the dangers of inhalant abuse.",
"     </li>",
"     <li>",
"      Review the appropriate use and consequences of misuse of solvents and gases whenever these products are used (eg, vocational programs, science, art).",
"     </li>",
"     <li>",
"      Develop a plan of action to treat students who use inhalants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11202453\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalant abuse is common. Unlike nearly all other classes of drugs, their use is most prevalent among younger adolescents with use peaking between seventh and ninth grade among school children in the United States. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Abuse",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Volatile substances produce a rapid feeling of euphoria and inebriation because of their rapid absorption through the pulmonary vascular bed and their lipophilic properties that allow for quick deposition into the brain. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Mechanism of action'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most frequently used inhalants include glue, shoe polish, or toluene; gasoline or lighter fluid;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"       nitrous oxide",
"      </a>",
"      or \"whippets\"; and spray paints. Each of these substances may contain more than one toxic compound (",
"      <a class=\"graphic graphic_table graphicRef75970 \" href=\"mobipreview.htm?28/60/29644\">",
"       table 1",
"      </a>",
"      ). Common methods of abuse involve sniffing, huffing, or bagging to concentrate the inhaled substance. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Techniques (sniffing, huffing, or bagging)'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalant abuse frequently goes undetected. Clues to inhalant abuse include chemical odors on the breath, skin, or clothes and empty solvent containers or bags, rags, or gauze in the child's possession or trash. Children may also display characteristic skin changes (eg, glue sniffer's rash) (",
"    <a class=\"graphic graphic_table graphicRef62589 \" href=\"mobipreview.htm?35/58/36780\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Recognition of inhalant abuse'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inhalant abuse is potentially life-threatening. Death may result from asphyxia, suffocation, choking on vomitus, careless or dangerous behavior in potentially dangerous settings, and sudden sniffing death seen with hydrocarbon abuse. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Toxicity and clinical findings by agent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac arrhythmias and central nervous system dysfunction (inebriation, agitation, seizures) are the most concerning acute toxic effects of volatile inhalants, especially hydrocarbons. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Toxicity and clinical findings by agent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional findings or chronic toxicity varies by agent including (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Toxicity and clinical findings by agent'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Methemoglobinemia (nitrites)",
"     </li>",
"     <li>",
"      Lead toxicity (leaded gasoline)",
"     </li>",
"     <li>",
"      Polyneuropathy and megaloblastic anemia (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"       nitrous oxide",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Muscle weakness, renal tubular acidosis (toluene)",
"     </li>",
"     <li>",
"      Carbon monoxide poisoning (methylene chloride)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Management of acute inhalant intoxication primarily consists of support of airway, breathing, and circulation (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Supportive care'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Supplemental 100 percent oxygen by a nonrebreather face mask should be administered to treat hypoxia.",
"     </li>",
"     <li>",
"      Clinicians should proceed with endotracheal intubation and mechanical ventilation if there is any doubt about the patient's ability to breathe adequately on their own or if pulmonary aspiration poses a significant risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with ventricular arrhythmias should receive treatment according to standard protocols (",
"      <a class=\"graphic graphic_algorithm graphicRef67438 \" href=\"mobipreview.htm?11/37/11860\">",
"       algorithm 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_algorithm graphicRef80003 \" href=\"mobipreview.htm?41/30/42470\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/49/21272?source=see_link\">",
"       \"Defibrillation and cardioversion in children (including automated external defibrillation)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with cardiac arrhythmias caused by inhalation of halogenated hydrocarbons may have worsening cardiovascular status in response to epinephrine or other catecholamines (eg, dopamine, norepinephrine). We suggest that these patients receive intravenous",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/41/9882?source=see_link\">",
"       amiodarone",
"      </a>",
"      (5 mg per kilogram) or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/57/37776?source=see_link\">",
"       lidocaine",
"      </a>",
"      (1 mg per kilogram) instead of catecholamines (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Specific antidotes may be necessary to treat methemoglobinemia caused by nitrite exposure or lead toxicity due to inhalation of leaded gasoline. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=see_link&amp;anchor=H24#H24\">",
"       \"Clinical features, diagnosis, and treatment of methemoglobinemia\", section on 'Acquired methemoglobinemia'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/5/21594?source=see_link\">",
"       \"Childhood lead poisoning: Management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acutely, patients with findings of inhalation abuse should undergo screening for depression and suicidality. Long-term management includes referral for addiction treatment and a formal period of detoxification if indicated. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Psychiatric care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/1\">",
"      Dinwiddie SH. Abuse of inhalants: a review. Addiction 1994; 89:925.",
"     </a>",
"    </li>",
"    <li>",
"     Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Abuse: Overview of Key Findings, 2010. 2011. file://www.monitoringthefuture.org/pubs/monographs/mtf-overview2010.pdf (Accessed on November 30, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/3\">",
"      Young SJ, Longstaffe S, Tenenbein M. Inhalant abuse and the abuse of other drugs. Am J Drug Alcohol Abuse 1999; 25:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/4\">",
"      Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ 2012; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/6\">",
"      Neumark YD, Delva J, Anthony JC. The epidemiology of adolescent inhalant drug involvement. Arch Pediatr Adolesc Med 1998; 152:781.",
"     </a>",
"    </li>",
"    <li>",
"     Osterhoudt KC, Burns Ewald M, Shannon M, Henretig FM. Toxicologic emergencies. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.951.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/8\">",
"      Beauvais F. Comparison of drug use rates for reservation Indian, non-reservation Indian and Anglo youth. Am Indian Alsk Native Ment Health Res 1992; 5:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/9\">",
"      Beauvais F, Jumper-Thurman P, Burnside M. The changing patterns of drug use among American Indian students over the past 30 years. Am Indian Alsk Native Ment Health Res 2008; 15:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/10\">",
"      Spiller H, Lorenz DJ. Trends in volatile substance abuse. J Addict Dis 2009; 28:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/11\">",
"      Marsolek MR, White NC, Litovitz TL. Inhalant abuse: monitoring trends by using poison control data, 1993-2008. Pediatrics 2010; 125:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/12\">",
"      Howard MO, Walker RD, Walker PS, et al. Inhalant use among urban American Indian youth. Addiction 1999; 94:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/13\">",
"      Sakai JT, Hall SK, Mikulich-Gilbertson SK, Crowley TJ. Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry 2004; 43:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/14\">",
"      Freedenthal S, Vaughn MG, Jenson JM, Howard MO. Inhalant use and suicidality among incarcerated youth. Drug Alcohol Depend 2007; 90:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/15\">",
"      Johnson EO, Sch&uuml;tz CG, Anthony JC, Ensminger ME. Inhalants to heroin: a prospective analysis from adolescence to adulthood. Drug Alcohol Depend 1995; 40:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/16\">",
"      McHugh MJ. The abuse of volatile substances. Pediatr Clin North Am 1987; 34:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/17\">",
"      Kurtzman TL, Otsuka KN, Wahl RA. Inhalant abuse by adolescents. J Adolesc Health 2001; 28:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/18\">",
"      Chadwick O, Anderson R, Bland M, Ramsey J. Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. BMJ 1989; 298:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/19\">",
"      Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG. Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev 1989; 41:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/20\">",
"      Jevtovi-Todorovi V, Todorovi SM, Mennerick S, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 1998; 4:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/21\">",
"      Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology 2008; 109:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/22\">",
"      Harris D, Mirza Z. Butane encephalopathy. Emerg Med J 2005; 22:676.",
"     </a>",
"    </li>",
"    <li>",
"     A campaign to prevent inhalant abuse. Bureau of Substance Abuse Services, Massachusetts Department of Public Health.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/24\">",
"      Henretig F. Inhalant abuse in children and adolescents. Pediatr Ann 1996; 25:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/25\">",
"      Espeland K. Identifying the manifestations of inhalant abuse. Nurse Pract 1995; 20:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/26\">",
"      Brust JC. Other agents. Phencyclidine, marijuana, hallucinogens, inhalants, and anticholinergics. Neurol Clin 1993; 11:555.",
"     </a>",
"    </li>",
"    <li>",
"     McManus B. Hydrocarbons. In: Pediatric Emergency Medicine: A Comprehensive Study Guide, Strange GR, Ahrens W, Lelyveld S, Schafermeyer R.  (Eds), McGraw Hill, New York 1996. p.538.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/28\">",
"      Inhalant abuse. American Academy of Pediatrics, Committee on Substance Abuse and Committee on Native American Child Health. Pediatrics 1996; 97:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/29\">",
"      Bass M. Sudden sniffing death. JAMA 1970; 212:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/30\">",
"      Hernberg S. Lead poisoning in a historical perspective. Am J Ind Med 2000; 38:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/31\">",
"      Kurbat RS, Pollack CV Jr. Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 1998; 16:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/32\">",
"      Wegener EE, Barraza KR, Das SK. Severe frostbite caused by Freon gas. South Med J 1991; 84:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/33\">",
"      Gerhardt RT. Acute Halon (bromochlorodifluoromethane) toxicity by accidental and recreational inhalation. Am J Emerg Med 1996; 14:675.",
"     </a>",
"    </li>",
"    <li>",
"     Scalzo AJ. Inhalation injuries. In: Pediatric Emergency Medicine: Concepts and Clinical Practice, Barkin RM.  (Ed), Mosby, St. Louis 1997. p.594.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/35\">",
"      Weaver MF, Jarvis MA, Schnoll SH. Role of the primary care physician in problems of substance abuse. Arch Intern Med 1999; 159:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/36\">",
"      Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol 1989; 8:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/37\">",
"      Shepherd RT. Mechanism of sudden death associated with volatile substance abuse. Hum Toxicol 1989; 8:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/38\">",
"      Y&uuml;cel M, Takagi M, Walterfang M, Lubman DI. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev 2008; 32:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/39\">",
"      Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol Scand 1983; 67:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/40\">",
"      Rosenberg NL, Spitz MC, Filley CM, et al. Central nervous system effects of chronic toluene abuse--clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988; 10:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/41\">",
"      Filley CM, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology 1990; 40:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/42\">",
"      Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/43\">",
"      K&uuml;&ccedil;&uuml;k NO, Kili&ccedil; EO, Ibis E, et al. Brain SPECT findings in long-term inhalant abuse. Nucl Med Commun 2000; 21:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/44\">",
"      Fortenberry JD. Gasoline sniffing. Am J Med 1985; 79:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/45\">",
"      Gallassi R, Montagna P, Pazzaglia P, et al. Peripheral neuropathy due to gasoline sniffing - A case report. Eur Neurol 1980; 19:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/46\">",
"      Kovanen J, Somer H, Schroeder P. Acute myopathy associated with gasoline sniffing. Neurology 1983; 33:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/47\">",
"      Maruff P, Burns CB, Tyler P, et al. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain 1998; 121 ( Pt 10):1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/48\">",
"      Tenenbein M. Leaded gasoline abuse: the role of tetraethyl lead. Hum Exp Toxicol 1997; 16:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/49\">",
"      Carder JR, Fuerst RS. Myocardial infarction after toluene inhalation. Pediatr Emerg Care 1997; 13:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/50\">",
"      Alper AT, Akyol A, Hasdemir H, et al. Glue (toluene) abuse: increased QT dispersion and relation with unexplained syncope. Inhal Toxicol 2008; 20:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/51\">",
"      Adgey AA, Johnston PW, McMechan S. Sudden cardiac death and substance abuse. Resuscitation 1995; 29:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/52\">",
"      Poklis A. Letter: Sudden sniffing death. Can Med Assoc J 1976; 115:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/53\">",
"      Fitzgerald RL, Fishel CE, Bush LL. Fatality due to recreational use of chlorodifluoromethane and chloropentafluoroethane. J Forensic Sci 1993; 38:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/54\">",
"      de la Hoz RE. Reactive airways dysfunction syndrome following exposure to a fluorocarbon. Eur Respir J 1999; 13:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/55\">",
"      Marjot R, McLeod AA. Chronic non-neurological toxicity from volatile substance abuse. Hum Toxicol 1989; 8:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/56\">",
"      Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance--United States, 2007. MMWR Surveill Summ 2008; 57:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/57\">",
"      Streicher HZ, Gabow PA, Moss AH, et al. Syndromes of toluene sniffing in adults. Ann Intern Med 1981; 94:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/58\">",
"      Taher SM, Anderson RJ, McCartney R, et al. Renal tubular acidosis associated with toluene \"sniffing\". N Engl J Med 1974; 290:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/59\">",
"      VIGLIANI EC, SAITA G. BENZENE AND LEUKEMIA. N Engl J Med 1964; 271:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/60\">",
"      Rosner F, Gr&uuml;nwald HW. Cytotoxic drugs and leukaemogenesis. Clin Haematol 1980; 9:663.",
"     </a>",
"    </li>",
"    <li>",
"     Shih RD. Hydrocarbons. In: Toxicological Emergencies, Goldfrank LR, Flomenbaum NE, Lewin NA, et al.  (Eds), Appleton and Lange, Stamford 1998. p.1384.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/62\">",
"      Sturmann K, Mofenson H, Caraccio T. Methylene chloride inhalation: an unusual form of drug abuse. Ann Emerg Med 1985; 14:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/63\">",
"      Carlisle EJ, Donnelly SM, Vasuvattakul S, et al. Glue-sniffing and distal renal tubular acidosis: sticking to the facts. J Am Soc Nephrol 1991; 1:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/64\">",
"      Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am 1998; 25:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/65\">",
"      Arnold GL, Kirby RS, Langendoerfer S, Wilkins-Haug L. Toluene embryopathy: clinical delineation and developmental follow-up. Pediatrics 1994; 93:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/66\">",
"      Khattak S, K-Moghtader G, McMartin K, et al. Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study. JAMA 1999; 281:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/67\">",
"      Hersh JH. Toluene embryopathy: two new cases. J Med Genet 1989; 26:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/68\">",
"      Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatal Ed 1996; 74:F204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/69\">",
"      Broussard LA, Brustowicz T, Pittman T, et al. Two traffic fatalities related to the use of difluoroethane. J Forensic Sci 1997; 42:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/70\">",
"      Bowen SE, Daniel J, Balster RL. Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend 1999; 53:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/71\">",
"      Layzer RB, Fishman RA, Schafer JA. Neuropathy following abuse of nitrous oxide. Neurology 1978; 28:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/72\">",
"      Vishnubhakat SM, Beresford HR. Reversible myeloneuropathy of nitrous oxide abuse: serial electrophysiological studies. Muscle Nerve 1991; 14:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/73\">",
"      Cartner M, Sinnott M, Silburn P. Paralysis caused by \"nagging\". Med J Aust 2007; 187:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/74\">",
"      Iwata K, O'Keefe GB, Karanas A. Neurologic problems associated with chronic nitrous oxide abuse in a non-healthcare worker. Am J Med Sci 2001; 322:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/75\">",
"      Miller MA, Martinez V, McCarthy R, Patel MM. Nitrous oxide \"whippit\" abuse presenting as clinical B12 deficiency and ataxia. Am J Emerg Med 2004; 22:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/76\">",
"      Sethi NK, Mullin P, Torgovnick J, Capasso G. Nitrous oxide \"whippit\" abuse presenting with cobalamin responsive psychosis. J Med Toxicol 2006; 2:71.",
"     </a>",
"    </li>",
"    <li>",
"     Kaufman B, Sutin KM, Wahlander S, Miller SM. Anesthetics and neuromuscular blocking agents. In: Goldfrank's Toxicologic Emergencies, 6th, Goldfrank CR, Flomenbaum NE, Lewin NA, et al.  (Eds), Appleton &amp; Lange, Stamford 1998. p.873.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/78\">",
"      Amos RJ, Amess JA, Hinds CJ, Mollin DL. Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care. Lancet 1982; 2:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/79\">",
"      Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006; 5:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/80\">",
"      Wroska-Nofer T, Palus J, Krajewski W, et al. DNA damage induced by nitrous oxide: study in medical personnel of operating rooms. Mutat Res 2009; 666:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/81\">",
"      Garbaz L, Mispelaere D, Boutemy M, Jounieaux V. [Pneumothorax following recreational inhalation of nitrous oxide]. Rev Mal Respir 2007; 24:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/82\">",
"      Haverkos HW, Kopstein AN, Wilson H, Drotman P. Nitrite inhalants: history, epidemiology, and possible links to AIDS. Environ Health Perspect 1994; 102:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/83\">",
"      Haverkos HW, Dougherty J. Health hazards of nitrite inhalants. Am J Med 1988; 84:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/84\">",
"      Lange WR, Fralich J. Nitrite inhalants: promising and discouraging news. Br J Addict 1989; 84:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/85\">",
"      Bogart L, Bonsignore J, Carvalho A. Massive hemolysis following inhalation of volatile nitrites. Am J Hematol 1986; 22:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/86\">",
"      Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf 1996; 14:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/87\">",
"      Bradberry SM, Whittington RM, Parry DA, Vale JA. Fatal methemoglobinemia due to inhalation of isobutyl nitrite. J Toxicol Clin Toxicol 1994; 32:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/88\">",
"      Edwards KE, Wenstone R. Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br J Anaesth 2000; 84:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/89\">",
"      Mortiz F, de La Chapelle A, Bauer F, et al. Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning. Intensive Care Med 2000; 26:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/61/33753/abstract/90\">",
"      Gindre G, Le Gall S, Condat P, Bazin JE. [Late ventricular fibrillation after trichloroethylene poisoning]. Ann Fr Anesth Reanim 1997; 16:202.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6502 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33753=[""].join("\n");
var outline_f32_61_33753=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TECHNIQUES (SNIFFING, HUFFING, OR BAGGING)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RECOGNITION OF INHALANT ABUSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TOXICITY AND CLINICAL FINDINGS BY AGENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hydrocarbons",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - CNS effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Nitrous oxide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Nitrites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Supportive care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Antidotes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Psychiatric care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Disposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11202453\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Abuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6502\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6502|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?11/37/11860\" title=\"algorithm 1\">",
"      Pediatric tachycardia algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?41/30/42470\" title=\"algorithm 2\">",
"      Pediatric cardiac arrest algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6502|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/60/29644\" title=\"table 1\">",
"      Toxic ingredients inhalants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/58/36780\" title=\"table 2\">",
"      Signs and symptoms of volatile inhalant abuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/48/19212\" title=\"table 3\">",
"      Volatile inhalant toxicities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/6/44140\" title=\"table 4\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=related_link\">",
"      Cannabis use disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/3/1079?source=related_link\">",
"      Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/28/4554?source=related_link\">",
"      Cannabis use disorders: Treatment, prognosis, and long-term medical effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/17/5402?source=related_link\">",
"      Causes of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=related_link\">",
"      Childhood lead poisoning: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/5/21594?source=related_link\">",
"      Childhood lead poisoning: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/49/21272?source=related_link\">",
"      Defibrillation and cardioversion in children (including automated external defibrillation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/46/43753?source=related_link\">",
"      Extrinsic nonautoimmune hemolytic anemia due to drugs and toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27736?source=related_link\">",
"      Hydrocarbon poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/21/22874?source=related_link\">",
"      Opioid intoxication in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/32/10759?source=related_link\">",
"      Overview of renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/53/40793?source=related_link\">",
"      Spontaneous pneumothorax in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21526?source=related_link\">",
"      The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_61_33754="Large plaque parapsoriasis 1";
var content_f32_61_33754=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87288%7EDERM%2F87289%7EDERM%2F68028%7ECALC%2F86681&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87288%7EDERM%2F87289%7EDERM%2F68028%7ECALC%2F86681&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large plaque parapsoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 498px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large, irregular, erythematous patches on the back of a patient with large plaque parapsoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large plaque parapsoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Irregularly shaped, erythematous patches, some of which larger than 10 cm in diameter, are characteristic of large plaque parapsoriasis.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large plaque parapsoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDt5D+/AOS23CnsB/ntV5Q8jLlvlx1HeqsW47g6EKP73QVZSQr8wOF2/L6GvPPan2JnkSKRcjL9Gz7VArIgkfkkHOzGeKbNgqWVhvXnJPPviiS4SONAYyzE4LEgUyOQdZz72kkaNWRekeOV7cntUbGR5CFA2ZyETncfTNMdQYcxq+5/4FGePXPtUET+WvmFmEjHLZB47VLZvGKbLoklLSSSKI24BU4HP402KUhGHzhuR97AOfX/AAqBpGZUSXzOhYDHA9x7VPGqsqnCZyOoOQfXrSuDiogEV5I2fvzgHj3q5LMFQhUDHGPm6Y+lQSRna5MhRSRlj8pP+FNR3wcbSBzwc7e+Cad+xLV9yVSyEkhdu0biwyB7VMJi3zH7pcN+lV45vNhO4joGG09asLIiRLlBsGDtPrTRlJa2sVkThjt5+YjPWmxwyKNxO5lwrKp5/CpdwRt2ME5xkVEhZWUD5CeCPQdaA1HT/OEEhJBBx+B5/Gq955sccbqhPzABcZK+9WJcOqMo3MCf+A0Md4Up97G0n+tA07DFbOGTERHJ459sVNEq7mlVQWPJJGMn61XyxlVTllRSAB7VZLGSN4drKSv3sfd75oL0Qxo5VWOYbCHk528BfeiHDFhkKmWKv6D396eS6REMpZemPX6U/A+0nIKx4AyRkUCvoEDK8olVWRsZIU43YokVpFZJRvA5O72pI+FDjJJ6g8HtjmmKjI8mBlH+ZiCc4xyPegXoT3ShREAw2FTnaRx9R+dQmLe8I5DpnoxAz7/hUiSH7R5bDaQudxUdxUa5G9/MJX7w3dcDtQJN7EkjJ5LNnJjJY+//ANeovN/dCZQWYkHa3H4imxFipxhcDJPfnt9asLwpj2qFduWPt1oSE7IkYvPHDjcqoOVGMHPr9KaVeSZwuPL4IOAWPY5/nUdvLHNOyuxQI4AL/wA8VLLK7Rp5R299wA55/QUCtYfagxvIVYsCuMcce1SrIGjkdS6hQflI/SqsodYkKlCWODyehpyGQtGI3CpyuAveqehPLzasssyGFWKmNmUblHQCob2cyyjYQQCOq4JPpTJBut/Jkc7d5YNknZjoKmcxyKUUncOS3dvajoVFJWsQsSQGOVVcr1wc0RxsY0EpDGTJ+X+Cn2kbySyyElo+Ag2/oabJujjLGICQtt6ce9D2Kvd2RGECeaRKWOcFmbIC9+1TyfvISI3ZlkAA+bv/APrqp5Q2kSYKtlcA8jvz/hUgQ+XGwVQORtU9ulJOwSj1ItU1GLT4lSZ1U4DdenbOaggcSKrxAEszZOMZB5zRrFhb3p/fguq4Y9gSOgNTWVvIoA3/ACBAAMdPpQ3cpciirblyGJcFiQJFXueg9qqW06S6jPw7SxkZ54Yfzq1JDvZ3R8Z+UY749+1R20e0F4kCljk5/wA96G2TFKzLXI3EhQeQMc/z6VUuZfLRfK3Echiv61PFKLhEDqChOcejZ6ZpJsK+UDNwBgDGD6UPVCjZPUhjUSKGZFIK7hu4I60svzSIyMQANpAGc+tOG2OIktu3ElRzn6Cq8snnRqVGSG+7jA9qRbHQZXcshBwSxZR27VEfMZxHgAFjg9se9OkLI+Vyu7k5Ocfj9aRsN5byjG3Iwfp3oBeYksAVixBLvyTnIz1/Co1kkIZTn88HpmizbzYQ7xyRFSdu5h+vrSSKVYYYlx82B06YoCz2J4NpPyE7VGe/J61CZVK5ChV6YIxmnB2ESqXXcSMcdv8AGoZiJsrKwwybcADj0pgo6mNq+g21xdJciSQSccAgAr6VYuI0ubdVjkKnIYtnoB2/pUt2VihJLbmQ9G6gAcVHagrEJFG1nG4ZHT8Km1nc6eaXKtdiOeB2GCwDgZ69sVQSTyYSHbzD0Bfkn3qysu9pyctyBz3Pt7Vn3IeYh5GKlCQwIxih6lW6M6OSZymEJLnILMuev1qnaSsr+S8jEr6ngHvUMEjNLy4Ehxt3HH86SQg3cuXGFHLY6npj3pXDkS0LTyxrcOvmBuMbsZIFSXM6z8RvnkDLdcY7D1rOuFihmkePzNoUHJGRnuD3+lT2rB596CR8DO0DDfmOlNai5FuaVrKR5KKN7MCrDrj3FNn2B4wDsbPORz9DWfLlXOxpEOR8hXH61caNY41bGCT/ABDpSu7C5baknkjaGBIkXLY7/n9KVprgsAqByQCPlPK1Gp81ChTJGcOTgA//AKqbZEyvIiAsu3HB24yPypPQaiyae4LRI3PA5Y/p+FS+ahjJjBDEYYY78VSt5Colgwmxlwd/b6VOXZ1UIy7GIwSeuPehMlxsMilWCX90SEZsnHbNT2syLIIZWZ3Izyc4Hbio41aXzDjaynJXOBjPOPwptm2xd5jVscDI5PanHQiSTNaRI5YAHA4Py7Tyc+/9KryQKkTEn5TwOalRiXkXy1Ppk4xnrSDo2Vx04z0+lU7s54q2hAi7IvvnJI3EDIA5pTLmILGDnH3getNu4i6AjDDqGXsM5qKZXQqqNFtI3kfU0GqjcuQkGQSN67R6kVMhCbsEtsXJJPX/ADmqNgxPzzEsu4gZ4IIFTNI7JIQQAQSPQD0o2ImrMkUqRkg7ic8dvapwGR0CbSOvP6YqqrOVXO0D5gSecVZBYlWD5G3LY6gZpJ3AjvCyCQQn7wyDj9KYmZoo2YsXQFQ2ccd6kncuQApZunAzt/WpI7UCECQ59cHGB6CjqF7R1K7FXBG4h1QEE5PPsTTyiMu0ksSSeADzjge1JdMR5apHliRnJqJg4cFsA/xAHrj2/GgaGqQQ8fDOrDcDxhvT3qaSXfCixjYE+/lvc0xbdISxGdztkn3prO+HIUdcBc9s96YO19CcSLH5kKfeYc56gds/hTnjBtxEgXG0bgrcjGOc0xSz7owRkDPJz2qS1ykYDDeoXgZA/DnvQS7j3w2UMoz0G4HODxnP4U2KQMXAjOxM7ff39qXyfkLAHAxz29+lRSFlIWESLGwAIVQefanclK5P5ipb7PmUklgc5pBIxaMSbirLliDkADkVVnXfIRIcoTuDe47CpLKceZIrbxIhAG7gEHvQ3c0ULK5KpDSb4A3lgZyOM/8A16ZLKJHXcoaPkjcSKa1yVWRf9WhDbQnA/Cq5YMroEJJwNwOOMdKXoNQb1LPliQgEyZU7sA9ak3hVWY5UMASAd2VHTFVIGnCvDyQflzycfnT41SLMcecIu7DYyAe350DaJrgCTLKpCnd1zgU+0lQGOOQttxkEHOR7n1zUJk/dICfLxz6gmnrdK7hQFDbPmLDnP9aDKzZoI0Q3AKGIO7aOKgmJKM8YIK5+X0/xpkRDOdpyeNzYxx60k8nkSCPO5m5DdOKBJdCVX2wgRqEJG7b6n1pI3Dt5ZwWRQenWmNEfNR3Yh9vBHXHpU7t5ahtvz8A+w600Jqz0KZRg5fO4Dpnk/n2qHyftCuhDI2VK57j1rSlRfKVwfmXnP9Pyqq8gVm8uMN8oIIPU0i077EYVdzKu5gBzuHce9I6o8JL5TOPqKkLBZSCIyx+UqPQDNRSMrMyZ2AjJweuPSgVmmVp3+cKF3IeS/wCFDtv2tuUneMt0PXFSkouCN5HIC45waaNsYbe67cZbcO3t6/Shou5ATIpUrmSNeTuHJ96p3SAzmZHwqH7vfn2781pMyE8EE8AJ0yD0P61A0TJAyhd6KMZzzTLi7ambczBRgbW80bdxU5B7/hUNxI0DxQMWK5A27uoP9CamlH74IUcx4JBwBtxULRQGXmQOThghGOn9ah7nRFoqTKVLozMW6gfzqpKzyQB2fYp+8Acn6VJq8h3FEJLAhVI7knpn2qvceXLEisWWQNle+WHr+VK5tFWtc0ZZtjREqqSY2gnncM9c9vSnl5JQzSo6zH7wI6en6UjmMrE81uROmMjPDAdBToJRdJJFNujuQPkGOOnGaL62HbS6JbWORzPEYWwcgL1qG2QRSiGBHWQZLHBJbrxipbczOUZixZj8xj5x9D271DE8zu5MrmX+ByQSfrTuCWrLMSrLcIk8jAZyznJP5VJdOpjIhdHiU5LbQC341GEeCXzY423kjcpbGPx7U5ZLdrqQwAYUZwFODnqRmkQ49S25mWyEqxozt82C2d3p/n2qOCdHA+QRBCS0ig/Nntx70kaxtbu8rRx/KMKE4YiosK6xNGHCE9xg5z6etIUUupYMO6ETRISWwxJblxUknmMjEeUHQBAAAD+lETpEjea7eXkgZB6U0qzXAdYhtVNwA+XODiixL8x6MRE0/O04DJndjsefSmSXEhminDBdpAYYz69qsh42jBXCKQAEwMsSM88etRTsJIi0a/IwwcgckHse3em32M7aluEcAs3U/MT2/wDrc1K+1mLKBg9eaqoI1gKqz5B4PXPPf8M1O+fLcIArevtVI53FXCUM8ZG443cAVFdB4kYOoPzDAz3qeFHbYzOODzkc0+aH/SWSST1I5pjTs7EFuwKGKRAWODz2PfH8ql3gqysA24bc9OPaoHDoBHsYFehP+fenQRjf5m0gZxw3U4oeonbcGLlV2IuM8k9P/wBdWIxuJIO3A4XPvUajy5T+8xhiArU0hioVyQPvDH6ip2Ha6LDSukrRY4Ug9se5+nFPWVbhvMVtq5znHHHfFMZiY2VQu9TzxzjFMwyOuSQWU59uO1UTZMVyqoXTJUsM57+9NRy+4KS2/wCUAn7vvVZpgsil8kP/AAHINSGUyLHuXAVskgYwew+lA2rEvlvIi7shSOjHn2pVf5EKHPzFeOMZ+nvUIkbzTJHLksoBwcbev5UsLxrcOp4BAwAeWGOo/GmKzHzBo5R5eQT1fHQ+oqHc0CI7OSAd3PX071ZmkIhiCkK/VsHn0qNnZrhgyuzhPzwMdKT8hx10YrSmaQouDHs5BHX/APVxSXBkRocKWwDgKRg+5qvCWV3ErMABjBwD+tQ3EgFykSI5icbNxP547dKDRRVySV13+WiOr/fwTwuKWCVzMHhVQ8ZPAb7pPT1qGeUu6xkrGhZlU5HOPr9OtNguEtmnlZV3cHA4P0yO9F0Xyu2helmfyW3iKSTnc2QMZqHy5cBBhcqGHOfwqG3KtcCcN+8JGY253j8eKkDSTzyjKR24Hy7Bjv6/WlcaVi5IUkVFkKqnJ3AHqByB+NQlfMllC5KrycDGVAz9ajcj7KsjsAWyQACGU98jpin+a0koxFt24+frnj+VK5PK+hJGpMceMYzuGRwR3/Gm+YplUlgJeSwJ9+1WIlIgfdMhUH5Vz7801rZJZvM24Y5JUEd/51SM9mWY5NpkzkJjK5PJXHP0pIyGjLcsAOneoS8qiffuK9BlcDHTmnXEe50ZGVAjZPNBLQ9B5bqclevI6H1qWVi+3Yx5+baRmmTPGdikZC4dWHc+o9qFugULfKG64A/n6U2rEWe40tI++PYuzaWZyeg6U/ywVwpUFQFyCCMf402Fmkld8qU4GAOlKsWyRZAdx6YP8qRTG3SCKVBs65BGOh+tVA7hwWVcsTz1wK0ZCr5OcYz16VXAIMm/GSuPxoBSbWpWluNtwiLgM3yqTxwOv4UpO6NlkK7GJCgdW5zg/rSEIZwZF2si9TyPoKhaMkBxt9flPQ0DtfUjdN92NgGwD+H1p26QFzvIiwFAHUnFWCVVCw4Lck+1UZTud8Kc4DA+3/6qNi/iIG3CUbpCEOAMDj3FVJkVFWTyuCSQ2eDVuVneIIRnaSwAHUdhVGWWdIT8xC4+Vc8D25/GpOiK6IzroqxxtbfGhC9znvUI2TxI+5duN2wdQR26f5zV51jEc4l3NOJMKc4CjHI/PvWbccAKnK7sscY474P5VDv0Og0dTe4uJByMJ8pA+8B71JJILdYZVkLblyTzxjqKq39xJFcNMJQXTaeO/PIPvT7o7tMSbfGZt2Hy3bHBA+lDLhG1ky/Y7PPJRMtLnbGG6k/xYPbrxT0iBcG2hJkYHO1goDD+XSsyymKxpIZT+7PTHOK3EaUWkdx8kachTgEA+nufemtSZrlYzT7drlXubl2VdpJL8DJ649unSlBt5rd5c+WEXeoYFi2B0A7Cq8GcQvEC+WOUfv8A5FdFpOnw3rGIwq0oUtIm7hV7AfSrhHm2OepL2a5pGPDCzJLPDIfs4QO7MOg7VVAVZmdz5jZ5w/TpyK2JbdrTQ7u3kXdI8vkABgOvQn1ArDSNobsIATDglASMDOO+O/8AjRNJWKpz5rtFubLTsrA+WODwCcjtmrUsoMe/dulY5G0fcI9ajtAqyB3+UAlgT8wB7fypsEgPmF/mZzjrtAOc9PxrMHZjvNVwkicOWKhvw6/pUkduoKYkAUHB6nt1NVzG7Rpt+cKSfl7Ee/0q6jmBNkmGbb8xBBXrVKxEtdiWIR+QjN1zzz7/AP1qtRth8SYK8kkcZOaqRSRSl3RgwHp68Hir6qJEBQKA2GOaIts5Zq24Lbh0YMcd93T/ADxTnhwyAYB5GfaklZ1KYGNucj+tNeVUXdyRkKCDyOKtbGd3crDIcOctx34BpcBUi35KDrkdfb9ar3l2BJKrY2gZHGTUUWoLPbmNgFA3BCTye1K+pqqcrF0RuSHkYdcj0x2/GgurIxDYXcCAOcGs8zywttkKncOechRgdqljlZW3qvQDIxyCOlRzsv2TNFSCrhgc52k9/wAaRFCIpbOWBIx+QzUFrKzyuD84HJYcfn/KnT3IAJ54/izx7VSl3M3B3sPCxlFDptlDYXJJ5plxbu0aoSVPJ3Dv9TTTcRglUcM2eCBwOPWgnYSBgkHdk9FBHSqvcWqKj5jAWNAAxxvbsCPT1qz5ccrIhVVI5yx5xjG2kjbcAHO2THyg9vqKQOkW126/3vT/ACaYO4SRuUkZiWY5IJXpTpgJpFldsP8AdUGTk+1SRFkKlWDMvKqOeD0J96pyFlD7TlQS3Oevpn1qJOxUdWFzvzKHfGW3AYyo4xn/ABqCV9+B8o4OGUcnI4APSppZDO7q+5gwXJYffHt6c1TMirwJDkEhUIGPbGfrS8zoSLNrEII0AljPyEsEAyoH3uT3pT5XkhzvfzHAUcc49earfbXikdZGj+RR8h55/Lk1EskcoBSLDoCM98mldFqLepdLRrOSXbygowCB8p/HNTxNGln9o2bsfMAVzxng5H41UTCoHUnYE+YEdPpzRLNHtYCFVQAbcSdfp9euKaJa7FmSQy4xGnA3Lzgnv0z61JNIZFBfYm8FyoQjn1z71SuZUhR5ngdyqgAjgKTjbnmpZJXW83KnyOAUyoyB6kDvRuCXYsMY18p7pPmHIBJUZNOlfy5Q8anZj5SDwenb061UtyNiRyzEuCSA2RkgcfjVmOb5iisd+MnOfyH5U02JxXUeWe5RNjFVLAnPBY/4Vbudrp5ZG2UjPTGMf5FRqu4RGPcfmyWz7dAKcsTLNkDa6jaWzweaaVjCUk3oMRgkwhkLBlXPTgew/GpJIyMlcFmI+bHQ1JbOizuZeXDcZ5/GnM8fLAEDHAHXPamS3qQ26bA0jnCFs7WbknFWZAoBbcTIV5XqB71WicGYrvG4jdjNTTybVKZCuRgle9BMnqODksFwdqjnPIP4VX3sqlj8ynO1evSnKfLi5JZiBxmkjYglJB8wJ5z0zzxjpQGxX5uolMybRgqccZ96rW2HBjU5KnZz0x65q3MzNIMHK45B4qqksDg+WpXjHJxzQvM06D3ieG3QEsT36fhVYytsIVFG7ClVGcVZYN5S5O7aNoOetQrbQGVz5iCQgHB4yx4/lSd+hUX3KUMkZkYuxHljBx/F3+tUbiRZSY5EUEjIyc4OTg/nVsw75XRyeGwHHPHpx2qAsRIp48vO4kHqPYetTc2VipecI4B2sB9RnoM/XNUGtWtLby23KvYO/Tqat3qIJ0XazHcPLVuQT6Gqt7E8uxGQrEjD7x546mg2jeyJbt4o7GV4oiznbhjjHB6fl3pkStcQxeYfKV2wWI+6f7v09/erDQIGV9zeXggjt+P0qxBYrLMkZlO5RuwOhzzx7GkdHNFRuLZogtvL8wMy8RswwDjrn15q6Z0B/wBJKRpGflSNuC2Ov+fWqtxbRR3AhkklCEYQg4+Y9z+GKRp2eIyP13EHdxyKCHaWpdM8N1M00kA8vGDErdT65q/4e1AaVOhCBg2V9cL1BP5/pWOzEW+0oi7iOepX1/DNTwIsZcYGMEgAc/n+FXGTTuY1IKUeU1dWcXiF49odW+8OhH09elZk0fmIEDSrIqKQw6E5/TrSJlJGUfdIBSM8n3ApivNJdOYsIG+QiRsY/PvSqSctSYQcdEWG3bTGm4Mz7i4YA5x0H4ipbeIhW+VY8t2JP8+tOdiYtkpZWD7gvbHvU7PELfJwrDJbPHHqB6ipYntYbEm11Rl24JJA9DSmEmHekaseV44984qeF12o4YZJGDU1sFlcAkKu7q3pSIbsUrOMqgKMGZcMP8K1WASHYSpckFSOM+1Up0ZQvlcc8np3qCS4aaZY2baynkk9Oad7Gcoc4+6u2ihLtyG+UDqc4NVbi4zHGS+5dy7gB1J4yP0qW4ADqobKjOeevI/pVVHQM0BKMxQMpxyGBPH9c0LXc0URku9E+8cOpw55O4Hp/Oq0jDy3ikAJb5gQcnOeTirLOcyuWL24kXcc9Nw5z+JqsrpEBjC8lSCOgwc0i0iToyFSWUrtJUcHn0+lPJKSIxYh3baT2wB8tR71FvGhGQFYts7DqKVP3m8+yv8AOe+MCpV29R2JrVvLjJX5izZGT155p8shaVo2bg/N+Hao2khSMblPlhxtwehPXOOtRLNumaNScKCQSPSqJtqTzzLAIgihWVuRnvwMH9DUkb5ZeWLZJYMOhz0zVaRka4AlXBOCTnpkdaZK7iTMfOExuz1I7/XFUr7olx0sWhK7zKdwBk53MOgqSR9uVYkqfmHPAqhBMRKnmFto/iJ5+gq1lcMRtU+h6ke1O5nJcpaguBHk5OD3H8/WkuGQ2shjcbm5VRnuetMUq5IwFKkkAHGMD+VIXKs0iscqucDH9aHqyFuVpZ3MsZVQVUBm3fyqqYioeYRoYcg5K9PcE8U+dFMKiNssx3OrcflVJfMmaPz1kZR8o3PtGB1x2pM64K+pYsxJLcZ+UwjK4LBDj3FWIiILcFMrG33iyggD1qgrx7o1Q3GRz8oBHtg1YlnGUjVyI+dxK5PPQdKmxry3JVkMbsrMuJeSoOCF+oNRO4cxSSeaXzkKrAgAHHP4VI/ltPETAp/gYleretLEIjcSJKT5BXanmIeDTWrIdi9cNHMo2iPyw+cY496ZKzzABHYAsCXXOPpUUDK00axyOAoYBSuR0/z1qe6KRwrtJZWOQY+Bnp1Gara5mlZk2Va5UbVZgPMLKpJA6f5FNt3zdSqAMLyrMMjp/OqqsWGdgDDGB6/5xVuCBbiIucjIPAPPWpBoswvL5yxou6ML16EfjVpObhhv35HQg5HtVfzhG4hAfcVOWDcr7UEuJkDOV3HDH2HrVoxcdSzCE5zIAuDheuKdKAJdxI2YwOOuaglO5dqkk4BG0fKe/Jp0cqNsV4jt7HPOfemmYtMtS7JJ0JXbgBCGHUVWmAQsQPmY5B9PcU27uFklZFwGAyO1BfcQ2cqPTk02ybNbiAboxIgzjpjjtU6qFhBd9zE5YGnS4iiBABH+f1qFPMWPkjg9z+PWkPcWUo8MrFAAP7pzkk9PpWUokWRhhArY5Tn69v1qaWZZJRtUYyS3oDjpUFwxhUSxOS/8aeoPcfSg2UWhktyCGxkuCNy57UwhFgDOqgYMnIH6/lSNtQiZ1Bd8E5+nHTrTr9m+xqVJTfxzx/wGpNbIoNcSwI/kklmYNt3dz396ieXzCgUbXIzjqOKfZeYYWyCzn5QO+aqs6o6ysjhlblV6gf1qdzSyFvZjHGWdTuALnHPPtWTM8wCSSOGAO9kbk89BWnPN5670GEIxhx/D6GsPUG8u5iEyuyFs5jOeetJ6bG1NX0ZuWztcybHlaFckOAMgj6Vosr2vlNE+GC42k9R7VRikaGEqo4jO7cD0DY6eoq6VDxI077SMNvHzKR25pmkkQ3zGSJBNE/mdWJPGOoAqJ51s7kKybhNwGJ+77VLb3ISby94Zlf5XwCpXv+vP0qxPEtxGGjaM4ba2T82AOoFL0EtNHsIm03CoxOWPLdBS3DI8rgKFJ4ULzg/jVYzbnMZGQi/LgfeqYBPMjDhsg7t6n8iKdyeXqWLcPGrFMsq8qDwSPX69aqvH9onEpXgHdtX69/WrUsgzGycyO+CD2PrmlUSQ3BVykh3jd0HHpx2P9KRN7Do3aUqjq2PvKCPbrmrN2sSRgqyuV555GD1/n0qO3l3SRuyjKHBIHGMnGPzqz5aYYqWU4OW6jApmcrbjbdxc2/kBDx0CirsChCoUHPGcDjvkVRt4lZcopHBI3E/L7e4NW/OKoNpGSMjB796DKVtgaf5nGCzKfTr/AF6VQln2M2FDFX2Ej+IED/Glfd9rSZ22KGCnA46dTUBDyNgkpCFOQehNDdylFIS6k8yKGFEMbMcksc1GsIWSMncsanazBck4HT9aR5AkzgljGQM9xn2/WnpduZFdmBcHL78YAAAz9eR+VCL1toNiw8TQtIY42iyyqBkHoAB/SqCJO/y28fmMx+YdAecGtFozMA+4F4yVOeMnAPP5U0xi3mDmY+eQH8tehyASB+VOwRla4RQiCKNk+aJmZNhOTjbkfSmGTzk2qoYgcjOe4PNJHH5Ux2KzCXcoY9F79fpUVu3lJJhQxbB6ZyCOtFgkWiXPlxMmN43hQevOCDTIY40uypzhMrLxyQR2P6VDFIy3aw8lSuCxGOpzViRYk34U7hlAygnPPBP61KasKV1oVIxibG7742HI+5juKcr7Wb7uwlVwOo9qblQY4gTuB37jzuPNKAvmrKFP3vMPOR+H41QMjldPtD+UAQxIXafar0Ls/wA6BlA6H3qpdxRwu6gjaOA4HQkdfzqWIfNJGX5K9R1Hv9aa1M5NWLseZPmZslMtyMfhTy4/eOiHA5PPWqljuz8uBGBjDHmrNu7vOYSSdg4G0nIGaL2MVuU7pjGjK2QrEHGMECsxpHcEbVSIJgFSTz7itm+t2NsSpK7fkPqfwrPlCweSDMRk/OrKcfX/AOtUnVTasQRukcccSiIqOrKWyasG2Ro2URgsOVZW+b6YqGHy0mbyWGVHBGQGq8LpYE/eDJQgqMZI9eaSXU6G+wkLAziUmMrtAzs24PcYH86nlaKJ1ZZF2YO5f0ABqm2yW6lbemSmcMApA4q1ILeYo0Q2KoGI1Jw/ufSrV0RJK+o+ORQJHfZ5ZbjnO7b1/OrkCjySgiifzG3bASMf0GKigEaFVjChiDxjPr61JEWZoyxQRRjB2EA57Z9fpSv0Mt9R8i7ZpPmC8hdobcCT708xoIy28uoYqDjlfXj8KijeNQzuSzO5+Xbwef8APSrQTaANpAYHDY6j1oJY8eXjhdzKNuUP55BqEqS7twVK45zgHHWnw7VBLB1QnDsoyR36Gku5FS38zjaylcenYULVEX1shwjkQkFyATkY57dqfKMW8iKc98Hjp1ptuFyu4kITuyDntwBSTKjqowqhRk59+gNWlYyluVY4pEuPOZ5GU4XaR0Pt7VpRxMEKA/7WR7dqRH3bcxbSBgEYOeOp/OmghST1IOcA8fjQS7yElchnUqcp83HfvTLqVjbFV4O35M+pqtNMbb5jE2wuBlF6f/Wp07h49sZZdxwG9ehoQ+WwkwO/AQITwdvfNVI4mhiJmZSx4U5ycHP61beIIyAlSw6k+vtTWSXzWcqCwwv04pM1voVf4iWCsepU9PYVBPJIV2ybOD94k8n1FSSuY5WdpDt4IAGeO1IjrMZdhI6Biy8HA6D1+tMtaMoxedGqyTBhgBmwc4Pt+FFzJm3MqqwXJG0nn1zSqJ9xV2yBJ064AA61FzGoRkXeGMmd3Uc1Gxp1uV7tiluyvIqs4CkZ69zisuZSMR/6vd94sc9/04q7cKjeUXVhIexH3c9QfeoDF5tsd6hXyQdzcDvn8qlO5tHTUv7NtqBCckDg4zz6GpFuEGwMd7MSWRWxj1p0zme4IhARTy8ecKT7f5702W0tnMdzDEFdeCmck8c59fWhKxrdbMml2NKT5BRSQApI4xmrXnRzAbNm5fl4GN3viqdxbt5a4kR0YHcQ3zBh3P4YqWIss6xhisbHJKrwrYx9MUJWI3ETMCM0iq3GMEcD6d/SprZAWcOxEIwwPrx0OOfU06HzDy4Mm0rySDgEVO8DQWrLsLs/zg9Cf/rVVuopStoQXiKbpch3izuODioj5KvIUD7Tnarckj61authsIy8zeeBgr2zntT7N5wpdlQErsClQc8dcetJCT0uhbQq7KoyAy8HPXjr/PirqymEOVVnOcAg/L15Hv61kxyRPPJErABDgEZB+tWG5bzM4jA2bGGCP/r0XREoXZdwwaN4mwp55GPxpl1ICqxDGFbcXHX6U+2/d3Jxl4VO0kng8cUXOyb5JMgsCvTkc8VXQw+0Z975jRQLhtsmCfXrxQpNuEVwC2CAGPb/ACKeiskW0ne54AbORgdvTpULTqGJYKVAyA3BzyD9e1S1Y0SbVgvVSWYIMbY5AGPY5x1H1/nUKQC4aRmbcMccYxjBI/Lik+VySryfPncAOgC9Se+DxikPmRxFbeMHbJuKN02Njof89aC7NKyLblPKYW7bCeAQM7hjIzn8RUZlaPZ9nGyRlZQB8x3Ke5+maryXYhUrOFbdgK6+2P8AGpQ+4qdw7EYGMjoDVEWaJpAJJY2Lna7h8lsAcY/pS2nlIR5jFZFKrnHpnH61AIWeUs5wDztXA+v9KfGoU4jBLBSDkZzznmgl2e48WysWjGCoByfU9gKluXwyHo0gOdvOOMYNV1ikEjEAKCgOBjJOQD+lFyFe4KY3RLwRjGDxnFJiZXmXcyAxtkdT0O3HWns2GVMj5QNrHHy47/rU5G3eTuYPlARyB3/lUEkj4aZhGCxz06A80JXBu6HgL5hdiCWxnJ6dcVF5xRmG0begOeoqRghIDN+7U8ccnP8A+uopGXYTtHyZxntTiZPVkyzpGEUHCHgkVJb3AaRSmVweorM3qSu5t5z83PNX42/cAAjqOR7Zqbk8tjSieQw5clWL8KBnPvWPqhKTMqbnOPvEYI98fpWpG+7b8zKMnnsT9azL18XBVfLZioyDycetEtjWj8Rno4LKrxb1DEk7MEA+pqS3CSXEkfRMfKGbt9T3z3pYo90bZiUbuMElSM9/enJG1sitCxJ+9z/KoO66sFqgWQSzZMhJHPQHGMjPWtdFRFD7fLhTocHGT2qrbRK6A53YIc5OMeoq0I2lKtsSSEscsrHLKO/5+1Wn1MpajmWSaBpdwLt8m3HQfh0/nTY1kgi8+NQxY4KkEVaQQEeZs3g8j5uMjvUb3Ti2ZmETSqcqCDnB/nQzO7egy1MMzKsuWUPnC9jVuaKVlAhk24zjPoOx9KT7MDCuAVdmOeMDp6/0qZFXdnkqARwOp70ESet4jDJhVzlUVMcjODjp7024VriKNWGyM9RUbTkPMAwa3ZRww6ntUqDfOyyNkKvGD3xVENW1HqVjhZW5yD04xTraPaULK24jC88//XqsoXyDjcwz36kURXAEaCVn4yNx7A+9JPuJxLzzFdioByeCR2qNy2OFDAkDA6deaZJIVUYAILD5u2D/APqqaTNvAWwdyAtg9iecVV0Ra2xBOFWXYFYsV6bsjH40mfMZVkjGxjgkEZBxj8KsFPMtfPaPEjLjd0IHpVaMBEO3LBuceh6UN6jvYS2QSlgX2jkMD3NSSIqhlhwJCCAzHqfSkZyYP3fB6Zxzk1FJMzMu5U3Rg4z15ouJXkyFoscXClWBwQDwx9RVKNpftDovEI5jTv05/Krsjh3bcQEPyjC4yMY/DmoG3ElVb5lQhc9OvUn6ZpGyKl1IEiwj5kZgQB1BNQX8wZZARwQAVXgE9m/XpTpblpMSOkf7lN2c+nT6nmqE0k0syTEDOdxQ9144PvmkaQi+pU+2ebFtAcyAnJxx15pheQee+VWPG5kwPwApt1KBc7JEEcj9Cp+97VBGFW4SMycyfMCT059qLG/KjcjmjdIyXMce7AZOqj+tXbSMLEk0QLuGKsyjBGfT1HFZlyhnu4oYjkxg429yK2Id0bxpCxM7dEPG0imOSSWhFeW/mPtjGcjG3OOe1QWsc8eYohIzNwEyDk/zq7YCSR5Vvl+bzCdsQwMemaWKSaOd8IpCsGBGeRjuaTEm17pHAmyIiVQCWOeTnp6frT45J1QySszluF/z2qeFftssedyy4JCEZ6/5NJcgwYhjcnaoZs9B+f5VK1BtN2K7qfldgxfgKWTqDwalWRwUQBFw+AwADHNSlGMCKJtzjkEnGP8APFPRFBZJAmFHKg9/8c00DlYrwWKQ3TSNOVaXO5jztJ5/U8Vow2m/zC/IOMA+v9aghR2dlaNo1DEAuMlj9farqu/mYdTI+3CEnqP/ANdOxjUk3rcVFaNz+7VgvB546dfaqlyfMhYj5OdhOCdvofzxUzjfL5UTNkqd2OeQelNkRo3VWPyuPm2j8qT0M1vcz5C5mUecwlk4DEe2Tz2PFV7d4XZoiGlGPmLdFyMZ/Or87h7sCRWVSAS2Oh71WKeVbSqyOzFh8y9wOg/rQbbIjm8vHkRgfN8u4cnt1pR5RmhOxucFlOMnj+WR0q6lkktnvAIK4Muw9MmqFzPGvm72YgnDEgnLA54P4mmmkSve2K2C15GSf3ivlFxx6Af0q47bkiyDhQFJzzjnp/KklEayrhymH5YD5gOx9/8A69C7RdEzRhjyV2nGcc9PyoRUtiWLd5CITuI3fP35weg9KQTABlDK8pIPynBAHWlMbtNJNGucL5nynHsais7eOKbaDwGIbHUg5O2jfQzsrD53KQRyEkkjB47c0HB3SDoTxj6Z5oh5mAlACRkHaTx17UKI/OckEB03bTyARx+eKLCfkIjKhkU9QhdCo4JzUO/zFkO7arMCAT1PpipQxRsIwKK3c8jA4okUBWl5WPd877R7k/zpogpxACV8FgBghc+uP/r1HdzeWzBi2wDkjp70rhYGDjcQjZ2nqV5FU9QnV0+cqN7BuvY5OMflQgSuxYJcwyS42lumfapftv750iHIHzd6xbmV3jCK/wDDwDxnr3qxpiMkisXVn2BiD9KTNfZq2p1FvPI1mHwQRzjnBNZtwruA7L8zHacHGM1Y0yQiwjyMENt65wahuVDyYZwSo5JP3sdhWTHSSTYi+Y/COdvcD2qVsou18AA8qep96hgMYiUK5DZIKHpUqqzujybWKg5UHoKRvqTKFSTymYhCNz9+DWhaTQ2sayRuwK529OmenNZaSqeJSVVWyCFxu9vpUkUka3LEszIPueZxVxIlG6saDn9yZAQwLE+Xg7vUnNSvbtKI/L4kbkLnt15qp+9Kfu/nycMQOMnnjFaLMoUGQgSEZyMFSTxjNUZN8q0KjPKJV2hgBnKsCct6fkKsEugUnB4Jwrc9PSnxZYKC21uTz1/Oo7h/JjQxnDgAEHqf85pGblditmUxghSGOPm6DuKfEGDnlnYNtJxz+H4VBI7Qw8EBXxnJ6461ZVAyI4bAUbioPIJ7fhTixS2GwozmRwcNgqoI7Uvkh49qqdn3gMZPSp9qsSrFGXj5SeDxz/OlkdjM0W0xhDt+TjoKZmpNkWUgjMSKTjuBkc1LH5ktsXc4Q88nORn/ABpIdwTa7NhjuUHPappQIIVklf8Ack/Mp6DGPyprXUUnbQpRzBTJHneoOU3E/jxSzTeSQVH7skAqo6jr+dRyFGiURK2Fztwe5PX6VHcnEuZTnA7c8UFbkjsN4fgDbu5OMfWq/lgEurZc++R9BUUqtM5mMhEXC7eT07/pUqqotcJnGAoIb7vrU7l2tsR26O+9ZCoUjKAnP0Of1qtcOJNw8wDJCAsdo9jjvz3pTOTI9vHhT93joaoXowWE2H28jHYDtTZpGOpVMjiZ3B3IAULDleDnI9TVKIiS4W4aVk8oEsoX73pU80iKcJv+bG7PGD34p7eTFCzSElWAXjGCRSN3oiDUYorlFu0TeqnBcHoTyR9TTokjm2faYZIJF4cSDG056AdcYxWgsUV7otvaJcrYmFyxV8gMTyGyKp6zcgRxJ5rXEsEao85GA55b8QM4rTZGfM37pq26RxtnaryKNpccAVZtQjKCPL8w53dSPpVhbQFPOhBQy8YHpUX2OVQRGycfLk8HnvUbFc6fUrWhuIbnNw6tESSCB1HvirhLRzQjdw4z8vAJ/wA96zoVK3LRyyyEnJaEDqf7351qwWrJAZM4fGGUc8U9GVN2dyJfN88OWZIkGUI7+nNVo7mCaRkiZkYZJz/ez29RWmI1kaKQMR8u3A7H6VX/ALOSC43q65kH8QySQePxoQRlF3vuMEbTRMwXLnrzgqAOn1pdORwSBnkkkDndzxUj+dFJGu3dkZZ85BxjqauJMka5TczNyfbiloRKTtoMeQxxbUXAB6kZx/8ArqKaaVuihWVSFI9quxMGjXdnacnpnmq8LK0u6VTHCRjHHXHamjNO3QfZhoQ28/OWyWHUe9Mnc4QkEDowz/nmrFwrhRJGmVwFORyDVeWDzhujYhQCMMOQKckKO92U33Sg7FfOM7ge/v8AlUVrPFAf3u5w7Fs+jD0z+FTFXgZGVCS/XaM4Peh7QMQThiq5O09PQ49ahGztsxts7CYO5/csu44OGFJcRokTxRxsEkPzBzlST0Ye+M1HdopjRYeW7q45B9PpjBpGmiW1gRwyyBcbs9xzRYTXVEMeYZiG8wKAdu3oB0/Ec1LDKpQJnMqc7sYHHAP14H51M+3zFDMSmCQoHIBPSoYUC3BeUBSeMeue36fpVCbTRN5jrAJvNAKAsSASAG7H86JmD26Hcwn+4QBg9Ac1GEO50IdFwTtJyCR2x7cVBJIWHmRSgNHnapHYUE27EzJmJFiJaTHQ8Zz60k7F1kfO5lA6ZyBj1/SiaQuRIiCRztw33QTwc4+gxT2UC4BCuI+V6EjDAkD8DQS1ZlbzBExVZAECgqWwTt6/pimm6MwdiP4s4xweoxSuhOJGIEwGAoXAPQ4/nUUylJdu1nwC3Ix1I/8Ar0ITIZ1WZ5HjGDjKgc56VmyW4Z/mI+6AD0wa0IIjsUtlGCjGOh5wMHtxUOAIVDP87EYyOp/zmkxxdjIvF2ZZtqhBg85OKfp8gSdUb5icAEDtUF8HaMktmQMRjHUUzTnKMHkfn+FcdPWpmzdq8DorVzDO5XIJ56/rU15+8ITeCAM7genfArP0uVcTFTkK2HAXpVsK7yosbBhL8xA4GfT8azbsOCJISrtEpjPlYGdo6VK/7sKwHJJG0Z3YqTT0AwckbiGHOcexpZgG3MARGmQMDqc96Y29SLymbdKrksBlvUH0qeWXzI7a18tto5YqOR9M1BGrLE6RuSXOSMcfnVw74WXLfMV2xkdx7+9UvIOo+GUG5WOMAIBglfXsT71Zcs6KGlxycAjPPp+NZtvERFMxdVI6E4z0zj3NWTLG1solVhsxjb69eKu5Mo66FtJnRP3ihtoAPGM8cUm5GlVZNzSdNvYjHr9aiM6/2cXXcIicAgfe/wDr805cRMHJ/f8AA46D/CkY8vcdJHuUKd7Bugz1x6VbVmmlhSTIQAbR64FZ1uyrM6u21z8oXrVgOxudq/dI4Oc7j6mkQ9S6Y42lV0kPygghe+en+fanICqbUP7w/KBzyMd6rL5nmsx78HHHSrFsmJBIvIIIx6YqtyNESRMyhC5LSgcDsQKjk/0hyspYx7fvKaenaVRhsfMCDge9MkDJIpDcoOnqDzVWsZpq9yvtZZFK/PEeTnt71JctEEIfGQwwV5+lRSExFSZPkA5QHI/HNLI6+a7+ap2KNuAMf/XpPY01uQSNkMASTwCAc4A9P/r0sTiNCQm4bh04GDjHHtUTyGWMMJVOE2Z9x/PFSWjbYk85WGepzwT/APXFSim7EF1xGCEJwS2QM8dc1lTSAxGRo3KnBCg8A56H+dbd0wwzLkHsvXI71i3kbFC/Kr0c55HccflVF0pIWS3JR4drKyYIyRknvVO6SNGAmEbW4xsGfvnvmn+a8rGDcUkcZDYywHr9aildFvkinUTAYZQ33Sff8aDVJpmzbve/2ND/AGc1vbzMXzvZAzHPynntjjFYviK3vROkd/cJK2FIkjKsAPcD3q6+qWomQS6VZb+oyDz+tUdRnhkuDMbaC3RMbY41PPfJ/PFN7GcVJSu0duGzYhXfavDBvTnpUM6u8LMjHrkA91HWoXkBLJ5RaJh83OMH196kEkca+W65RhkMO/bj2okZxRGCRH9pxlgpHyjkjvir1jIZUR5OE27ggGOKSaTybbKr0XKA9qrS3Gxf3gO7HIwR1/lS21NF7xdEMKsrHKo2cE9hWXcRtPMFlYJsPykrzU08yTxBo3Ac5HJyPzpLK5320scqgFDkN9ODT0KinHUSHMYAdsqAQSTnnFJHGzMCjBVHzjd2NSWTJbswDBl4Y/KemcfmKtSRxyRnyCN0mRg9BUq4SlZlXe/mP5e4xjPyY6ds0jN5kuxl3KuCAB1Pt71OkbRMobaZehHTn2FJbPIVVnUAI/0xVolytqWVZPs65VvNGQwJxn0NQz4kZd4bcTtYjoR3P16USKpuBukLSEdxgDnkU8xkqO3bGeM+1SSrIju/MgjDQOACMjnPFVopEkYJuHmjGWz06Dn9KvW8Mhgw6oxY/M3YenHaqvlxQuVkBVySjd+DS6lRasUZ3OD90MTglhnB5GPy5piyTOHRSjyc72CjIySD19qlWPfucNuDk8EcZHTH41ApnjuNsUQIU7iR2J5H8jQma2WxIWKKjklPKABH97nAP5elSWSlmEyswwSMngeuf51Hcx4uGMjENJjD5yAD6Y6c1KqhTkSlmYEhexf/ADmm9yHYWSX5iyuWRCGdOxJ4xVZkSS2kCZfOXCkdO45qwGhh2Fyyo55CdvXP51UaNjlYm3HBABAHPUf1o6CjuSQKt01uI3MXzDJ2cAHt/OnSSmGWPYQp2kjPOACc/jzUQkZzmMlUUj5T1ww5/DNRahMkTp1LOcnuVx1FHQHG8hdyctK4yQwDAckgZGaS6lkEkTRJu2ja4BycZyT/APWpkDKzCSMAKSVKMP4h1GPpipcrmIAsyFSFG3HTkfj70kyXZFfzvNkzIP4cfKcfTj2NVrkoQVZf3mcM574/+vRqC4mjmQtJJL8x21Xu5jIVC7WBwwYDGBxnNMGrbGReMxuBzhH+6fxqlESMqp+YNuBPf1FaF3JhWRQpYOMYPQ1jXTMsyPglmzk+lSbraxu6IXUX/BAWTPbuAav20oFyuW+dSPoPeuf0C4CX19ESwEihlA5GRmtqJy06TITgjJHTOPWsmaQ0vc3beDfhVZQh+YFf5GnEkiOID95Jkjjkntmo9OnYLcLuQgL8oz1zSRkCYMQCFwWzxzRYy1uywYNoTywUO35gcfN74poilVIZYjvXnkfw49RVq38y5VpVOwngcY/z3qX7HsidSARwF2nHfmqitRe0S0KMRJlZ9iopGfcepx34qRIVLyGNtw24KgcD3qwLfa2WBJ+6pAyMY60WoxIwTahYFSGHrxVS1Byurih9sKjbGYhj5ASc9uM96qysjFXQEZ3YPc4q40UkgW2ijbe5HIPK+3tVUCQ6gyxj5M/KmegHWhXsQtSaECW5TkeZyfMc+2P/AK1SW5IQuOF4Kh+/NQQxvOZHXHy8EnsfarNuZHZImxtG7DEUIhlmzkJVvJCyODgE9OnSrNszIkhkVkUgfLnNQQQGF1AfOOSPT8KvxFWTcyhicgED8qrU5ptLYaYm2hyMBQPc1WYC4lJ3bWU5yRjp3NWWlYZDYKrg9elU1AMv7wgRAYOTzVomO2pHPCkrESj5FGRx1561FJEArInzKU9Op9KsSyhVVkjH1PaoSEjk3tw/bnGKTLjJooz7CbdBE2MlcdgO/wBKknmijRSQijgcngcYzU8oDuyvhUx9/wBR6GqTBYYwshVwTxt5xk8Cp2NE1IeM71jDjBx8zDrn/wCtVS5jMzsGYbM4yB19vyq8YwxCMCpLZGcZFMi81pjE27YOQSMc56e/WmPRGbII0hcwqu4kfUn/AAqldRi/VAhETLlRjrt6k1o3EEcUmIsH1HqfeqYd1vQHjc27jJbGPr/Kho1i+pUFvvYRKAzg7QSv8WM49z7VV1a5itTDbC3uYrxSN/mH5enHGM+9dZDdQQWCyoJPOto5XEaxkjc3AYntgVka1PFILfIefyYvLZpFIZsncTzyAARTtoONVuWqOlSNLW1bzpGAXAU98ehp8xSVWBkVd2AjHgH6U+R4zmNkPy46jk+4qOcxSkSs5DcKyBeOvWnZGSd7DVLxJnDGTGEOeDxUgjzGJii7Rw2Tj86SKFGkSbc0mAd3oPoKmuPliYookGcgZ4oSKcrEKQiXDxeT1wCfu4x1/pUS28sUZyEZyucL/KpYp1nLpHAQ5GAQM4Pr9DUVql8JpfNC7ExtZuPwxS0NFcZHGZCUl3I+CFPYZ7VY0yOXc6TKkZzkD1I7fXvR55a6ClBkcDCnB9/6VLOheWOWLCqB8w5/T6dKnzJlLoxGYXJbZIYyeGbOS1EbR27CJIic9STn2pYLcZZydhOcHpUtrDvZVYxsAc7gTz26VWpDkkiSSBXZNmwqW6kcjIpJGQIWGGzyVGflI607ymju3ZygjkIVVzjaajLlppVIwqsMkjIJpWI6kiM0qFlPGMFT29Kq3EZZif8AloAeucA9ua0IkJxMnyRnoN2APbFIY5IfMVTuLjJz69Rz60coozSehi29vIA+UC/dBU+9PLBcBoxlxj7uPp+HGPrUsEj3Mc48nGxhyOveqct24kVRCWVMbQDwT1/xpbG9+bQLthJ8oiGDwCOD7f4UCJ0hRDsYNxjPK8Z/+tU6h3gYuzBUbBXIBANJ5KMCAQJA3fBH1/SgXMtiBomkhKGN0iA7jqe3WqDEm7KCN/N42tnGP88Vo3EjsFhQr5bdDuGBxx+tUbmXDQs5IkUjgDOQe/t0p9C4FmC2by2kuN288ZJ475Ipk0aNgyldjfIAcfeI4Iq15qiV03rtYEEOevqD6dM1Qu2AiVwqnccjjJ4wTjj1PekQm2wuo1FvvIUyk52E4I/D6d/aq8m+J442k2sxwQozgg4/DrUU8jyqk8u4SND9xTjHJzgfnSOwARmdvLGGYkDccg/pTQ1FoS7cRb4pEOeFBHHbGf0rMk8yMlJVCMFYYyOuOK1ZLgSRHKZkjLHcxySQB1rPvkE7BpQEPHBwueQePwo0BaaMzJIl3yStnnnbn5sViXcjeb8rYUZGCe2a6RmSKAyyqTG6gbQ2Mcmue1mMxeaAgDoQ2Af8Pakzam7uxR0q6V9ZWLIQMpJIPoeldlbtJG4yAByOa8ygn8nxDbyOVIkBT5Rkcr6V6Fp8riNVRs4A4bk81ElY1kjo7VkZkEa7VbkZ7VdgiJfLsu/BB3Dj3/Gse0by/LXBxtyD7+laiSM0MKFtqSDdnvTcdLo5paPQ17MNHGzLtMnIIAxkVLLKUA3svmHgKec/5FV4IyCzBiMc5qec5w+NyjBAJ60LYxerK8gkhTKYwWPCjIXPapLWSOOLzJE37l4XsOe9Q7SyRlXyzHcFJ+7z196qyAG6d53Yp3GcZOPSlrctJNWLpkWEGQEmZzxg424/XHNMZMqHUDk4x1/Diq1vIst1ti5VeAd2OKuoiky7x5fl8gr0Pv8AWqYm+UZCBnbIFyQT/wDWq9HbvNINoKhQCAxzn2qKOPai/IpBPHGD071ejEoieQDB7ADpTS11MJz6B5axuFRhkjcxxSkFEKhsc7gc8YpiuNueQ3pjkVHvG4YIAB55q7Ix3CQO21F+8V4kHIB9TUE4fYFCq3GFCjqamO5VYbxsHOCev+fSq8szLMWLZCjcOMbR7UFryE8tjGU3KGJ9efcUxx5qkcNtJGGPoaJvMEglcM4OOOgA9P61ISBbkKCvOB8tMZA6M8SwgACQ7gDnp6Gq8qGNFKxEjp8v+NXpZMbWIG8cAEVXKyeZISc/Lswe3v8AXFS1fQcZWKyJvlTJfA4wo5+tW5A3dfl79+3FNtZJJUZdm0DIBJxn3qO6kA+RVZnIwM+v1oSsDd2VmgjXzPunOSR1IpEnJiw6MuGIPAxUyLDtZ3zuxjpx+dVrqQNYgruXc3y5PQ+pH+etMpSu7GjZTJc2ZjWZY12SrIjOE3luje/p7Vi61NutoY9ou2jQRSyqxwSO2e+BgZrWWOU6bbCzsILlm3eYzRhyvoPxqvq0KG1uYxaQxSRWwkfy12lJM8Lkdcjt2pgmua50tzaM7ZQAAc5HP4VVu7eKWIRvlVc9CeM/WtY7y2EbC5G4ZqC5szLMH38r24+akTTm+rMm4kexijeCPPOMk7iR0yf5VJC6CAwlioI4AHJq3GrKJ1kAKqMge9QIiOhdht5Bweg+tC0NnJNEtjYiPd8zbT1IOAKlcFpC7SFWAwBgU+NZHmJVswx/eHt6+9JNDG8iB3AmXBHzYyO2aLGTneV2MaEQrw4EmeMDGM/0qtKTMFQSKpBwCTnFTzLKJRsICkYcdRTUsULeYrlJR/CCMcUjRSS1bLEVptslVpOmOp/Wo5wsERkCsxHy4U5/H6VKssaQh7hioHvke1LDKrH9xygPRqZjd3bKy5fa8xKlj3HFWYCrq6xkn1Pb3FSKQTtdCqDgc8NQWSCMKCo3erdPWhg5X0Qs0R8kBGXjng4+lABWPsz4IPPBHemSDy95U4yOp55pwUKFLDc4B5oIsyr5e9naIYUncxHB+tUb2ONyCuC6kFge+TWyzEM42qcDgY61QvreLcJVJBHHqfxpWNqc3fUz5Io0t0LZAPGOuPx+n8qnEtvA6gnypFVj8wxyMdj7E1mtCJZW81GLN93HAGKWSOeQbRufZgZfByT0/lilc35L6XJLjypYVCBEVWIzjAznIJqhcbmVmkT5nbG5f1P0q3ISlhnaGmjZmwRgKOmKpXTzy3RjmCqmcblHy9Bg/n/OjoXC5AJDKwVULSAhxMT1q3cEpEjxxhiDgnqDyM55rMtpJgzxsqnaSueQcZzgVdcyw23yqPJB5YnuMHH1pWKqLUZHI0lyVZCWVguwLkkHIOPrmq90QY1KqyAnhHIyMHFSWk+blGDOiyjaoB6H/Hg1FeMWmZViyzsCGY9uxFD0Qra7EKq4UqxYlgSecjPvWfMWluEtGLeYAcnr6dPwFaHltHCVGGkJ2uW65J5+tU5kCTlo/lOdvJGfahDtuV5X2h44lHJHl7u3OOaw74yq8jzj5gSQex56V0ki5mBdcM55z0U1z2tQu7SLk5VicDpRYmD1ODu5FTXLJVIAMmPTGRgV6PYzYeInazBcHivMNaZE1C2J4YTAlh26Yr0bTWUxRCTDBlHK0SV0dTl0O00tVwkiuUwM8+tXwhaaRwqBQQFIz9azrTCPGkab8NlewINaiENNI0qkIG7dTRsrHHJ63NG3/dxjz2JYnkAYqS4JWIoDnd2Yd/SmISmWKMy8HBPNWEw0GWXeDzkZ/DmixzN2dyoVUDhVCqM5z1qO4tI5k81nAfOAB/StGKOJPlIyGHXPB7/hUi2ySMRIAARnA7GhIr2ltUUIbZYCqRgFN2SxGD06c1a3RyShfL3IeBz0FSC1wgK5J65boajMbIJAqguvQDv+NNJkOfOySSPbLlvmBXKhccVK6y+ciqQibct6ewrMsZHaNpJF8txleep/wrSicSW6uD84HO4dR6CrM5ppla5ukEvknO5x97HOfSokjjZ0RnJbHPf8qc7PJuOwFs4+QZzQIXJV+Ayk84OT7elBSSSJfkOAnBXnkVUcmSSTzASnUjAGTVlJBLHtXKy5xmoI/N8plZlxjOQOg96TEnoNjcywqGBBGd319qaUmKbJSvmdck8Y7CksWcyzFeIw2Mk9abcy7WM5PnAAqR/d/Cle6KtroTuv7kJ5qeYBnd6+1UrmTbKkKOAeOB0+tMMhJL4YsO3rntVh0VgpIG8Lk7e1CY0uXcS6jBUDzCuOevvT5WCoWYDHTmonZHlaIk7gufyqvqN2LWNRIu9W6gDiqJs3oR3KSLKZI2Aj24C4z361nSmeR1ETgDIJ4/n6VsTSfulijyd5BBK9OOlUlSSLezFSxI6jt34pGiaNfSxAYbcsHaWdXO8OU+6Pu8Vn64tuDaeUjRxTRhwrMTubkfNSwzRQ2kbPNdiSSRmAtyMIRxk574/SoL+4FxdLtmlmkVdpeUAt+GOMf/Xquhk73udhbKyyyP5oKt1B5wauqIo8kMCSCcHqKpLAY5lUbimSd47n0NWIbXYr453/AKVJMmisp8gySI4YPnI61Ak8d4AsWQccHuO3T1zVyKFYt0O37wJFQxwpBI/kYV8dCO/eg2Tj8yG3ZoJDHJJvLn5RjP4mp5mTb5skXCnkgcqfaktUeaJ5JUKSbvSp/LDBhIuwDqB3+tUlcTauRQTi4iBj5QcdeRSbGUgRvtUN83sKIfIKMLdACvBHYVPKqQwjzPnducdMCpFfUWSOG4jCvhwxw3pgUyOyVInSIEEcAjoPSpIFjkiyxAGQAQP1qxPcGJl6bV+ZmA/SnYzbfwopgESCMREvgZ+tEVubhpBcRgYPAU9fxqW3uBLKzue/LepFE7+Q7sMgFugOT/8AqpA306kciq0bKrhATt5FSxopQrjBGSef88VDNICRsjJ6bvanHBZmU4OMH3pXKS0JWVlLAEFlAxgcjFV7qLdAjSDae4HWmRNM24EBGz+B/wA9Kl3iWQhxjHQmncdmnoUp41ikZk3N8udoPWs5wsdyzAsFfI3E8e3HbvWxM7PIq4+VR2XpUc7Fgsbcg4OVXrUyV1c1hK1rnP3agu4MmRglWQHBOcnjtSzJEHQ24Z1XPLdT25H5flUl1AvmlUPlsj43Djdk9qiiYMZFkTYYv43P3s+n0qYu+jOhvsZ96sst1I64DMdxwOOBwaRFkKrDJEZXY7iM8jJGP1NT3snnSKVZhLkhQo4f1qFEkZYZRIS0uSVXsBTuWm2tSFQ+XZTtYDMZzwG+lQYuGtmcg+YPmjXPAXnt61ZndRAyP95R8uepB7Gq0O6S4CpEwkb5RtJx0PBockxkTSyeYTgtuyxJHO71/OmIu+38yY/eXI3dG54/OrKTxSqGwyIGYlMflVC4l3bm2Z4z8np2NMT1GfNuSF8bkHOefes7UwZQxwwLkg4zwatyJtWGSNpN8h5yfXPb+tVpJCCSgaQrnOO9Akux5f4xQR3TCMFQrKxJPpXbeEZ1kitzJgv/ALPOQa5bxqnmRy7MNsGTgjjua3/BYE+nxFv3eArxnH3ab+E2f6HpWnI2+Lbx82TkdvoK2oNrzkE43MT833fwrK0p3jvAwO4kbQT6HvW2rmOTLYaReMEe1JvQ5Kjs7FpjkoRwB1zyKlDs0T+W23v071VaTepTABx0AqXIRYyO3AIHWpOe3RkyIcRqykjrkdTVwE7nXaMZwCaqRR/umO85zwBx+VPMmxGbcM9TjjIqkyH2HPIyPtdySTx7VBKWkYiMOrHoT+tRiR03SyD5cngdcfWpEc7DJlmUjgDr+dVuHK0Mk+bZwVwPmJGfenwy/ODhjGB8x9+34UyISOCGG0joGzyKJ2ZFyZD5SjkYoQ2ug55lbCKhUdQwPT60+JgFZHlySc4qFfLL5GwYGeT1/wDrVGGIlJOBtOMt3z/hTDlT2LDTBZlSOM8Z/wAaqMsjSgxg7GJ3Io4P+TRdXyxoPkKAk5OeRTbeYxvtlYqo5x1xml1sNRsrk7MIxsCkP15GKo3DSkBcncM4IHXj/P5VM6OG/wBb0GcYqhqd4bdYWVdzNwWAzgf0plQJrZyZxDHvIRQS3Q1JC0zSOzYMecfKcc01XLSFgqLGwx/tf/rpzBYI8O24g5LN+Z/pQEnrqM3JJHuiALjIJJ680khjjtCXThshQOTTLRcRs7bRknGPT2pstuLmHbBII8Nzgc0E3s7EM1xPJCnlR4lUAAMen1/Wlud3yfPhsgYzyfanJAyuHaRvlYFh2NDiOS4WYBZTE2dpJx9KCXJXLlozx6Wi2l1bWkquxlLsMnPQ8jtWPqZuDe+bPcxTlkG3yiCijJ447/41f/tG0aeSBtMg3Yy+C3Q9utUb9wssa2dpHFlcEKOByck5NPoRs9Ts71b0yoImVo9351eSTKowJyOCuKzdNmndCJhtZRuUZyB7UlrPePPIJIiseSQQ2cAUI1cHZrsa6ZdTJsIHbPaoIGVneR1KuBjnjNIuoBNsbEfP/P8Axq24EiKHOARnaOtDRi247kV47eUzBcA9RjkflQuJIC25uRyexqJbreXATAXIwQaespWJ0MXBPTt9aa0HqlYq2MUaSPJE4bDEkEnGfen5BLeYw2k8YP6VEhS3dVjiILZyc5zSPbyPMSc7G4G3gHH9ag1trdlpAkjN82c9AB0o2sI2jB3OMHkjpVUKloXkCMXY5JpSNkpllY7G+6v9DQLlJLq4WztdzoBk4Ix0qadppkTYqrE2Mq3UVVcPJKBCMr6NU10ucMs2Vbv02kdqFcGtu4596MgXBX65z7VTuHuxclUBCAjdk8n8KZBJe/bcSKgjBJOO+avTuJoplj3E5HsPeh6j+F6ldZWU7uWI4JHpUlkTIWaUBUzhfpTLeGWLaskqmRF+7nqKsxjGX4A3fKo5PuaAlbZFbVGeCM/Zx8x4yOxqGVGZMq4Z+AccdP61JdGWVlVmAQDKuO4zTEKsrqspDJkEkZzSvrYcVZKxlXunreM0wZVaNRgY7+3vVWRMKSWORwR2FasymOLcH3O3OPpTEUSw732gn7yhfy/WhxNVUZj3UJMuJpghXptH3eB0qGQxLBH9mkYkZPJx1x+dWJYWiVopHbzAd6lh19KzLiB12+YFzkHPQkZ/z+VQdEJXVrj5J4mUylj5i4KAcYJHHFTOkYY+S7Djdu9OvH1qnI0aCRnRBvHA7KcDHPbvUN5K8cIiilkAZgZCCCDgcHP41SE1crzHZI3kbwwbapLZLD3FQoR0U7Y1wCAeWHGeKkliZ2cq6nGOeh/OnoVWKR0AYOSqkjlSARQtSm0VVlTLStCOcBVznA96pTiKMkB1zgkDHerCzh4vkxsJBxjuKo6iv+kvhArbsEjoBxkCgS3ON8UoHt7rG0ZG4n046VpeAmUWFpufhhtJqHxHEkkMm8ERkbiSB9BVn4cokukxs7AEMVH4H+dH2TWUktT0q0m2MFbcVOOh/St7zCzZOAjEEZPQVkadEjqqhiWHT2rWbLPsZBlMqdvTiovoccmrk0bESEr90nlW9KkgBYFUXA/LvUMQSNFLuWz2PGD6fSppMqzKOh5X6+1NambkW0IjZQX3FumRyDTSgklICkBerDBqGJw7hXwQMEcc1KuQOX2ZON2OceuKfkZieYxmeIldvPUmi33rL+8fbHnIXGQfrSOoSE4JEhG4HHekJ2xKZSu3GSB1NWhPUsMTksJMhuSFHeookWSEl23IOSxzyc9KdDN9oUpAyhR2HNRsXYNGIyo6uQOBTBaCxsm/ACjHAAXPH0qGSTKmIgknkMP1pZHNuoLnIPQjjFSxEGXhRs/hGcYNIp6O5kzxrLceTcKxVTuIH86uWxSUF325jzgsvBPpT7q1CuswYkA8qD1OPWqku54tkTKpVvc0ypPmQS+cbk5ISEDpnJb0pGQRqsRO5nJPQYx/jT3cxwkoS4UHJzk5+lVMi4lWSTekigEKKBp3JB5lpbE3LbuflC+npTLmeFE2s7PCOpHbPXNPkuDcQZtR88Z2k46/hVe5JV4kCIxPDY9fakTe/wAW4+4uAIl8pMoi/KgPLVNaGOWziaOMws3UHqT9abJaholy3lknBP8AhRFMhi3Bi2z5cnsfSmZu1tCgJLk30juu2BRtU460trNCLnafv53FQcbue9W2O0EySAt2x/Wqy2a7jO/DED5cdvegUpK2p0FnbRTgvFpQKHOXM2M/nWVrkLQ3GwQCAPHygk3kc9c1Ot9sht2kjkHlM8TYHykMP5+1QakXCpbybzIkYQyONrHknOO3B4rR7GMU+a50ey6SaRnjHkMcq6/1p8EytyMbcZznv0NaMis0JRBiMjIHfOKzoEWCMwvIWY5KqeoqbWOiMuZD4ZLZpmjXG/H45qeWdbY7pM7umfWqEMaxTeYchmznB7VbvIIZoUabhXPA9x/Wkm0ElHmV9h7TIVDRnIHA44qJgZ1QAuoGMf4VOypbWsbZBUDGaYXVlVlK4Py4Jx+nehkxZVln8hk+R9wYgnHWrCoDCRGQG5OT0z61E8iI2yTawJxzRIziUopj2lMqzZz17e9SaMnsyyAB2UnFUbx5/taLFHlHPzEDp/8ArqeeQmMiNfnXjcTgn2qRQ7R7s7WOOD2/yaBLR8xRmNysieUCEX7ytwR+H0q0QGi3Sth1I2nHJHrR9pT7WYnO5yTuOe9TfYxEdwcvnkAn3osOUtEmMZZiSzEbFXlR3NQpeO00saRsEAJ3EcUpDI8g3MWYHHOMY69aqy3KQ26JNKFLNj5fr/8AqoLSuT3NxHbyQuSN5BC4PTPrT7je7IYiAxzu+Xgccn61Wv7VLgJmQlgOcDoO9LEzpGjRKTsYYJ6sKXUGlypllFEUKglmkHc8Z7VWhAJccqyjOd3+c1aTe6ESD5jklc1VuJNoxChDMQrEcc07dRRd7ollX5WdhkLgehFVIvM+0bMtHk5znI9qbG9w8DeaABnAz1pCYwP3j7WGCuzufemS1bQTUkTdlcvIBjcRyaxJIA6ORICdx4ZenFbd04faDyDgHPAqlNulWaGOFTgkbwc0mi4TskjnrmUsBEu0FexGcZ6Gm2pe2tbhXAkLMFzjjipLuM295sQllcqrfLnbio78vF5qOTtkOcg84HepN276IrS3KCWRVAK8K3OCRmqojVy8PzBAd+Ub5fx9TRastwWkDOXQZORx2FQHas4ZmYBuCwxgDuaa7mkUloSktskRVUtFjb8vSqc0xZGMZDHPPPUkU+4DgjyZcpISBtHPHSqc2RAduBIB8wxjnpQJqxg+IYfLgwzFgU6Zqf4XFWsjHgbldmBzwPmPFRatAfIcoSzEEDntVf4Yyyh5wVBj81sj3xS+JMc9Yo9f01lKRyRk7uSeuMitBJXcN5hGW546A57msi1YfZGCEhF5IJ6GtFcRnHBP9faoaujnsXRhW+dslm4PUYpwucsYSGAA4YjtVbzGbIyvAyuRgmrUXNuTuJkHVR/npTjoRLQc6tiPy5MrnO3H86lAkeV9x+XOAB1qB4pnTO9Qencf5FSKC0B8xtrDHIPaqM3sTttHySEtL93B6gVBcxPjckZyByPUUskyeZsAZiOrVLgGFgsjYPB45qkLltqNRThVUBHPrwAaeVbZtkZSTkYB5qFG8tS1wzFuv0NNMrMuxG6HB3DnmmCTFMwbIuIgSh6nBqUAzQ43LjJOfX3qB1V44xMApxTsPbwYiG5Se4xmkN7WHf8ALJoo8sVPQ96oLKZHkQBlA4VgMAmpb97zyUjtYgNxJBLY+oqAylLONZCDt++Tx8xPGPahM0UdBkUJiDvI5dmbr0AFQKjSSRyxyvGpzkbcl+1W0A2MUIYnkjPFMtBOzOkvl7iTtCnjFMnmsRPLHBKIAmAx6p0/OnRJHcOgJy8JyO1OMZhYmdw2WGBjgZ7e9PIhjlwCCznoOSfSgmT0G38rqm2AeY3A45GKpyYihRY8IS2UDHgmnJay/bmkaVzGR0z2pt08ahWc8qeCozg/T6UEdhBa+bMrvKc5ztHPPepZIzMyxscEsGHPOKpCaFGW4MhIyAo7fUfypbm5a223EYIlHIbGSCKasKV27Gu3k3VvDAbowyRlj8yEhsnrx/F2rL1Fi11FCLmWbyYghLLgvyecfjitCK6ay0yG8nvLuHzCzCFIt2eeWpdQtoriBrxLuW5m8oSbmXBaPPQfQ9qpolNxWp10Uc29xK2VGCCpouo4ISl3MMlehFR28qoxBc4PTj+dSSMjtjYGQ/ezyKRdmmMJglthKMn0OMd6tyFJIF3ZyecepqBo48GM4Ct2z+lOEqb/ACwGIBwS3Y0gs+hVWZhcNH5Z2qc5bo1WHQ+coQAgfw+lSSeUI9oAaRuuKoRyC2VzuYqen+FK5WkthbiyW5k+cANE3XNN1G3aaMJE7Aqc8cEYqzMSkLiF/mJ4I6j8aZGPLidCrZI5ZvT1zR0KTejILUyDAmdXUNgcbiO/NOxKG2yuWjbpzwOc0kdqLdZNkhJPO4nNIzCGLY+XLHGffNIW8hJUhR/NY5lIzuY9u1PvbhobUm1UPnH41GkKyBY3Axgkk/oKb5wiR0kKoijkZ60x7tDJJnWAvKPMdQMqetNjXzIvMlCMqHdjvmp4TBcqXRw4C8dsCoJC5lJUqEXrjg/SkaRl0sMllinidfMwqn7y8ZHfrUtl5fnLsIK9h1FUpLVWkZZAxgc7jzk//qq5GqHEMQWNlGAScULcqfwmlcDyoPmcE44OOOaoN5QAKlycdOnPP9alH7iBlQ+aQOGPr65qmJJ3IBAUk5x3J9qfUwjHS6EZ4/KDMQGUZZc4z/nNNV0yXRcMw24PTNRK0skrNMgAXnBXijzPmcIxMhGAPQ+v6UFyRNdEowQKvUDIHUVTl3MzFOM9jxTtpXyxLJls5w3FV1mE0juuQVIGDxmgixUuYvNkdEGzPPrn1OPWsm5kBXBVyy/ICw7Z5zWxcs00ZUAIpOQ3Q59Kwr+YvcFIldZFYqVJx7GpZtTYj5tZFmg53gpkjIGe/wClQSKVXnDHOWG3OfpS3MMyJtd87hwB1B9KjleRXWEcMqhRhvQYzSua38yGd444pTgKSM46YrKuFbfsHAdQVbPTHUVYuFBV0DHAHU9zVZplYoEkPyrkDtRe43psZusuWt5PmUDkHA9BWf8ADUEy3m7kCVvu49qn1wIts65IJ+YHrUXwtQSJd5P/AC1Y8n6U1sxuVonrFjucnChSB8x9PwrQhGGMSBSCOc9Qe/0rK05is7EbQCBk+9a6I7OXUfMOSPWoMbjkJaNuVDpwCx6jNWIXO4N5m0kEbSPu1BFJnchTccZUnqKnAHl4OQh6k/yquhE5E8hEYdgXdgOinOajtGjeQtjEjDIHr+FNjlIm2BRtIwGJxj2ppQSyBwMbOOBjIoElZFvny2efAycDb2/+vUTyHz1CrJgnBJOcA05m8wIzoMAYA9DUQiaSRos4Y8nB6e9UhWXUeYWSNjKjGNsjJ6e3NVoUiVWSErnOCCf5GtBmU27RCZiB1yvX8BWZlIs7hsBOBuPNMIstwsYnSJwGzzuPan3cshJWPaV2456e5PvVNJJRMphKGBRyCealVmBbdsY9lH/16BNWdyCSOSWWIeZ+7HU4zgf3RmnzFAhLRqWPHTjP0qGKB5pDKHA2ElQD39cetWIndH8uWPIxkN2pJWCUhj2+ZFl3ZVOAMfnULTQ/bSm870G4rjr2zUs06bxHG7KducZ6+tV1VGme4jjCv689elMm19WRXscN3PhnIZW34B9KkjZg7FkUgAAHFLbwRAyzjdvJzyM5NRMGibzTKXRzgL0wKBSkrWRXWe5bVmDRnyBkZPAqed4pC1vubkcBeMVWED+c0pnZEU5VSevpUkDiUSvCVBYZJ/pTRL2K6oLcrEi7lztQEdP/ANVSXDAMiswUYPy469KbFFKC5kVvmyw+b7v40+3HmR7nKmRe55xTE31Na3mjFnGl81qLUswiEqsxyOuNvOPrULm6i8/zGt/KnRQkka4URDoqjsM9abDfWQs1F3DJKkOdjxnaRnqD681Dd3LXVpayiP7NC0X7hM7vlyevuTmrRm4s62G1eO6Lb1CscsG/Sr8Ep88xOm4nncvTHeqiQyM+52JQd/6VNLcCJogiMVPGV/hNZnS/e0H3VuDKk8bAKMg9s/hUU8XmoGQlexA6ipJvnjcFQynuPWq1m4mDKHOMEEA9G96NxJNK7YtlayKp/ebmz8p9v8asrD+7BdQH9zx9KkheNAyEhZPu7SPxps6SSyllcggZ27uKVhOTbGSkLHuRMngn061Ukvoy5RRtweBzke3vTmcibfvIA+Xbxikg2ySuWj2FgOD1z60dC1FLcazQJOnnnbKQNv8An1prMz3DhFVB6tnHWo7xwF3FcsoIDHjFZ+lamdTtZVcvFsfZkdvxqHLVIuMNOY1ZlldPJSYAjB3Y6/Q028hWa1VZgqsvr3qXaILUJGPMVDgkjqD71BMgumRmbbnGB3x2qiUtblVYfJG1flUc5HapoISIt7Slmb7u7p+NTT7gkghfeSMFcY9qZbRyMo8xQoJyBngU2rD5rodPujiVGwwJznp9RVeO3jt337mGSdxK5H0rReWGRNhVSVYgDHOf881UnPl7PtGUQjkE5z70IUW9iUJujBkUxhhxzwKpz3KrOiQSqZgc+350+G8gunaPzAU5G4U2W0ijcyqefQdvek73LSs/eEdiY2WYgsRkc456moRbpG5wpO7DZJ6Dvz+NV2H+kI5XJHQY6VJqdwZLUQQqEZT19aYpaaDLr5J2EalsjAPXP0qnfxyFlU8SDn5RwBVlZfLjCzjBx1Dd8VVb5nMjSFcjGN3WglLqUJJ4ZGdTITKDx2HSmziBUViAZWHQD9aa8cCXAMG0g8le+c4NQ743kIA4PzZJ6D0pW7mm+xEVcrI0g3MvIP8AjUU8btKpRQVwOg6VcEMjrPywRCDn0HpVWaUQyMTIdzD6Y4pWsHNfYpXEJZWwTheMisa4jEcLbxtQjBAHYdK1Lr7pWJ8seR71j3wChiXaQt69M0ik+5gawWW0kbhTtIyfSp/hWMWUxAJ3SN247f4Vna3JiGYuuRkggduK1PhblNLy3O5mIBHUZql8LLnol/XY9Mt0/eCNiFBX8vc1pQTbvmAIK8E461n28u5uB8h4OKuQoUYiNvlXDEE1mjF+ZY3l2SQbVI55HWrMUjOrAxBhncDnI/Ks9Jcx5bZ5ZOcdMVPbyNHJtEq4OQMNnP41RLSZI6mWRWyo56+gq0iF5mKSg7R6AgioolIkP8KHt1wadJIIpAQw3YznHU+lNITfQezKVZo5MuRyD60+J/3SuQY5CPmbrVK6uY4jlIo2O4A8dPfNPhZ3wVYbTkFQeT+FUTYtiLByWDykcc4qldQJLuWWE492Hy1LEgtIWeNXwDnr1pHijuELMTuPOAcUCjo7kIjkifZHCxTIJJ7CmXduu1njV2fqBnp9KtiVN3lyMMsM7icnpwB9KbEsceFJwWyaC3LqNhhMsWSPLb88etPCqgCjcy9QM54pirHGzAzMd5znt9Kg8+WO5Csu5T93Ixn8qd0RuyOayghmNwCySvgEnnB9BSxNIrS+YwK7QMDoD6/WkkeSS4Kyou0HIUHqamilWXzWEQG3AUk8Zo3HK6WpVSVpISIR5bgdWGBThG0sKxuRIMZ9OaryJJCzSu4YHoMcAemajtbyR7d3iB3YO0/0p2IfdFktGjfZnwwAOWI71AMRl0ijBUknjgCoYZ7gWI89MzH15NTPayMqOjNGFGSinv6U3Ehuz3IYleMFJXO6QdB0B9KW1hhtWi88sUkPzbTyc+nvVq3ZWYqR86cZ9P8A69QwCea4MZAYsQkag5IJoQnI0Lx9EtIiSb0RBcYG3n8PWs7WL2CeG3+ymZYIotgEgAbqT2+taMlhYElb3UFaRSeFiLAH696ytagktsC2RZ1kXdCydGHrg9O9UyYW+Z6BcvIjAqeFHIHeo7yaSJQIUB3c4Hr7UaiZpIx5SbH7/NwKS28wLGssQUE9c1k9GdMbJKRahfdCkjoAOjD/ABFMjEURdV2x5zz6inwxy/aHQMPKIywxkEioLlA0irEflcfNtHI47U07E73Qy3ngeczkh3Xv1qO4uxNM6PuQgbSOf51QkkWxZ/LRix/jHf0z+NWs+fF50jAA8ketDfY25EtRVieLLybmwRgDkCpWkc+Wqj5UzuCjmoVeXzG84IsAA2sOv5U6S6YTmJISG2j957fWlexTjoWZEF2skcfzp6tnJ4rMgs47YMikEtycjkVZu5kaNU3yKzj+Hgf41Glk0VswDZduVPt70mr7BFNRs+oQyvvPmZCpjgHGR9KcrO4JJC/N8rKMDHHSljZre3AwC46nPIpiuI2+chu+3PH4UBbXQkifyV3GQEEkgr6+9Rw3pmkzDuxnaSRyPWmwXdvPu8gISCST6+1KWdI9yLtXd1PHWmSl3LbeUg8yPDBj1I6H3qpdgzW8iPgnpyvamXga4dDEGQAfMvY8VM8qRCNYwHIPUf40hxVmRWdhBax+WFUADGc+vt+NOkg2zhyeOgwe9V2wLhZDJsUjPXPNWmkVZRhN3fPrTCfNuVpWK3OzYuOxH602SIthmbleM45HWpN0TXkazkKFOSoOM++ar3DyCYlNpizknocCgjd2KsbkxHCRhierd+aqTupLHf3wx6Crl7KWUCMRq5ORk5qCG1hfaXOf4Q2ffHT0pMvRIylVbJS4DBGI+UDoPWopyxQvjaoAP1q7eBoRJ5ipgAYA56Dg1TaYPGGy251A5HFFhp9R9vMzW5O8gfxA8kiqmovCj7I8F3OOFHA9SaZkpEzMccZ449vxqqoSWLzp2CsCQNvtSsJQs7gzIiFXYAqM4Az+NYl6itAxJAQ8qG471qTMhJYMUC9WIzmsS6uVdJHYbucrnjJpFo5PX5c29xjIwOOMV0nw3TZpMBRjuxkZ6cmuO8Sy7kmGSrAlR7V3HgaP/iT2qo2XKDGR0py0iXPex6DbkIiHqwPP+yamQhlEchIcMSCvQioLdgVUSHG4YI9T61PbRhXZZOo+5k4zWUXqY36EofOwMoyTjn0qdW8vP3UQ/wCPaqh3qADmTJ4ORxTlbLrHIMKT0zyfatVqKXkXDcSiIoGBJPy7TzTo45JGXOSyjHqfrUe1UG0AuW5wo+YCpMmQgrtU4xtB5NDTWxnzW0GgOoIGNi/e7nNLYxLcMskJfI+8A3GO1RyMRL1Yjq2On1q/p/lgyPlVZc4DDgH2x3p6g3ZEd2ryY8pxgHILd8e1VLllVPM53emcZ+tWmeGdZBAzbyMHPOKqPBGzhCRKx5JPGMe1McXYWGWOdRIvzOD+GasXj7YEdQCM9h17GqsQiiMiAbUTj7uAc0i3RBEDE8fd78e9A3qySUhVB8siRV3AY/pVaG6mlh3qpWRicBhyMVYLyLJ95TGuTk9fx9BUd8plZPLkUR5B246/jQTzd0OETC6V3clwOB65HWpJy8kDoSEwAM7c896rPK0k6k5BPR/T2pLSS4ivQ0oXyiuMDufeqXmRK9riwDKGMHcqnBJ/XNReeBNJhNkPABHGauMIYg8qfMT0VRzmqtzHIylmVPOA3FDkD/PShkJ9xYkkLGRivlZ4Hf60oSXzlYsDEQcju3vU2n4+wMJnO0fe9zUNvcxMGCIFRTgEjGTV3Mr6sZJIwcADIGMjpmnWAngmVnbEsZ3HaM4OeB71W2XH27fIyiIDgA9D71fV8yo0ThAhznPftQNlqV4rtlml0gswJbKl1G7ucVm63qQjeFDCY2ICxoAQFUfz71e1C416eWB7eK9RSoEhViA57EA1nai8seTqRkeWJcfvCcjv/Whq5MdNWdysku52ZSChzuxnNStJco+ZUUxE/fHOBTGLGQJJExU/KXA6+uamvsSWpt4ZSCOASelZvzOq62QyO42MQZEBIwpA4P196gubfNyksLkbeCRxuquIAsamYKVJJZsHnFDzSrjbt8phyc8/SpLS7Eqpvbc4CvnuKbHbyQxN5oUgkkEDrzTU88SYVFO7lctUr3Rt4T9oYrztxnhTVWVgs1sQQmOVVdA+RnjuPpToJA5O3O1DzkY596Q3SrJi3AYNzu/u1Vvrsl2fB+Y5bbnr7UlYuzZo210kkrgR8D+MjI+tVriAT3e6ORhjJ8sHC+/FRW8xmt3aHC7RtJ9exqKzu1BOVIVWxnHQ0w1WwrqTI5U5kUcAn5TUUhiEO6U7AepznGff0qaZjJ80Ox/7zHPH9arrJDLI0L/MRgnPTA7CpLWpbtEgjiaW3YAk5BP071Ibn7VCTIEVV5ZQeOnJqOd9kGy1cANnkDpVGZUKeU7AMV2sQfWhabCST1ZcY70JtnypwQR2qmrzMziTaQMjJqzBaiCzRUmZn4ALcYqNriNCVbDHr8g4pjUuiK5f7PE7oULAYCuMj8aZp17dXTsZV2A5/CkZ2lLlov3eeoHH4Cq0cgt7gmIZzkkt/KkXurdS1NAzXDzs28BcBcdDUMb3jvIAw2nOFA6Crbz7IWIAMvoefxqjbSTSvJJMu3jGBTMW29xv2ZluTODl2GGUenY1DLGsN0rAs24E4Bz39e1XbuaOG1keJWGeAccVmtO4i3EhpH5wBgAUCbclclnc3YbzcBW5xjNVmUGJ2iH3clU7YqxBLtlAcqoZcZHGRVGeb7PIY1YqW+Xgg8GghN9DOldiTkYcDIUcnNVdyyJtnJGeVQ/xHvU93vacOJNm3ggjr6VWc+akhlCqVPyg/wA6DdO6ILnesDA5ZfvY7/8A6q5+8I2I0jlVI3gVr3U5JbZlVUYyfSsDU38yMjeNmM5HepSKizjPEBLYHHJ6Z969P8KxItnCCOigZI4FeV6x+8uo1G0lpAARXrXhx2+yIQMxkDPrRU+BFTfvHTQs0W1ZBuBwBnkYrSiIdVLA9cpx0JrNiKBTgbuBlfSriswiO7cP7nOcCsop7mTHSk8hyFy3X3pysgYE8Y7/ANaiyzxeY/LAcoRyaVpVMS4AZf73THtWq2JsK9zsuBuZpCT1HU1ojzJUkC5B6DiswZZiScbeeK0IbiXaDEu4YwxboPpTREnZaD4g0YO8AtjJUA9P8aW1nWRHWFcDOWXB/Wq1xcT+YGQNt6PzUiSF428tQrAcEHGaZD2JVm3twBE4+83Qn8KbHCkrByfnb7x3fnVO8i8xll81hIq8q3G6p7eWJX+fbvYgKOgNItrTQsukTODxtxjG7rVZxFLcGMLtcEFmHIOOlBYRTu28KWHIzmojK3mgLgAnlvWmLYLtRNL5EkhYH5iuece9SwqIQIVxsJ++TnPpj3ptxLHBuYxkuwGPXHTmqd2bgtEQDwcmM8HPtQJNssW6mKRlkfeWPIP9fenRIttMfOlU5IwR0HHQVRguopL8CQsJgOc/w/8A16lv7WO4mVhIQUbcADx7UxPsy5GQJRM8p29NoPSqt5fILkW5JYs2Rjkj60yNolmwSd23I3c5PrVe4P33CsCM845PvTJSVyeSSeJYkt0JTJ3Fz27k1OXjKbnUhEUttHTPqf8ACq1heefCvmDa3QIQcgevNPuZ0jiYRHLysF59atIzabdrEdlcySJNOd5LcDPA4p2mXAsr6OSdzLlwwRv4sc4qK8kjt41LPxkA7Cck0tqbc3tu10oIEi5GPurmjqNrS50Pl2s981zLqihHO5UkDBsdh6fl6Vna1dW9zfIIpzN5EWzzGGNxyTk+3NT3+oyNqxs9UEL2TH93LHg+Xn7rDHb2NVPFNvHaixCSIWEAXfGcg/M3NMyStud9qN60QWQfvFYc47VFceYLNpUA34ByTTpDvQujqyg5AHp3qKQYuF8tiybclQefpis3rqdUUlYzUle5XNyXjbnau7gH1qxdDyogJX2lR0HBOKrzTg3RikjbexwOODS7htBGX9UPJz6VB08uzI7W7C75pY3ZVyFOPvD3FWJzFqNsPNGA3YDj8aT5ZIzjEeRuXaMkH/PrSaQk0CmO6IIbnpnP507ikr6oZLHEtuiRFlUfKT0BP19KjMbLuFw24FDgkbs//Xqe7t2FyWjkdYSclOCtVZ7eZS5MuF6qc5C+hoEtUXbGXMMq+Uqpt2nP+etU7hreJ3jBBn6KxPSq2jR3QZ47qQMWySQvB/yKW4EMd6yvDhgeWPpTbK5Umyus86ozm4MjBQdp/ix9Ks27k43ldx6EDp7ZrPliJuBKJcRnhYwe31p8bCeRWdSoTkKBwfrUmrs9TQup2gjVI4ixdsDA6GlnaTycxqm/Ib5vT0FSQTYLx7lZWHHoPxqKMzszPK4JDYBx1HpTM7j5Lkxx5Kbs8ED+Gs5DKZw0S4JJ6elWppGzukK5GM/n3pyRuMCQx7DkjYOtAloUJTP9pCL/AKk5JOenPSmyzNDIqu2MjKjjkY5Bps90ltMhdiCc4z0GDVS+gSa7S5n5AXg+3WpemppFX3L0LKiAklnH45FWopC77XHBHHPP/wBas4XqzW7NAu7aPlCjr9ap/aJztbcwAIbgcE9aozcG/ItXl1Kb2VGjHkqM7s5GapSznzEMX+rznA4wfeodSlaVlLSAAHPyjpmsybUFU+UAxkyF+oovYtQvsbD3QlZEidWIOTnofaobzyjKr4/eYxu9qhsVRVYZAGMnJq1ugcooDBm6ntQYSfK9DMl/fRmRskr0A4yPrVOV1VN8g25GVB6Gr104iu2wRswVI96xJZ2cSbwDgHt0FA4yuRXjo8bjdgMPyrAvdqRoVJG7P5Vqs4C7k+UYOB1zWTqB+XCk+ZjkHooqWzaOhx8436xbqg/5ar+letaGGhgXbwV6rnqK8ntf+Q5a7SCocnI5yK9Z0qTEGFJIIGARwaK2yE/if9dDoYMYkcbsd+etWin7kthmbqpHpVC2KMgeJck/eHpV2B2+ZW4U/wASj9KmOxLJbUuy7mbapyGHUimgFZWC4MY4K+tOSXY7fKd4ycVJuMis4Vt/fPBqr2M23ckSE8AHpx15xUuQIy0fAPYfzxSWbqYsx9WyWJ7VDuXcQjjce4PNNGbi7kc0c/mLsdWHViO4pIyd2VdiV42kZGKlWIOSDyD044pUieKZkVwQvB7/AJUx30JpJXVQ6xFlAyV4OfxqNZtpaR0BbGBgZxRN58YxE42f3O/T1qhEJjK/mj5V6Y70DVmmzQSSdCTCsbA5LBlyQD3FTSXCRwjbtYtyOcbarNE5V1jlVjjkn+E/T1qtB5sSESOzc8/Lw1AuVMtXqtJEqwMqPjG084zUbfuY41uZzI54LY5Y96rySR3DqEkZdhG4DgMfSnNHFdXGRw6H7o5xQO1lZj3SElmgUF885GM/41UiiaS8efzmKr8oQdM0+eeC2kG58IPlwvGSamGFIVkbaRwMYFO5OqIpIUMgeJGkk6HDYz7e1SM8/wBnZpk/fBfupzj2FMilCXBjSMD5fmIFDNKL1j5gVB0VBjP496a8yXroLaMZI83EY8zso6/TNU7nTJPtCXBlcEdIwfl56g+9WL25e3eILG5ZiQCvJPfJ9BVa8S8u7u3khlMcEbhnXoTVKwoqSd72uXGMJUpInzpwCfWqUcltLqAjJYsmPlB71auXL7Y4kDMxO9j0Aqvptnb6fq0F064CTCR2Jzxn0oadyUlZ3Ny50O2ZoVu7iKKbPEYDcNj+IjgVk6laSQzGNiBtGdoO4H0IPpW7dyPDd20j3Ui7QEVViZy/JO5CBg7uOtZ+ryQQrChZUaNTuUEZVixIXPtnFUrszV0drbxiCyUxk/MQDk09Y1hnfZnAfbgnPGOlFFR0Ot7hLEkTyOigFVBH1zVa9QLMrqMNxyKKKkqnuUQP9ODZIJBJ56mrO5mufLLHbjP0ooqTae5FrE0kNqsisSQQMHkEZ70yJt9ruYDOaKKCehooohkdU4XaODz71WubeOdiZFywAAIooqjOO5lX0QaLdkrjnC8A1YZVjs4ZVUbycc/SiilHY6HsiDy1hMk6D94QDknPeqwBeZXLOCxGQDwfwoopBIiu8t5jZIOD0+orPsJ5JLmVGdtoGQM+lFFMqn8LNZ7WK4aPzVzn5s+9UNWO2dY1wF/+tRRQRB+8hsTbFCqAABnp70xDufyz90c/rRRS6g9zL1ZfKClM8OOprHnYi9QA9W/Liiil1No7GuhwQQADgdqbeyNFbtKhwzDPsPpRRVHK9zMctJc4dmOXx1qhejMtwnIAPaiigFuVX5gYf3cgHvXO30rmB8nqdpoopM2gc9pfGv26joCcflXqmm/LbR98nHNFFKtsiFvL1OlsvlX5eOMVPG5kHzHkHiiioexnLcfI26VRwPpVicbTAwzkjJooqog9xzKPNKDIGM8dae0KiIsM5Of5UUVS3E+hGsjC2BBIx6VbX5bVnAG4nr+FFFUYzIJ13W6sWbOeuahLt5ijJ5I/UUUVKBDzEkLEIMbuT70MoBJ54IGD06UUUxslWNA67VCkqCSO/NMMCR3hK5BfJbnriiigmDevoUr63jkKSsuW38e1PnGyRQpOD70UUDexLqbFFdlxlRmmlydIWTjcBu6d84oorUziUtOkefT4pJWJdhkn8aUyN9qiiGArICcd8GiioKe7KL3MqawYlb92oJx6/Wp2j828bc7bQu7aOATRRVIJdPQNQ8yOPZFcXEcasB5aSsqnPqB1qK+O1FYAZDYGaKKa3ZnLZH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous patches with minimal scale that are several centimeters in diameter are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large-plaque parapsoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread dark brown patches in a patient with large plaque parapsoriasis.&nbsp;",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33754=[""].join("\n");
var outline_f32_61_33754=null;
var title_f32_61_33755="Lab studies musculoskeletal CP";
var content_f32_61_33755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F60641&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F60641&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potentially useful laboratory studies in musculoskeletal chest pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        General",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete blood count",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver enzymes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal function tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinalysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest radiography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrocardiogram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other cardiac studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Rheumatologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythrocyte sedimentation rate (ESR)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid factor (for true inflammatory joint disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sacroiliac radiographs with or without HLA-B27",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Synovial fluid analysis and culture (for true inflammatory joint disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Synovial with or without bone biopsy and culture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Chest wall",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rib radiographs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sternoclavicular, manubriosternal joint radiographs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scintigraphy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Computerized tomography",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33755=[""].join("\n");
var outline_f32_61_33755=null;
var title_f32_61_33756="Causes palpitations child";
var content_f32_61_33756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of palpitations in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Life threatening cardiac conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         Arrhythmia (eg, Wolff-Parkinson-White syndrome, prolonged QT syndrome, cardiac structural abnormalities [congenital heart disease, intracardiac tumors])",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Hypertrophic cardiomyopathy (HCM)",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Myocarditis",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Sick sinus syndrome",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Pacemaker malfunction",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Life threatening non-cardiac conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Hypoglycemia",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Toxic exposure",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Pheochromocytoma",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Common conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Premature atrial contractions",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Premature ventricular contractions",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Fever",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Anemia",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Exercise",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Emotional arousal",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Anxiety, panic attack",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Hyperventilation syndrome",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Drug-induced (caffeine, herbal medications, dietary supplements, albuterol, isotretinoin)",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Postural orthostatic tachycardia syndrome (POTS)",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute rheumatic fever with valvular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mitral valve prolapse",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <span style=\"color:#ff0000\">",
"     Red:",
"    </span>",
"    life-threatening conditions.",
"    <br>",
"     <span style=\"color:#008000\">",
"      Green:",
"     </span>",
"     common conditions.",
"     <br>",
"      Black: other conditions.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33756=[""].join("\n");
var outline_f32_61_33756=null;
var title_f32_61_33757="Defibrillation waveforms";
var content_f32_61_33757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Defibrillation waveforms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 495px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission by Mittal, S, Ayati, S, Stein, KM, et al, Circulation 2000; 101:1282.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33757=[""].join("\n");
var outline_f32_61_33757=null;
var title_f32_61_33758="Duration symptoms TIA";
var content_f32_61_33758=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F82729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F82729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Temporal behavior of symptoms in patients with transient ischemic attack (TIA)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 451px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The probability density function curve of symptom duration for transient symptoms associated with infarction (TSI) indicates the absence of continuity within the first 24 hours. The probability density function is the probability that the variable takes a value in a given interval and is equal to 1 over its entire range of values. The area under curve is almost equal to 1 at around 200 minutes. Also note that the curves for TIA with or without infarction overlap (p = 0.82). The distribution of duration of symptoms as seen here suggests that symptom duration is not a reliable feature to be used for predicting whether a transient neurological spell is associated with infarction.",
"    <div class=\"footnotes\">",
"     DWI: diffusion-weighted magnetic resonance imaging.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ay, H, Koroshetz, WJ, Benner, T, et al. Transient ischemic attack with infarction: a unique syndrome. Ann Neurol 2005; 57:679. Copyright &copy; 2005 John Wiley &amp; Sons.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33758=[""].join("\n");
var outline_f32_61_33758=null;
var title_f32_61_33759="Tibial spine fracture";
var content_f32_61_33759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62929&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62929&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intraarticular fracture of the tibial spine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior view of the knee demonstrates an intraarticular fracture of the tibial spine (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_61_33759=[""].join("\n");
var outline_f32_61_33759=null;
